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ABSTRACT
EXPLORING SERVICE PROVIDER PERSPECTIVES ON FACILITATORS AND
BARRIERS TO NEEDLE EXCHANGE PROGRAM PARTICIPATION BY FEMALES
WHO INJECT DRUGS
Tammi Alvey Thomas
September 9, 2021
As the opioid epidemic lingers on across the country, many areas have set up
harm reduction strategies such as needle exchange programs (NEPs) to combat the longterm consequences of injection drug use (IDU). Males and females face a plethora of
health issues associated with injection drug use such as human immunodeficiency virus
(HIV) and hepatitis C. While males comprise the largest portion of the injection drug use
population, most research is gender neutral, which makes it difficult to discern issues
specifically related to females inhibiting our ability to design interventions and
procedures targeted to address their needs. Females require varying reproductive health
needs, prenatal healthcare services and childcare. The research explores service provider
perspectives on facilitators and barriers to needle exchange program participation by
females who inject drugs. The study is descriptive and exploratory in nature using survey
methodology. Data was collected from mailed surveys to needle exchange program staff
from Kentucky and the seven bordering states (Illinois, Indiana, Missouri, Ohio,
Tennessee, Virginia and West Virginia). Exchange theory, the health belief model and
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feminist theory and intersectionality were used as the theoretical frameworks to explain
human behavior and what motivates people who inject drugs to utilize needle exchange
programs. Determining the facilitators and barriers females face in accessing needle
exchange programs will allow for revisions in service delivery and policy changes to
promote increased utilization of services by females who inject drugs.
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CHAPTER I
INTRODUCTION TO THE SOCIAL PROBLEM
AND CONCEPTUAL FRAMEWORK

Background on Drugs and Drug Use
Drug use is not a new phenomenon and dates back to as early as 3000 B.C. with
the use of opium by the Sumerians (Crocq, 2007). Throughout history, religious
ceremonies and cultural activities often included psychoactive substances (Westermeyer,
1988). While many drugs were initially created for medical use, personal use often
followed (Musto, 1998; Jonnes, 1995; Courtwright, 1983). By the mid-1800’s, the
hypodermic needle was invented which allowed people to receive medication quickly
(Hickman, 2004; Musto, 1991; Courtwright, 1983). Opium use increased with the
expansion of trade routes and the Opium Wars (Pletcher, 2018). The use of opiate-based
medications grew and legal restrictions on drugs were not in place until the early 1900’s
(Jonnes, 1995). With shifts in cultural and political views, invention of the hypodermic
needle, growth of industry and few legal restrictions on medication until the 20th century
there became increasing drug use throughout America (Crocq, 2007; Hickman, 2004;
Musto, 1998; Jonnes, 1995; Musto, 1991; Westermeyer, 1988). As drug use increased,
so did addiction and there became a need to understand how it affects someone
physiologically and psychologically.
Drug use changes a person’s brain chemistry and inhibits self-control over the
urge to use drugs (NIDA, 2018). Persons who use drugs may become addicted which is a
complicated chronic disease (NIDA, 2018). In 2017, it was estimated that almost 20
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million Americans over the age of 12 have an illicit drug use disorder (SAMHSA, 2018).
While there is no cure for addiction, it is treatable through various interventions.
Addiction treatment includes behavioral therapy and/or medication. Interventions play a
key role in decreasing and managing the harmful effects of drug use on the individual and
the community.
Most drug users begin taking illicit drugs by smoking, snorting or taking them
orally. Injection drug use is not generally how initial use begins. Non-injection routes
become more costly because the drug use frequency has to increase the longer a person is
taking the drug (Young & Havens, 2011; Strang, et al., 1992). As the dependence
increases, there is a need for a cheaper, quicker and stronger high, which can lead to
injection drug use (Strike, 2014). Drugs typically used through injection include cocaine,
heroin, methamphetamines and opioids (NIDA, 2016). Research has shown some
prescription drugs such as OxyContin have been associated with transitioning to injection
drug use (Young & Havens, 2011). Injection sites may be under the skin, in a vein or
into a muscle (NIDA, 2014). Of particular interest in the research is injection drug use
(IDU) which is defined as, “taking drugs directly into blood vessels using a hypodermic
needle and syringe” (NIDA, 2014).

Significance of the Problem
It is estimated 13 million people worldwide injected drugs in 2017 (WHO, 2017).
While the global population is not the focus of the research, it is important to understand
the severity of the issue being discussed within a worldwide context.
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The exact magnitude of injection drugs use in the United States is difficult to
determine, but several studies have attempted to develop estimates using meta-analysis
(Cooper et al., 2008). A 2011 analysis of four surveys, which measured injection use
within the last year and throughout their lifetime, estimated nationally 6.6 million people
over the age of 13 injected drugs during their lifetime (Lansky et al., 2014). The National
Survey on Drug Use and Health (NSDUH) data from 2011 through 2013 estimated 4.2
million people over the age of 12 have injected drugs in their lifetime (Kooreman &
Greene, 2016). Based on the prevalence estimations, an accurate depiction of the data
presented would be to state between 2011 and 2013 it is estimated that 4 – 6 million
people (12 years and older) in the United States have injected drugs at least once in their
lifetime (Kooreman & Greene, 2016; Lansky et al., 2014).
In reviewing the population estimates of persons who inject drugs, the
underreporting of the data must be considered. The NSDUH survey did not collect
information concerning route of drug use prior to 2015. In 2015, a question was added
regarding the use of prescription stimulants with a needle (SAMHSA, 2014). Estimates
of needle use cannot be assumed based on drug type reported in the survey. Other flaws
in data estimation methods include the use of self-report data, which may be
underreported due to the illegal nature of drug use (Sweeting, Angelis, Ades & Hickman,
2009; Aceijas, Stimson, Hickman & Rhodes, 2004; Normand, Vlahov & Moses, 1995).
Additionally, the “hidden” population those that inject drugs such as persons who are
homeless, persons in treatment or incarcerated are not included, therefore an adequate
estimation of IDU is difficult to ascertain (Sweeting, Angelis, Ades & Hickman, 2009;
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Aceijas, Stimson, Hickman & Rhodes, 2004; Normand, Vlahov & Moses, 1995). Given
the stated limitations, data presented should be viewed with caution.
Gender Differences of Injection Drug Use
Globally, nearly four million females inject drugs (Degenhardt, et al., 2017).
Females who use drugs have been shown to progress quicker to drug dependence than
males (Tuchman, 2015; Hecksher & Hesse, 2009; Piazza et al., 1989). Greenfield, et al.,
(2010) provided several explanations for faster dependence, which included varying
hormone levels, which contributes to receptiveness, stress, and co-occurring disorders.
Hecksher and Hesse (2009) also suggest females have a “biological vulnerability” which
is similar to what Greenfield implied (p. 52). Much of the literature on the prevalence,
needs, risks and outcomes of injection drug use does not differentiate between males and
females and therefore reflects a potential underrepresentation of females (Tuchman,
2015). Females who inject drugs tend to have a variety of risk factors that begin at a
young age. Indicators are often family members’ use of drugs, juvenile delinquency,
early sexual experiences, sexual abuse and living in poverty (Tuchman, 2015; Roberts,
Mathers & Degenhardt, 2010). As a female ages, there may be engagement in the selling
of sex, incarceration, trauma, social networks that include persons who inject drugs and
mental illness (Tuchman, 2015; Roberts, Mathers & Degenhardt, 2010).
The influence of social networks on drug using behavior has been consistently
acknowledged throughout the literature for both males and females. Females who
transition from non-injection drug use to injection drug use are heavily swayed by their
social network and their initial injection is often done by another female (Tuchman, 2015;
Bryant & Treload, 2007). Research concerning who is involved in the initial injection is
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mixed. Some research has shown a sexual partner may also be involved (Sheard &
Tompkins, 2008; Gollub, et al., 1998; Powis, et al., 1996). Once a female begins to inject,
they are typically part of a social group of persons who inject drugs (Epele, 2002; Roy, et
al., 2002; MacRae & Aalto, 2000; Doherty, et al., 2000). A female’s principal partner
will become part of her social group and often have influence over her injection practices
(Sheard & Tompkins, 2008; Bryant & Treload, 2007; Frajzyngier, et al., 2007; Epele,
2002; Roy, et al., 2002; MacRae & Aalto, 2000; Doherty, et al., 2000). Sharing
equipment with her partner becomes acceptable behavior because it is viewed as safe
(De, et al., 2007; Sherman, Latkin & Gielen, 2001). Research has shown as females
inject they are more likely to share injection equipment and reuse needles, which puts
them at greater risk for blood-borne viruses (Evans, et al., 2003; Montgomery et al.,
2002; Sherman, Latkin & Gielen, 2001).
Not only do females tend to share injection equipment but they are also more
prone to other injection risk behaviors such as involvement with sex work (Kimber, et al.,
2003; Evans, et al., 2003 & Montgomery et al., 2002). Sex may be in exchange for a
place to live, drugs or a safer environment (Pinkham & Malinowsk-Sempruch, 2008).
Females who inject drugs often have multiple sexual partners, which includes a principal
partner, a casual companion and customers, which increases their risk of blood-borne
viruses and sexually transmitted diseases (Breen, et al., 2005; Reihman, et al., 2003 &
Roberts, et al., 2003). Females engaged in sex trading often experience violence from
their sexual partners and are unable to practice safe sex, which contributes to their
heightened risk for disease (Pinkham & Malinowsk-Sempruch, 2008). When a female is
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involved in multiple social networks she becomes a link between networks (De, et al.,
2007).
Disease Transmission Associated with Injection Drug Use
The injection drug use method has the greatest number of negative health
consequences associated with its use compared to other methods of drug use (Kooreman
& Greene, 2016). The risk of disease transmission often begins during the initial injection
of a person who has not injected drugs; many initiators will share their drug injection
equipment and/or drugs (Rotondi, et al., 2014; Bryant & Treloar, 2008; Day, et al., 2005).
For the novice person who injects drugs, this is believed to contribute to the
normalization of the behavior and therefore promotes the cycle of sharing throughout
their drug use career (Rotondi, et al., 2014; Day, et al., 2005).
De, et al., (2007) found the relationships between individuals who inject drugs
and their social networks contribute to disease transmission. Research has shown social
networks and equipment sharing behavior is impacted by structure, composition and
behavior (De, et al., 2007; Vaux, 1988). The larger the social network, the more social
pressure that exists which contributes to an increase in unplanned injections and shared
equipment (De, et al., 2007). Smaller social networks reflect less equipment sharing
possibly due to less peer pressure and the creation of a more protective environment (De,
et al., 2007).
Individuals who inject drugs suffer from a change in brain chemistry and a
plethora of health issues. Sharing drug use equipment has been found to contribute to
skin abscesses and infections (Irish, et al., 2007; Gordon & Lowy, 2005; Bassetti &
Battegay, 2004), transmission of infective endocarditis (Rosenthal, et al., 2016; Cooper,
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et al., 2007; Frontera & Gordon, 2000), hepatitis (CDC, 2020; Young & Havens, 2011)
and human immunodeficiency virus (HIV) (CDC, 2020, February; El-Bassel &
Strathdee, 2015; Leukefeld, 2002; Sherman, Latkin & Gielen, 2001; Abdala, Reyes,
Carney & Heimer, 2000).
Females typically have a harder time accessing their veins and therefore are at
greater risk for skin infections (Conrad, 2000, as cited in Bassetti & Battegay, 2004).
They are also at an increased risk of contracting Hepatitis C (HCV) compared to males
who inject drugs (Esmaeili, et al., 2018). Over half (60%) of females that inject drugs
have been exposed to HCV (Iversen, et al., 1999).

Other Health Related Consequences of Injection Drug Use
Females of childbearing age who are “sexually active are referred to as bridges
for disease into the general population” (Roberts & Mathers, 2009, p. 7). Conventional
gender norms view females as caregivers and mothers, which contributes to shame and
can influence healthcare seeking behavior and have long-term consequences for both
mother and child (Roberts & Mathers, 2009). Injection drug use while pregnant puts the
health of the child in danger. The child may experience Neonatal Abstinence Syndrome
(NAS), which is contracted from maternal opioid use (McQueen & Murphy-Oikonen,
2016; Kocherlakota, 2014; Finnegan, Connaughton, Kron & Emich, 1975). Symptoms
and severity vary following birth but may include maternal bonding, nervous system
issues such as tremors and/or seizures, gastrointestinal problems which may contribute to
weight loss and irritability (McQueen & Murphy-Oikonen, 2016; Kocherlakota, 2014).

7

Injection drug use puts users at an increased risk of a fatal or non-fatal overdose
(O’Driscoll, et al., 2001). Following a non-fatal overdose an IDU may face serious
health complications, which may include brain injury due to the loss of oxygen, kidney
failure or pneumonia (Darke & Hall, 2003).
Intervention Approaches
Intervention is defined as “the action of becoming intentionally involved in a
difficult situation, in order to improve it or prevent it from getting worse (Cambridge
Dictionary, 2020). There are numerous types of interventions used to combat drug use.
While the intent is not to explain every intervention option, several are highlighted
below. Interventions have been categorized based on the approach.
Preventive Approach
Drug use can cause serious consequences and possible addiction. Drug use
prevention intends to modify drug use behavior and has been noted as the best strategy
for decreasing use (NIDA, 2018; Tobler & Stratton, 1997). Education efforts may take
place within the community, schools and families and are often undertaken through a
variety of electronic and print media as well as in-person. One of the most widely known
in-person drug education programs is the Drug Abuse Resistance Education program
(D.A.R.E.) which began in 1983.
Educational programs for injection drug users. Educational programs are
designed to inform persons who inject drugs about the harms associated with injection
drug use and include topics such as transmission of infectious diseases, injection risk
behaviors and medical issues related to injection. Programs may be conducted using peer
educators who are recovering drug users that provide mentorship to current users. Peer
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educators are a resource and work with the users to motivate behavior change, decrease
risk behaviors and prevent the further spread of disease (Garfein et al., 2007).
Educational programs for health care providers. Systematic efforts have been
developed to train healthcare professionals about the complexities of care related to a
person who injects drugs, treatment of co-occurring issues such as mental health and their
role in providing education to the user. Professionals have the ability to educate person
who inject drugs on a variety of topics such as wound care, overdosing, drug treatment
programs and combatting the spread of infectious diseases. Education not only assists in
decreasing the harmful effects of injection drug use but also can contribute to cost saving
measures for the healthcare and criminal justice systems.
Curative Approach
The curative approach is used in healthcare to eradicate an illness (Fox, 1997).
This model views addiction as a disease of the brain, which can contribute to compulsive
and obstinate behavior as well as unfavorable changes in mental health (NIDA, 2014).
The disease must be treated and abstinence must be sought.
Drug treatment. Drug treatment is designed to assist those addicted in halting
drug use. Treatment is offered in a variety of formats, which range from residential to
outpatient and can include medication-assisted therapy (opioid substitution therapies
including methadone and buprenorphine maintenance therapy) and/or behavioral therapy
(NIDA, 2018).
Coordinated treatment and care programs. Coordinated treatment programs
are specialized programs between a system and a social service agency which, places
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users into treatment. A common example is drug court and the goal to reduce recidivism
of criminal activity and relapse of drug use (U.S. Department of Justice, 2020).
Coordinated care efforts are “a person-centered approach across health and social
systems (i.e., cross-sectoral, collaborative and interdisciplinary)” (McMaster University,
2019, p. 7). Care efforts include setting up supports for persons when transitioning out of
incarceration, treatment of life-threatening infections across medical disciplines in a
synchronized and systematic manner, working with co-occurring mental health issues and
addressing concomitant barriers (McMaster University, 2019).
Punitive Approach
The punitive/criminalized model views illicit drug use as against the law with
legal consequences such as a fine or imprisonment. In the United States, illicit drug use
has been criminalized since 1971 when the war on drugs was declared (Jakubiec, Kilcer
& Sager, 2009). The goal of the war on drugs was to eradicate the supply and demand of
the illegal drug market through the enforcement of anti-drug laws. The 1980’s focused
on stricter drug sentencing laws especially for crack which flooded prisons with the
African American population (Courtwright, 2004; Glasser, 1999; Langan, 1995). The
criminal justice system was inundated. Those incarcerated for nonviolent drug offenses
between 1980 and 1992 increased almost 170 percent from 50,000 to over 400,000
(Gilliard, 1993). The war on drugs encouraged society to view drug use as a criminal act
that had to be punished through the use of mass incarceration.
Alleviative Approach
The alleviative approach is used to provide assistance to those dealing with a
social problem and decrease the consequences of the issue. The 2000’s saw new efforts
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to combat drug use through harm reduction programs which use a combination of public
health and public safety measures (Executive office of the President, 2016). An example
is NEPs which are designed to reduce the harms associated with injection drug use.
Needle exchange programs. Needle exchange programs cannot be discussed
without providing some background on harm reduction. “Harm reduction refers to the
policies, programs and practices that aim primarily to reduce the adverse health, social
and economic consequences of the use of legal and illegal drugs without necessarily
reducing drug consumption” (HRI, 2018). Harm reduction began in the Netherlands in
the early 1970’s and is used as an alternative to the disease or criminalized model of
prevention and it acknowledges people will continue to use drugs (Marlatt, 1996).
Harm reduction principles are not new and do not solely focus on drug use. Harm
reduction is used throughout many facets of our lives, which includes use of seat belts,
sunscreen, designated drivers and bicycle helmets. For the purposes of this study, harm
reduction will be discussed in reference to reducing the harmful effects related to
injection drug use such as hepatitis human immunodeficiency virus. The field of public
health has increased the use of harm reduction programs (e.g. condoms, naloxone, clean
syringes, etc.) substantially over the last two decades as the awareness of health problems
of groups that have been marginalized have increased (Roe, 2005). These types of
programs can empower disproportionately affect populations to seek assistance, which
not only benefits the individual user but their families and the community (HRI, 2018;
Marlatt, 1996).
Harm reduction is not without controversy especially in the area of drug use.
Many view this philosophy as the promotion of an undesirable and illegal behavior
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(Kleinig, 2008). Others see it as a contradiction to the U.S. war on drugs, which
criminalizes drug use (Irwin & Fry, 2010; Tammi & Hurme, 2006; Levin, 2002). One of
the core principles of harm reduction is the individual makes their own choice regarding
their behavior, which places value on the user (HRI, 2020). From the harm reduction
viewpoint, the drug problem is a multifaceted social issue, viewed through a public health
lens rather than a criminal justice or medical model (Irwin & Fry, 2010; Tammi &
Hurme, 2006; Levin, 2002).
While treatment seeks abstinence as the ultimate goal, harm reduction programs
support safe options during drug use such as syringe exchange, supervised injection sites
or medically assisted drug treatment, which, work collaboratively with social services
and law enforcement to remove punitive concerns.
Persons who inject drugs are a hard to reach population which face severe health
issues and social stigma. The study focused on needle exchange programs (NEPs) which
play a vital role in decreasing stigma, the spread of infectious diseases and are often a
referral source for persons who inject drugs to enter drug treatment. Research has shown
NEPs are an effective public health approach to reducing the consequences associated
with injection drug use (AMFAR, 2013). In some areas of the United States, NEPs are
the only alleviative programs offered to injection drug users.
History of Needle Exchange Programs
Needle Exchange Programs (NEPs) began in the 1980’s in Australia and became
widely accepted internationally (Kleinig, 2006). In the United States, during the 1980’s
illicit drug use exploded, HIV risk behaviors such as the exchange of sex for drugs
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increased and HIV rates peaked (Des Jarlais, et al., 2014; Courtwright, 2004; CDC, 2001;
Golub & Johnson, 1999).
The criminal justice system became inundated with drug related crimes and was
severely overburdened. Those incarcerated for nonviolent drug offenses “increased 168
percent from 1980 to 1992 from 50,000 prisoners to over 400,000 by 1992” (Gilliard,
1993, para. 1). The war on drugs encouraged society to view drug use as a criminal act
that had to be punished using mass incarceration. The U.S. faced a moral dilemma with
proposed public health alternatives such as NEPs, which were viewed as contradictory to
the government’s stance on the criminalization of drug use and the war on drugs.
In 1986, a Yale public health student named Jon Parker created the AIDS Brigade
and began a grass roots campaign in Boston to distribute clean needles to drug users
(Kirp, 2010). Parker was the initial voice of the cause in the U.S., an activist that
challenged how people viewed IDU and HIV. In 1988, Dave Purchase set up a television
tray on the streets of Tacoma, Washington and effectively launched the needle exchange
movement within the United States (Kirp, 2010). Three years later in 1991, Tacoma
became the first American city to adopt a NEP (Kirp, 2010).
Formed in 1992 in Tacoma, the North American Syringe Exchange Network
(NASEN) is a national organization of NEPs, which supports and advocates for harm
reduction programs (NASEN, 2020). Currently, NASEN reports over 400 syringe
service programs in the U.S. the District of Colombia, the Commonwealth of Puerto
Rico, and the Indian Nations (NASEN, 2020).
There is controversy-surrounding NEPs in the United States. NEPs are viewed as
programs that work against U.S. drug laws. Providing those who inject drugs with clean
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needles is viewed as perpetuating the drug use problem. U.S. federal and state policies
have created systematic barriers in the development and funding of NEPs. Drug use
prevention programs which use an abstinence-based model are favored in drug policy
initiatives though research has shown that “attempting to eliminate drug use entirely
rather than reduce its harmful effects has proven ineffective” (Renteria, n.d., p. 17).
Federal Needle Exchange Policy
Due to the criminalization of drug use, funding has been a substantial barrier for
NEPs in the United States. Since 1988, federal policy has shifted back and forth
regarding whether federal funds can be used to support NEPs. Federal law does not
prohibit NEPs but there are restrictions on what federal funding can be used for related to
the operation of a NEP (Neeley, 2014).
Since 2016, federal funds can be used for NEP operations (e.g. staff, syringe
disposal, HIV testing, etc.) if a location is at risk or experiencing an increase in bloodborne illnesses due to IDU and receives formal approval from the Centers for Disease
Control (CDC) (Paz-Bailey, 2016). Even with the 2016 revision, needles still cannot be
purchased with federal funds or other items which will be used for injection drug use
(e.g. cookers) (Paz-Bailey, 2016).

State Law Considerations for Needle Exchange Programs
While federal law dictates the parameters of federal funding for NEPs, state laws
play a vital role in the execution of the syringe exchange programs based on their needle
prescription and drug paraphernalia laws (Gosten, 1994). These laws criminalize the
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possession and distribution of syringes, which limits the accessibility of clean needles for
FWID and becomes a barrier in the prevention of blood-borne diseases (Burris, 2017).
Burris (2017) and the Centers for Disease Control (2017, September) proposed
the following program components for NEP programs, which must be considered at the
state level:
1. Is the sale and distribution of drug paraphernalia prohibited by state law?
2. Does paraphernalia include syringes?
3. Does paraphernalia exclude any drug related equipment?
4. If paraphernalia includes syringes, are there any exceptions for disease
prevention?
5. If so, what are the exceptions (e.g., NEP use, medical purposes, etc.)?
6. Are the sale of syringes regulated by state law?
7. Is a prescription required for the purchase of syringes?
8. If so, is there a minimum number of syringes that can be obtained without a
prescription?
9. Can syringes only be sold through a pharmacy?
10. What information is the buyer required to provide to purchase syringes?
11. Does state law prohibit NEPs?
12. Does a NEP require local approval?
13. Are NEPs required to operate a one-to-one exchange for syringes?
14. Are syringe starter sets permitted?
The complexity of offering a NEP involves examining the state laws related to
syringe exchange, access and sale of needles and paraphernalia (CDC, 2017). In 2015,
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the Council of State Governments reported NEPs are authorized in the District of
Columbia and 16 states, and one state allows NEPs to be legal only during a state health
emergency. Some states have modified their drug paraphernalia laws and have created
ways to work around existing barriers to providing clean needles such as nonprofits
running NEPs (CSG, 2015). Local governments may have additional laws/ordinances
that must also be considered when trying to implement an NEP, adding yet another
bureaucratic layer to an already multifaceted issue.
Needle Exchange Program Utilization by Gender
Usage characteristics of needle exchange program participants is difficult to
obtain given there is no required global reporting due to the confidential nature of the
program. Because of this, we must rely on research data from NEP locations to
understand the demographics of the client population. Historically, much of the
information examining individuals who inject drugs is “gender neutral or male focused”
(UNODC, 2014). Until approximately three decades ago, females were not typically
included in basic and behavioral science research (NIH, 2020). If studies do recognize
gender as part of the drug culture, “females’s experiences still lag behind males’s in
research around drugs” (Ettorre, 2004).
A CDC report released in November of 2016 examined NEP utilization in 22 U.S.
cities found 54% of injection drug users used an NEP at least once in the last year,
compared to only one-third in 2005. The report provided injection drug use data by
ethnicity but data was not located which was analyzed by gender. Researchers in Canada
examined 15 years of NEP research to determine lessons learned and gender was not
acknowledged as factor worth examining (Hyshka, et al., 2012). In a 2004 article
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Ksobiech conducted a comprehensive review of the NEP literature between January 1988
and July 2001 and found that within the 500 articles examined research outcomes were
not generally reported by gender.
Research conducted with Baltimore NEPs regularly reported gender as part of
their data analysis. A 2001 article found that of the 2,574 participants only 27% were
female (Valente, et al.). Riley, et al., 2002 found a similar result in which 28% were
females. Research examining NEP usage and entry into drug treatment in Baltimore had
a sample comprised of approximately 32% female (Latkin, Davey and Hua, 2006).
International research on NEPs included gender as part of their data reporting.
Gender differences were examined at a NEP in Oslo, Norway at three points in time over
a five year period and found females comprised 41% of NEP clients in 1992, 33% in
1994 and 34% in 1997 (Miller, et al., 2001). NEPs in Ireland found between 10% and
30% of their clients were female (Health Research Board, 2008). Based on the limited
reporting of gender, it could be inferred that between 10 and 40 percent of NEP clients
are female. El-Bassel & Strathdee (2015) noted that females who inject drugs are
underrepresented in research and warrant further study. This research supports an
understudied population and provides data to respond to the specific needs of females
who inject drugs.
Success of Needle Exchange Programs
Evidence supporting NEPs in the United States began as early as 1993 when a
U.S. General Accounting Office report reflected findings supporting needle exchange
programs (Bowen, 2012). Research conducted by Cross, Saunders, and Bartelli (1998)
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and Ksobiech (2004) found that NEPs reduce needle sharing between people who inject
drugs and have contributed to the decrease in HIV (Bowen, 2012; Kerr et al., 2010).
While there is considerable debate-surrounding NEPs – the majority of the
research evidence clearly supports this type of program (CDC, 2019; World Health
Organization, 2004). As evidence continues to grow in support of harm reduction
approaches (e.g. NEPs), there is still reluctance to implement these strategies in areas of
desperate need (Irwin & Fry, 2007). At some point, there may be a less controversial
solution to decreasing HIV transmission related to injection drug use (Villarreal & Fogg,
2006). Until then, harm reduction approaches such as NEPs remain a programmatic to
decreasing the health effects of injection drug use (Villarreal & Fogg, 2006).

Theoretical Frameworks
Harm reduction programs do not prevent drug use but instead focus on
eliminating the adverse consequences of the social problem to the individual and the
community (Hilton, et al., 2000). Core tenets of harm reduction programs include being
rooted in pragmatism, respecting the choice of the individual to use drugs, providing a
non-judgmental environment and focusing on the effects of drug use (Hilton, et al., 2000;
Marlatt, 1999; Conley et al., 1998; De Jarlais et al., 1993). The research problem will be
analyzed through multiple theoretical frameworks, which will provide structure for the
basis of the study. Exchange theory, the health belief model and feminist theory and
intersectionality will be used to help us understand factors which may facilitate or inhibit
females who inject drugs from utilizing NEPs.
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Exchange Theory
Given the nature of harm reduction programs such as needle exchange programs,
exchange theory offers a useful lens for examining factors which may contribute to
participation, exchange theory examines why we interact with others the way we do and
is rooted in behaviorism (Singelmann, 1972). This theory is shaped by rational choice
theory and views people making logical and appropriate choices based on what will give
them greatest satisfaction based on rewards and costs. It can be defined as the social
interaction between individuals based on the exchange of social or material resources,
which in this case is sterile syringes (Singelmann, 1972). Exchange is a calculated, selfcentered approach used to examine and maximize intrinsic and extrinsic benefits within
the relationship rather than normative requirements.
Instrumental theorists in the study of exchange theory included Homans, Parsons,
Durkheim, Blau, Emerson and Cook (Rosenstock, 1974). It is a multi-disciplinary theory
and has its early roots in the areas of economics, anthropology, sociology and
psychology. Homans (1958) applied psychological principles to rational human
interaction comprised of propositions, which included stimulus, success, value,
deprivation-satiation and justice (Heath, 1971). The foundation of exchange theory is
rooted in the nature of human relationships and has several core assumptions: (1) persons
prefer rewards rather than negative consequences, (2) an interaction is based on the
greatest yield for the least expense, (3) the expense and yield are considered before
interacting, and, (4) the rewards will vary by person and are influenced by a variety of
factors in one’s life as well as what they value regarding the exchange of resources
(Rosenstock, 1974).
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NEPs work on a premise of exchange theory which views interaction based on the
trade of clean syringes for used ones. When considering using a NEP, stimuli guide a
person’s behavior based on how the potential reward is viewed. NEPs incentivize the
behavior change of the person who injects drugs by providing clean needles in a safe
environment, which does not criminalize their drug use. NEPs may provide other
amenities that entice the person who injects drugs to utilize the program such as other
social services and medical treatment.
Costs associated with NEP usage, may include concern about potential law
enforcement harassment. A pregnant female who injects drugs may be worried about
NEP staff notifying Child Protective Services and jeopardizing the custody of her child.
Additionally, individuals who inject drugs may fear stigmatization from NEP staff and/or
other community members.
While Homan’s conducted his research, he developed propositions within
exchange theory (Emerson, 1976). Homan’s propositions regarding human behavior are
useful in applying exchange theory to NEPs. The propositions include: (1) the success
proposition in which a person may engage in an action based on the reward of the action,
(2) the stimulus proposition in which a person is more likely to engage in an action if the
current stimuli is similar to prior ones, (3) the deprivation-satiation proposition in which
an action is less likely to occur if the same reward is used often and is viewed as having
no real value, (4) the value proposition emphasizes the value placed on the outcome of
the action, (5) the rationality proposition concludes all actions are evaluated to compare
costs and rewards, and (6) the aggression-approval proposition which has two parts: (a) if
an action does not receive the intended reward and may include punishment, the person
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may become angry and the result of the anger may be viewed as being more valuable, (b)
following an action if a person receives an unexpected reward which is more valuable
than expected and does not receive punishment as expected they are more likely to
engage in the approving behavior because it is viewed as being more valuable (Trevino,
2009; Emerson, 1976).
In further examining these propositions related to perceptions of individuals who
inject drugs and NEPs, this theory illuminates a number of deeper questions that may be
relevant to the proposed research. For example, the success proposition may provide
insight into why persons who inject drugs utilize the NEP. Do they value their health and
the well-being of others? Do they view needle sharing and the spread of disease as a
potential cost they wish to avoid? The stimulus proposition involves consistency. From
the perspective of the individual who injects drugs, are NEPs consistent in their service
delivery and syringe distribution? Do they receive enough supplies at each visit? When
examining deprivation-satiation to what extent is the same reward considered valuable to
the person who injects drugs over time? Does the NEP educate the person who injects
drugs about how their individual efforts in using an NEP are contributing to the decrease
of the spread of disease through the use of clean needles? Does the person who injects
drugs continue to see the value in caring for their health and the well-being of others?
The value proposition is used when an individual who injects drugs is determining the
importance of the action or inaction related to NEP usage. Is the concern regarding their
health and others important to them? Is their current injection behavior more important
than making a behavior change? With the rationality proposition the individual who
injects drugs will compare the costs and rewards of all actions. What will it cost for them
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to use the NEP such as transportation, time, time off from work, etc.? Are clean syringes
worth the time and effort? What other benefits do they receive from the NEP? Is the
person who uses drugs treated with dignity and respect? What will other persons who
inject drugs think if they use the NEP, how important is this to them, and what are the
benefits and costs within the community if persons who inject drugs are associated with
participation in the program? The aggression-approval proposition has implications for
how NEPs are designed and operate. Are the associated health outcomes being realized?
Are NEP clients free from harassment from law enforcement and community members or
other types of punitive consequences? When traveling to and from the NEP with
syringes and drug paraphernalia is there a risk they may be arrested? If an individual who
injects drugs uses the NEP and receives an unexpected reward (e.g. a free meal or
healthcare), they may place a higher value on their participation. Their program
participation may increase, and they may encourage others to partake based on their
analysis of the costs and benefits of NEP usage.
Exchange theory may help us understand the dynamics of how harm reduction
approaches such as NEPs promote the health and well-being of individuals who inject
drugs and support the premise of decreasing harm to the individual and the community.
In applying exchange theory to the way these programs function, it is suggested that the
person who injects drugs may feel valued as a person because they are not being told to
stop their behavior, and can receive supplies, which permits them to continue to inject
drugs in a safe manner. The person who injects drugs may maintain drug use, which they
may view as the greatest benefit of the exchange.
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Exchange theory provides a distinct perspective when examining NEPs given the
transactional nature of the relationship between the NEP and the individual injecting
drugs. It can be beneficial in determining how the individual views costs and benefits,
which can assist in modifying and creating new interventions, as well as changing policy.
Health Belief Model
The Health Belief Model (HBM) in many ways draws from exchange theory,
focusing, as midlevel theories do, on the substantive area of use in preventive health
services. Therefore the HBM will be used to specifically inform which factors should be
considered in the research of this harm reduction program. HBM was developed as a
result of trying to understand why preventive services (e.g., tuberculosis screening, flu
vaccinations, etc.) from public health departments were not being utilized during the
1950’s and 1960’s (Glanz, 2016; Rosenstock, 1974; Hochbaum, 1958). Social
psychologists Godfrey Hochbaum, Stephen Kegels, Howard Leventhal and Irwin
Rosenstock wanted to explain preventive health behavior and were influenced by
cognitive theorist Kurt Lewin (Rosenstock, 1974; Lewin, Dembo, Festinger, Sears &
Hunt, 1944). Lewin believed behavior is viewed through the significance that is placed
on the result if the outcome is likely to be achieved (Lewin, Dembo, Festinger, Sears &
Hunt, 1944). HBM is a value-expectancy theory and considers an individual’s
willingness to engage in prevention behaviors is based on their belief regarding their risk
of the health issue (Glanz, 2016; Rosenstock, 1974). The core components of HBM
include (LaMorte, 2019; Glanz, 2016; Rosenstock, 1974; Hochbaum, 1958):
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•

Perceived vulnerability – An individual must believe they are at risk of
experiencing the health issue and believe the risk is worth engaging in the
preventive measure.

•

Perceived seriousness - The seriousness of the health issue depends on what the
consequences are believed to be as a result of the issue and its impact on their
quality of life.

•

Potential rewards – The benefit a person will receive in return for making a
behavioral change and it is generally based on their belief system.

•

Potential obstacles – The difficulties (e.g., time, money, inconvenience, etc.) an
individual may encounter if they decide to take action.

•

Prompts to action – The stimulus (e.g., visit to the doctor, media campaign, etc.)
which encourages an individual to take action to make a change. The stimulus
may need to vary in frequency and size based on the perceived benefit.

•

Self-efficacy – An individual’s ability to follow through with a change.
The HBM provides another contribution to the research as it lines up in many

ways with the majority of the propositions outlined in exchange theory. The HBM has
been used to explain injection practices and harm reduction program usage among those
who inject illicit drugs (Bonar & Rosenberg, 2011; Gyarmathy, et al., 2009; Strecher &
Rosenstock, 1997). Bonar and Rosenberg (2011) used the health belief model to examine
if persons who inject drugs would utilize harm reduction strategies. Gyarmathy, et al.,
(2009) used the HBM to study the acceptance of a person’s social network regarding the
utilization of harm reduction behaviors. The HBM has also been used to examine HIV
prevention behaviors (Fisher & Fisher, 2000; Rosenstock, Strecher & Becker, 1994).
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Many factors may explain why some females who inject drugs engage in harm
reduction opportunities and others do not. Applying the Health Belief Model constructs
to the examination of program communication methods will provide insight on how harm
reduction strategies are viewed in relation to the susceptibility and vulnerability of the
negative health consequences of injection drug use. Determining the barriers and
facilitators of females’s needle exchange program usage will assist with improving access
and types of services provided at NEPs to create a more inclusive environment. By
examining what is done to encourage NEP use, mechanisms to promote self-efficacy can
be created or modified. Overall, the HBM constructs will assist in creating an
understanding of how a female who injects drugs approaches the use of a NEP.
Exchange theory and the HBM assist in the identification of variables that may be
contributors to action or inaction of NEP usage by the individual who injects drugs.
Given the proposed study’s focus on females in particular, whose participation in NEPs
has been understudied, it is important for the study to examine those factors which may
be unique to the experiences of females and may influence their engagement with NEPs.
Feminist intersectionality theory will be used to illustrate “the relation between systems
of oppression which construct our (females’s) multiple identities and our (their) social
locations in hierarchies of power and privilege” (Carastathis, 2014, p. 304). In order to
fully understand intersectionality theory, a brief overview of different categories within
feminist theory is provided.
Feminist Theory
Inequality between the genders has existed for at least 4,000 years (Lerner, 1986).
Feminist theory emerged from periods of social and political struggle which highlighted
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the inequality of females. Feminist theory “is a wide-ranging system of ideas about
social life and human experience developed from a female-centered perspective”
(Lengermann & Niebrugge, 2010, p. 193).
There are a variety of feminist theories but the underlying goal is the
advancement of females in society (Lengermann & Niebrugge, 2010). Categories of
feminist theories include (Ritzer & Stepnisky, 2018):
•

Gender difference - Males and females have different experiences in the same
situation.

•

Gender inequality – In the same situations females not only have different
experiences than males but are not equal to males.

•

Gender oppression – A power differential between males and females where
females have less power.

•

Structural oppression – Experiences of females are influenced or determined by
embedded processes and structures within society in which are designed to
subordinate them.
Feminist theories of gender difference include cultural feminism and existential or

phenomenological feminism (Lengermann & Niebrugge, 2010). Existential or
phenomenological feminism attributed to Simone de Beauvoir, views females as born
into a disproportionately affected group, highly male created environment (Lengermann
& Niebrugge, 2010). Sociological theories of difference view gender differences from
other perspectives. Feminist institutional theory views females’s differences based on
their role within institutional settings (e.g. home, work, family, etc.) (Lengermann &
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Niebrugge, 2010). Based on a females’s role within society their experience is different
than that of a male.
Feminist interactionist theory views gender through continual interaction among
individuals, or “doing gender” as described by West and Zimmerman (1987).
Accountability guides people’s actions of performing in a certain way based on what is
expected on the basis of gender to maintain gender identity (West & Zimmerman, 1987).
Postmodernist philosopher Judith Butler believed gender was a performance which is
viewed as similar to “doing gender” but that our acts were learned performances that
were to some extent set up for us within society (Felluga, 2011). Butler viewed gender as
a process of performances based on personal biographies (Lengermann & Niebrugge,
2010). She believed people imitate others based on culturally accepted ideas of
masculinity and femininity in order to create their gender (Felluga, 2011). For the
purposes of this study, the term female was used.
Feminist theories observe that males and females have an unequal and different
placement within society based on its configuration (Lengermann & Niebrugge, 2010).
Gender inequality theorists differ from gender difference theorists because they believe
this situation can be changed (Lengermann & Niebrugge, 2010). The core construct of
gender inequality is liberal feminism in which gender is viewed as a way to stratify
systems and promote a sexist ideology which is a cornerstone of societal organization
(Lengermann & Niebrugge, 2010).
Rational choice feminist theory acknowledges an individual makes decisions
based on internal and external limitations (e.g. institutional constraints, opportunity costs,
etc.) (Lengermann & Niebrugge, 2010). Rational choice theory allows females to create
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a preferred outcome weighing constraints and costs. The addition of feminist theory to
the research acknowledges and prioritizes the gender-based roles and constraints that
influence individual choice.
Gender oppression results from a power relationship between a male and females
in which there is domination by the male and is heavily rooted within society
(Lengermann & Niebrugge, 2010). Radical feminism suggests that oppression of females
is achieved through patriarchy which often goes unnoticed but is the most pervasive force
in promoting inequality (Lengermann & Niebrugge, 2010). Patriarchy to radical
feminists is seen as control maintained by males based on their power and resources.
Radical feminism acknowledges there are cross-cultural differences in the dynamics of
oppression and how it is experienced.
Structural oppression theorists assert oppression involves controlling others
through social structures of racism, patriarch, capitalism and heterosexism (Lengermann
& Niebrugge, 2010). Actions of individuals are not ignored but examined through the
lens of how their actions were influenced by social structures. Some theorist focus on
how females have experienced oppression through capitalist patriarchy or domination
(e.g. Dominelli, 2002). This is informed by Marxian theory, capitalism and class
oppression as well as historical materialism (Lengermann & Niebrugge, 2010). Through
this intertwining, domination can be examined based on material and social
arrangements, and resources should be adequately distributed to limit disparities and
material inequalities.
bell hooks’ and Kimberle Crenshaw examined the intersection of feminism with
social classification (e.g. class, gender, ethnicity, etc.) (Huff, 2016; Carastathis, 2014).
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Intersectionality theory recognizes that females experience oppression and discrimination
in a variety of ways with varying intensity (Carastathis, 2014; Lengermann & Niebrugge,
2010). Females experience oppression through not only gender but “class, race, global
location, sexual preference and age” referred to as “vectors of oppression and privilege”
(Lengermann & Niebrugge, 2010, p. 219). The vectors of oppression are connected to
each other and cannot be separated (Biana, 2020; hooks, 1984). The experience of being
a female is changed when these intersections collide and inequality must be viewed
through “a hierarchical structure based on unjust power relations” (Lengermann &
Niebrugge, 2010, p. 219). Within the third wave of feminism, feminist theory and
intersectionality views gender as performative and not based on an individual’s anatomy
(Felluga, 2011). Using the term female acknowledges inclusivity given a person will
self-identify when using a NEP.
An example of the use of intersectionality theory is the examination of a pregnant
female who injects drugs. She may not seek prenatal care out of fear the healthcare
system will report her use of illicit drugs. The pregnant female may experience law
enforcement and criminal justice involvement if she is caught injecting drugs while
pregnant. Her drug use could result in Child Protective Services removing the child from
her custody at birth as well as possible imprisonment. All of the systems mentioned have
power over the female and therefore she is experiencing intertwined systemic oppression.
Females have complex lives with varying interdependence and interconnectedness
(Dominelli, 2002). Within the area of illicit drug use, it is important to consider how the
lives of males and females are very different. Females’s substance use is multifaceted in
that multiple determinants of health impact their drug use, and the harm reduction and
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treatment experiences. Female substance abuse research often does not address the full
scope of problems females face because gender is not recognized (United Nations, 2004).
Accordingly, less is known about the incidence of use, needs and systemic barriers
females face. The literature also suggests females who use drugs are typically
unrepresented within the creation and assessment of harm reduction services (Larney, et
al., 2015; Springer, et al., 2015; Iversen, et al., 2015). Services are heavily influenced by
masculine concerns because they are often designed by and for males and offer little to
meet the needs of females (El-Bassel & Strathdee, 2015; Ettorre, 2004). A female’s
autonomy in accessing harm reduction services is significantly impacted when gendered
inequities exist within society which increases their risk of illness associated with
injection drug use.
Because the concept of intersectionality within feminist theory has been viewed
as the way “things work rather than who people are” it informs this study through
identifying the structural and political inequalities females face (Chun, Lipsitz & Shin,
2013, p. 923). The goal is to “deconstruct and redefine concepts previously defined from
a male perspective” (Parpart, Connelly & Barriteau, 2000). This will provide a rich
framework for the creation of a responsive and inclusive harm reduction plan for females
that have been marginalized who inject drugs. Cho, Crenshaw and McCall (2013)
identified the utility of intersectionality across a multitude of disciplines and found it
beneficial in the development of best practices, organizing communities, advocating for
change and the creation of social movements.
Both exchange theory and the health belief model inform the design of the study
in terms of the factors that serve as benefits and costs in the decision to participate in
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NEPs. When studying females’s use of NEPs, feminist intersectionality theory provides a
lens through which we examine the individual and their experience within the macro
systems that contribute to privilege and oppression. Informed by these theories, Figure 1
depicts a conceptual model which is relevant in understanding females who inject drugs
participation or non-participation in a NEP.
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Figure 1.
Theoretical Model of Exchange Theory, the Health Belief Model and Feminist
Intersectionality Theory
Costs1

Rewards2

Negative
value
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Perception of
NEP from
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Feminist
Intersectionality
Theory3

Determine
Action
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NEP
Outcomes of
the Action

1

NEP Use

Perceived vulnerability and seriousness, loss of relationships, time, transportation, stigma, confidentiality,
fear, health issues, etc.
2
Free clean needles, healthier use, decrease health risk factors for self and others, receive other services,
etc.
3
Categories of identity vs. structures (e.g. economic, social, educational, health care, criminal justice, legal,
social service, political, polices, and laws) of inequality.
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Importance of the Proposed Study
This research will examine service provider perspectives on facilitators and
barriers to needle exchange program participation by females who inject drugs. There are
few studies that aim to answer the provided research questions. Females who inject drugs
are involved in multiple social networks and endure different consequences associated
with injection drug use. This study provides data that will be useful in the modification
of current harm reduction strategies to increase utilization by this underserved and
disproportionately affected population.
The study has significant implications for social workers, healthcare workers,
public health professionals, policy makers, researchers and practitioners within the
criminal justice system and the legislature. Professionals across systems will have a
better understanding of the challenges females face in accessing services. Harm
reduction and prevention approaches will be viewed through the lens of gender, which in
the research literature has typically been “one size fits all”. Stigmatization may be
lessened due to a better understanding of the drug-using environment and what a female
must contend with. Services designed to empower females who inject drugs may be
created. Policies may begin to consider gender in order to acknowledge males and
females face different ramifications related to injection drug use.
Given the opioid crisis, the study provides data to support the efforts of harm
reduction programs, which continues to be debated. Despite the evidence, the valueladen argument has prevailed with U.S. NEPs rather than the evidence-based argument,
which substantiates the use of syringe programs in combatting the harmful consequences
of injection drug use. Until a more effective, less morally charged approach is

33

determined to combat the effects of injection drug use NEPs are considered by some a
viable approach (Villarreal & Fogg, 2006).
The design of research to explore these issues must be informed by an analysis of
the extant literature, and the gaps that remain in our understanding of NEPs. Chapter 2
provides a summary of the research literature to date related to needle exchange
programs. The chapter concludes with an analysis of research gaps which the current
study addresses.

34

CHAPTER II
LITERATURE REVIEW

As the public health issues related to injection drug use have increased, many
communities have implemented needle exchange programs to assist in mitigating the
consequences associated with the behavior. While research has shown NEPs are an
effective tool in combatting the health effects of injection drug use, little is known about
females and their utilization of this service (Mills, 2015; Bowen, 2012; Knox, 2012; Kerr
et al., 2010; Villarreal & Fogg, 2006; Wodak & Cooney, 2004). An extensive review of
the literature is presented in pertinent areas and includes research focused on harm
reduction, harm reduction programs, supervised injection sites, medication assisted
therapy, needle exchange programs, needle exchange programs operations and policy,
needle exchange program location, rural area access to drug paraphernalia, law
enforcement involvement with needle exchange programs, impact of needle exchange
program location on crime, impact of needle exchange program location on discarded
paraphernalia within the community, syringe distribution and return trends, needle
exchange program client characteristics, healthcare utilization and injection drug use
disclosure, client needs, client utilization and retention patterns, high risk client
interventions, clients perceptions about the needle exchange program, gender specific
needle exchange program research, needle exchange program outcomes research,
prevalence of disease, disease risk factors, disease prevention, needle exchange program
cost effectiveness, treatment referral, admission and retention, barriers to drug treatment,
service providers perspective of usage barriers, summary of the extant literature and gaps
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in the literature. Summarizing the existing research is necessary to understand what is
currently known about needle exchange programs and to identify gaps in the research.
An exhaustive literature search was conducted to locate peer-reviewed journal
articles, which focus on the primary research topic of needle exchange programs.
Inclusion criteria for the search included articles be published in English and reflect
findings of a research study. The time-period for inclusion is 2000 to present. Databases
used included EBSCO, Google Scholar, PsycINFO, Ovid, JSTOR, Social Science
Abstracts, PubMed, ScienceDirect, Wiley Online Library and WorldCat. Each database
was searched using strategic search terms, which included “needle exchange program(s)”
and “syringe exchange programs”. Additional articles were located by reviewing
reference lists of identified articles. The search identified 334 publications but the
majority were editorials, responses to the editorials or policy updates. Fifty-five NEP
articles were deemed applicable for the purposes of this project. Each article was
reviewed to determine the objective of the research and a list of topic areas was compiled.
Literature was assigned to a corresponding topic area based on the primary research
objective.
Research related to NEPs cover a wide variety of topics. To lay a foundation for
the problem being studied a brief summary of harm reduction programs is provided
followed by a review of the research literature.
Harm Reduction
While needle exchanges programs are the focus of the research, it is important to
have a basic understanding of other harm reduction programs available to injection drug
users. Programs include supervised injection sites and medication assisted therapy.
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Harm Reduction Programs
Supervised injection sites. Supervised injection sites (SISs) are facilities that
allow persons who inject drugs to bring in their own drugs to inject and the facility
provides sterile injection equipment in a safe space. The facility has medical staff on site
to oversee injections and there are strict regulations that must be adhered to such as who
is permitted into the facility and behaviors that are not allowed (e.g. selling drugs,
violence). Sites were created with the intent of connecting groups that have been
marginalized to medical care to improve health outcomes, social service support,
providing education regarding the health risks associated with injection drug use,
behavior modification, decreasing disease and the reduction of overdoses (Potier, et al.,
2014). SISs are not available within the United States (Beletsky, et al., 2008).
Medication assisted therapy. Medication assisted therapy (MAT) uses a
combination of pharmacological treatment (buprenorphine, naltrexone and methadone) to
combat the physical and psychological symptoms of additions (e.g. cravings, and
detoxing symptoms), and behavioral therapy and counseling to treat opioid abuse in
addition to educational and vocational training and medical care (SAMSHA, 2020).
Practitioners interested in providing MAT must apply to SAMSHA for approval. MAT
duration varies, and can be indefinite as long as there are regular health assessments
conducted (FDA, 2019).
In a systematic literature review of methadone maintenance treatment (MMT)
from 1995 through 2012, Fullerton, et al., (2014) found MAT was effective in improving
outcomes related to criminal behavior, mortality and decreasing HIV risk behaviors, and
showed positive maternal and fetal outcomes in pregnant females. Tkacz, et al., (2011)
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examined compliance of MAT over a period of three months and found relapse decreased
with the use of buprenorphine and was determined to be effective, although there might
not have been adequate time to allow for the assessment of compounding issues such as
mental health concerns, stress or employment issues.
A review of cohort studies determined mortality rates were significantly lower in
buprenorphine studies compared to methadone, particularly during the initial month of
treatment (Bahji, et al., 2019). While MAT has been shown to decrease overdose deaths,
it has also been shown to reduce HIV and hepatitis C (Tsui, et al., 2014; Schwartz, et al.,
2013). A study examining patient outcomes related to the three MAT medications is
currently being conducted in 65 sites across the United States (CDC, 2019).
Supervised injection sites and medication assisted therapy have been shown to be
instrumental in harm reduction efforts. While these programs provide significant benefits,
the remainder of the chapter will focus on another harm reduction program - needle
exchange programs.
Needle Exchange Programs: Review of Existing Research
Needle Exchange Programs Operations and Policy
While needle exchange programs have a common goal of providing sterile
syringes to injection drug users, program operations and policy surrounding service
delivery will often vary by location. This may be attributed to local laws, resource
allocation and program support.
Needle exchange program location. The location of an NEP is a frequent
concern of communities where they are housed. Residents often view them as promoting
drug use and fear an increase in crime. Strike, Myers and Millson, (2004) examined the
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challenges of finding a place to house NEPs in Ontario, Canada using “not in my
backyard (NIMBY)” phenomenon. From the NIMBYperspective, home may be viewed
as a desirable location, which becomes part of our identity. NEPs were viewed as
undesirable and a threat to our identity. Based on qualitative interviews with NEP staff,
researchers found that NEPs continue to face difficulties finding locations due to
community opposition based on the stigma related to drug use and safety concerns
(Strike, Myers & Millson, 2004).
Rural area access to drug paraphernalia. Fisher, et al., (2017) examined access
to drug use equipment in rural communities in New South Wales, Australia. The sample
was comprised of injection drug users who utilized an NEP within the last month. Over
half of the sample reported picking up equipment for other persons who inject drugs,
which suggests there is an issue related to those not accessing an NEP. The open-ended
responses suggested longer hours of operation and the need for easy disposal options for
equipment (Fisher, et al., 2017).
Law enforcement involvement with needle exchange programs. A crosssectional national survey of U.S. NEP managers examined police interference based on
program characteristics, physical environment and the laws associated with NEP
operation (Beletsky, et al., 2010). Over 40% of participants reported monthly harassment
of clients, 30% had NEP items seized, 10% reported arrest of clients going to or from the
NEP. NEPs serving persons of color who inject drugs were almost four times more likely
to report seizure of items and arrest (Beletsky, et al., 2010). The study highlights the
need for law enforcement and NEPs to work collaboratively to maximize the benefits of
the intervention.
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Impact of needle exchange program location on crime. Marx et al., (2000)
examined the crime rates in Baltimore surrounding two NEPs following their opening.
Arrest data within a half-mile radius was collected for six months pre-NEP and 14
following the opening of the NEP. Drug related arrests showed a slight monthly increase
following the opening of the NEP in both program and non-program areas, both
economically motivated offense arrests and resisting arrest saw an increase in nonprograms areas after the NEP opened. While drug related arrests did increase, this was
consistent with other areas of Baltimore and was not statistically significant. The study
found the opening of the NEPs was not linked with the increase in crime rates (Marx, et
al., 2000).
Impact of needle exchange program location on discarded paraphernalia
within the community. A study in Baltimore examined the amount of discarded
paraphernalia pre-NEP and over a two-year period while in operation (Doherty, et al.,
2000). Randomly selected city blocks were sampled and it was determined that the NEP
did not contribute to an increase in discarded paraphernalia in public areas (Doherty, et
al., 2000).
Syringe distribution and return trends. A study in Hungary examined the
closure of two NEPs on the impact of the needle supply (Gyarmathy, et al., 2016). NEP
registry data from 2008 – 2014 included almost 23,000 and distribution of over three
million syringes. The number of new clients, contacts, syringes dispensed and syringes
collected increased annually. Between 2012 and 2014 the number of syringes a person
who injects drugs received decreased and NEPs collected approximately 50% of the
syringes distributed. It was noted that HCV in individuals who inject drugs in Hungary
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doubled between 2011 and 2014 (Gyarmathy, et al., 2016). A similar Australian study
reported a significantly higher return rate than Gyarmathy, et al., (2016), using other
disposal methods, including secure disposal containers placed in public locations (Miller,
2001). A third Australian study examined needle distribution trends from NEPs,
healthcare agencies, pharmacies and vending machines between 1990 to 2009 noting a
nearly 30% NEP usage increased (Lilley, Mak & Fredericks, 2012).
In Brazil, Bastos, et al., (2006) employed focus groups and observational data to
determine the reasons for the delays in returning marked versus unmarked syringes. In
over 500 boxes of injection paraphernalia during the study period, the majority of
returned boxes did not contain marked syringes. Participants reported they generally
receive more syringes then needed and often resell them outside the area of the NEP or
smuggle them into correctional facilities (Bastos, et al., 2006).
In a study of NEPs in California, Blumenthal and colleagues (2007) found that
NEP operational policy on the number of syringes a client can obtain ranges from a one
for one exchange with a maximum cap or unlimited based on need. The researchers
determined the majority of clients have acceptable syringe coverage and are less likely to
reuse and share syringes (Bluthenthal, et al., 2007).
A Chicago study of NEP users classified them as high, medium and low users
based on the quantity of syringes received, number of visits, and time spent at the NEP
(Valente, et al., 2001). Syringe circulation times were shorter for those participants that
used the NEP frequently and they returned syringes they obtained at the NEP (Valente, et
al., 2001). In a subsample of participants gender and syringe relay (returning someone
else’s syringes) interacted significantly. Females who returned syringes for others had a
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higher rate of HIV compared to males who returned their own syringes (Valente, et al.,
2001).
Needle exchange program client characteristics. A study in Rhode Island
conducted interviews with persons who inject drugs to examine depression of those in
methadone treatment versus those utilizing an NEP (Brienza, et al., 2000). Researchers
found that over 40% of participants in methadone treatment and almost 55% of the NEP
users were found to have major depression. Participants that did not have a partner, had
an alcohol use disorder and were female were more prone to being depressed (Brienza, et
al., 2000).
Studies in Philadelphia and Chicago also examined client characteristics (Mauer,
et al., 2016; Brahmbhatt, Bigg & Strathdee, 2000). A majority of clients were male and
younger clients increased over time. Researchers also found a variability of geographic
location of residence based on the proximity of NEP (Maurer, et al., 2016; Brahmbhatt,
Bigg & Strathdee, 2000).
Client characteristics were analyzed based on hours of operation (Brahmbhatt,
Bigg & Strathdee, 2000). A majority of clients using the NEP during the day were
African American and older. While the majority of evening NEP clients were white,
nearly a third were Puerto Rican. Researchers determined NEPs should offer convenient
daytime and evening hours of operation in order to diversify the population they serve
(Brahmbhatt, Bigg & Strathdee, 2000).
Healthcare utilization and injection drug use disclosure. In order to impact the
health of persons who inject drugs they must be comfortable with disclosing their drug
use status to healthcare professionals. Researchers in Australia surveyed NEP clients to
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determine healthcare utilization and the disclosure of injection drug use to general
healthcare providers and emergency room personnel (Islam, et al., 2013). Females
sought healthcare in the prior 12 months compared to of males. Nearly 70% of
participants reported some form of disclosure to their healthcare provider regarding
injection drug use. Further analysis revealed participants that identified as homosexual
were less likely to disclose injection drug use and females were more likely to disclose
their injection drug use compared to males (Islam, et al., 2013).
Client needs. Many NEPs provide other support services such as referrals to
mental health services, housing information, condoms, immunizations, anti-viral
treatment and wound care. A comparative study of persons who inject drugs in Rhode
Island utilizing an NEP and methadone treatment examined client needs (Stein &
Freidmann, 2002). Participants reported the highest need for housing assistance and
treatment of mental health issues. NEP clients reported the highest number of unmet
needs while both groups reported a need for mental health services. When the data was
examined by gender, it was found that females reported a higher need for mental health
services (Stein & Freidmann, 2002).
Client utilization and retention patterns. A study in Scotland examined the
attendance patterns of over 1,500 clients during a four-year period using retrospective
attendance records and semi-structured interviews with NEP staff (Hay & McKenganey,
2001). There was a slight increase in the number of clients utilizing the NEP annually
and females who injected drugs used the NEP more often than males. Over 30% of
clients utilized the NEP once or twice following their initial visit, which is much lower

43

than reported by Gindi and colleagues (2009). It was assumed the client return rate was
low due to confidentiality concerns (Hay & McKenganey, 2001).
Client retention is an important factor when examining the effectiveness of the
intervention. Gindi, et al., (2009) examined retention of clients at a Baltimore NEP over
a 12-year period. White, single clients with over two decades or more of injection drug
use that lived in the NEP zip code were more likely to return. While the sample was
comprised of a majority African Americans, they were less likely than whites to return to
the NEP (Gindi, et al, 2009).
High risk client interventions. A randomized clinical trial conducted in
Providence, Rhode Island targeted NEP clients that were also heavy drinkers, to
determine if a motivational intervention influenced injection risk behaviors (Stein, et al.,
2002). Participants that received the motivational intervention had fewer injection risk
behaviors at 180 days compared to the control group. The one month and six month
follow-ups showed an overall decrease in injection risk behaviors for both the treatment
and control groups (Stein, et al., 2002).
Clients perceptions about the needle exchange program. A qualitiative client
perception study was conducted at four Canadian NEPs (MacNeil & Pauly, 2011). The
participants described the NEP as a safe place where they did not feel stigmatized or
judged for their drug use and have developed a connection with NEP staff. They also
described the NEP as a referral source to other services which was viewed as beneficial
by all and reduced stigma (MacNeil & Pauly, 2011). This study found similar results to
the McLean (2012) study.
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Ethnographic and interview data were collected from a South Bronx NEP to
describe the needs of NEP clients in a poor area of New York City (McLean, 2012). The
results indicated the clients used the NEP for basic survival given its location. The
majority of participants utilized the NEP to obtain necessities such as food and clothing
and acknowledged it as a safe area. Others used the NEP to generate income such as
trading necessities with other clients for goods, transportation vouchers or money.
Participants also saw the NEP as a place to socialize with others as well as be treated as a
human being and not judged. Staff viewed the NEP as the heart of the South Bronx for
the population it serves (McLean, 2012).
Gender Specific Needle Exchange Program Research
Only five of the above studies reported data related to gender (Islam, et al., 2013;
Riley, et al., 2002; Hay & McKenganey, 2001; Brienza, et al., 2000; Brahmbhatt, Bigg &
Strathdee, 2000). Data provided was generally related to a single variable. Studies
focused on different aspects of the proposed study and included healthcare utilization and
injection drug use disclosure, referrals to treatment, NEP attendance patterns and
depression in methadone clients.
Three studies specifically were designed to focus on females. Miller, et al.,
(2001) examined gender differences in NEP use by administering a cross sectional
surveys of clients. Surveys explored high risk behaviors, drug use, sex work and HIV
status. Moore, et al., (2012) examined reproductive health services for exotic dancers as
part of a mobile NEP in Baltimore, Maryland. The majority of participants reported they
were not receiving reproductive healthcare and the mobile NEP was able to provide
pregenancy testing and contraception.

45

A study in Oslo, Norway examined NEP use by gender in one-week periods over
three years (Miller, et al., 2001). The majority of females reported involvement in sex
work. Females were three times more likely to utilize other NEP services, used more
syringes on a daily basis compared to males, and reported a higher rate of needle sharing
(Miller, et al., 2001).
Needle Exchange Program Outcomes Research
The mitigation of risk is critical in decreasing the spread of blood borne disease
within the population of persons that inject drugs. Research has examined disease
prevelance, behavioral risk factors and prevention efforts.
Prevalence of disease. A study of a Swedish NEP examined the prevalence of
HIV and hepatitis B and C and associated risk factors of a longitudinal and baseline
cohort (Blome, et al., 2011). The baseline cohohrt had significantly more hepatitis B and
C markers but had a longer injection history. HIV across both groups remained low and
hepatitis B declined due to vaccination but hepatitis C transmission was high (Blome, et
al., 2011).
An ecological study examined the prevalence of HIV among persons who inject
drugs in areas with and without NEPs worldwide (MacDonald, et al., 2003). Areas that
had an NEP had a decrease in HIV prevalence and those cities without NEPs saw an
increase in HIV (MacDonald, et al., 2003).
A Monte Carlo simulation study was conducted on the impact an NEP had on the
spread of HIV (Rabound, et al., 2003). Modeling found by increasing the population that
injects drugs that utilized the NEP and decreasing needle sharing, the spread of HIV was
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reduced. The model also showed that given the worst-case scenario of NEP utilization,
there was a reduction in the spread of HIV (Rabound, et al., 2003).
Disease risk factors. Unprotected sex is a notable contributor to increased risk of
HIV. A Canadian study examined psychosocial elements affecting intention to use
condoms, which was determined to be based on self-efficacy and normative beliefs
(Belanger, et al., 2002). Self-efficacy was more difficult with regular partners and with
causal partners; a cognitive aspect was identified as a relevant factor in consideration of
condom use. HIV status was not linked to intention (Belanger, et al., 2002).
In another study of risk behaviors, Knittle and colleagues (2010) found that at
follow-up participants were less likely to share a used syringe and were more likely to
clean their skin before or after an injection, and syringes reuse decreased over time. A
Canadian prospective observational cohort study of persons who injected drugs found
increased HIV rates associated with NEP usage (Wood, et al., 2007). The baseline HIV
rate was higher for daily NEP users compared to non-daily users. When cocaine use was
taken into account, HIV rates were not statistically significant for daily NEP attendees
(Wood, et al., 2007). A prospective cohort study in Vancouver examined syringe sharing
and HIV rates following a policy shift to end the cap on the number of syringes
distributed to an individual client (Kerr, et al., 2010). After the policy change, syringe
borrowing and lending decreased (Kerr, et al., 2010).
It has been hypothesized that NEP use decreases injection frequency which is a
high risk behavior. The reduction of injection frequency is a key to limiting potential
exposure to blood-borne diseases. A study of a Victoria, British Columbia NEP examined
injection practices of FWID (Gibson, et al., 2011). Survey data provided information to
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calculate a risk behavior score of low or high. It was found that persons who inject drugs
living in a shelter or that were homeless were almost six times more likely to have a high
risk score (Gibson, et al., 2011).
In Bangladesh, NEP participants completed a survey on injection risk behavior,
were tested for hepatitis B and C, HIV and syphilis (Azim, et al., 2008). Over one-third
of participants reported injecting with used syringes in the last 30 days. Associations
with HIV positive status and syphilis included being single, homeless and living alone
(Azim, et al., 2008).
A study in Puerto Rico examined rural and urban access to NEPs and if NEP
utilization was associated with decreased injection risk behaviors (Welch-Lazoritz, et al.,
2017). Overall, persons who inject drugs living in urban areas were more likely to access
NEP services compared to rural participants and report a decrease in risk behaviors
(Welch-Lazoritz, et al., 2017).
A study in Baltimore, examined social networks related to the HIV risk behavior
of persons who inject drugs participating in an NEP (Valente & Vlahov, 2001).
Demographic information, drug use frequency and social network information was
collected. Social network questions examined behaviors in the past two weeks with up to
five individuals and consisted of injecting together, using alcohol, having sex and sharing
syringes. Researchers concluded injection drug risk taking behavior occurred with close
friends and could be considered selective risk taking (Valente & Vlahov, 2001).
A case study by MacNeil and Pauly, (2010) examined the impact of the closure of
a fixed site NEP on service access, risk behaviors and injection supplies. A mobile
outreach program began with limited outreach due to client displacement and an
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increased police presence. Researchers found injection drug use risk behaviors were
impacted because clients often commented that it was difficult to determine where the
mobile site would be located. Clients felt like they had to choose between using the
mobile service and standing in line for other social services, which took priority because
they could share or reuse needles (MacNeil & Pauly, 2010).
A ten-year study of four U.S. cities hypothesized NEP participation would affect
injection risk behaviors and therefore have an impact the rate of hepatitis C (HCV)
(Holtzman, et al., 2009). Participants reporting recent NEP use reported fewer injection
risk behaviors. Those attending the NEP and not participating in injection risk behaviors
were less likely to have HCV (Holtzman, et al., 2009). A similar study in Seattle
examined NEP use, risk behaviors, and hepatitis B and C virus transmission (Hagan &
Thiede, 2000). NEP usage decreased the utilization of used syringes but not for other
drug paraphernalia such as cookers and cotton. Researchers found NEP clients might still
be at risk for hepatitis based on their limited reduction in risk behaviors (Hagan &
Thiede, 2000).
A cohort study in Chicago examined the sexual risk behaviors of NEP clients
(Hue & Ouellet, 2009). NEP and non-NEP users were HIV tested and interviewed to
explore condom use, number of sexual partners and unprotected vaginal intercourse (Huo
& Ouellet, 2009). NEP users had higher odds of using a condom with their primary
sexual partner and both groups had a comparable number of partners over time.
Unprotected vaginal intercourse was reduced more for NEP users annually compared to
non-NEP users (Huo & Ouellet, 2009).
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NEP, detox program and methadone maintenance participants were recruited for a
cross-sectional, correlational design to describe and compare HIV risk behaviors and
demographic characteristics across programs in Philadelphia using secondary data (Mark
et al., 2006). NEP participants were the most likely to have shared injection equipment
and methadone participants were the least likely. A difference in sharing behavior across
programs was not found. Participants in the NEP and detox programs reported the
highest drug-risk scores (Mark et al., 2006).
A study of three U.S. cities examined sterile syringe access related to police
contact, syringe sharing and syringe re-use among persons who inject drugs (Bluthenthal,
et al., 2004). Researchers found participants residing in areas without access to legal
sterile syringes was associated with police contact. Participants using an NEP with
exchange limits were found to re-use syringes less but this did not decrease sharing of
syringes. There were no changes identified in non-NEP users related to injection risk
behaviors (Bluthenthal, et al., 2004).
A prospective cohort study of Chicago NEP users and non-users examined
injection frequency and cessation (Huo, et al., 2006). Overall, study participants reduced
their annual injection frequency. It was determined utilizing an NEP did not affect
cessation. This result is contradictory to prior studies conducted by researchers Van
Ameijden, et al., (2001) and Hagan & Thiede (2000) and variances are assumed based on
differences in methodology and sample (Huo, et al., 2006).
Disease prevention. A large majority of NEP literature focuses on the efforts of
disease prevention specifically related to HIV and hepatitis due to the risk behaviors
associated with IDU and the similar transmission routes. Harm reduction strategies such
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as NEPs and methadone treatment have attempted to decrease other diseases among
persons who inject drugs. Researchers examined two NEP sites in Baltimore that offered
tuberculosis (TB) education, testing and medication (Riley, et al., 2002). Over an 11month period, nearly 700 NEP clients received TB information and approximately 40%
received testing. Over 80% of those tested returned for the reading of their skin test, 15%
tested positive for TB and made over 15 NEP visits during the study period (Riley, et al.,
2002).
A comparative study of Denmark, Sweden and Norway examined NEPs versus
HIV testing and counseling to determine the effectiveness of HIV prevention (Amundsen,
et al., 2003). Denmark relies primarily on NEPs while Sweden and Norway focus on
HIV testing and counseling. Researchers found HIV testing and counseling to be more
effective than the use of NEPs to prevent HIV transmission (Amundsen, et al., 2003).
Needle exchange program cost effectiveness. One of the many ways to justify
the use of harm reduction approaches is the examination of the cost benefit ratio.
Programs such as NEPs are generally inexpensive to operate in comparison to treating
someone for health issues related to injection drug use and several studies have attempted
to explore this topic. A cost effectiveness analysis was undertaken with seven New York
State NEPs (Laufer, 2001). NEP operational costs were examined for a calendar year,
data on HIV infections were calculated, and treatment costs were estimated based on the
research literature. It was estimated the NEPs prohibited an estimated 87 HIV infections
with high-end HIV treatment costs estimated at nearly $17 million dollars, and low end
costs at over $7 million dollars. Based on the annual snapshot of operational costs, this
study demonstrates the cost-effectiveness of NEPs (Laufer, 2001).
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A modeling study in Philadelphia was developed to determine the optimal
resource allocation to reduce of HIV at a minimal cost (Harris, 2006). A circulation
model was used to estimate the number of needles exchanged to calculate NEP costs and
an estimated decrease in HIV. Models showed the current NEP needed to increase the
number of satellite locations by a minimum of two and increase the client base for
optimal cost (Harris, 2006).
Nguyen and colleagues (2014) conducted an economic evaluation of a theoretical
increase in U.S. NEP funding. The model included an estimation of new HIV infections
over a one-year period, the number of syringes supplied based on the current research
literature, treatment costs, averted HIV infections and varying levels of investment in
NEPs. It was determined that for a minimal investment of $10 million dollars in NEPs,
an estimated 194 HIV infections could be prevented and save almost $66 million dollars
in treatment expenses (Nguyen, et al., 2014). As the investment in NEPs escalates, the
number of HIV infections prevented grows and the savings in treatment expenses
increases.
Treatment referral, admission and retention. One of the goals of NEPs is to
not only to provide clean needles but also to make treatment referrals for interested
clients. Hagan, et al., (2000) examined injection frequency and methadone treatment
admission and retention of ex-NEP users, current users, new users and non-NEP users in
Seattle over a 12-month period. Researchers determined former exchange users were
more likely to reduce their injection frequency, end their drug injecting behavior and be
retained in drug treatment compared to those that never used an NEP. FWID that never
used an NEP were less likely than new users to enter treatment and ex-NEP users were
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more likely to enter methadone treatment. Overall, NEP usage was associated with
reduced injection frequency and retention in methadone treatment (Hagan, et al., 2000).
Another study in Baltimore by Latkin, Davey and Hua (2006) focused on how
NEPs assist clients in entering treatment. NEP clients were more apt to enter a drug
treatment program, which is similar to the findings of Hagan, et al., (2000). Those
entering treatment were also more likely to have some form of employment, have a
history of mental health issues and be HIV positive (Latkin, Davey & Hua, 2006).
A randomized trial examined Baltimore NEP clients that were referred to opiate
agonist therapy and received either strengths-based case management or passive case
management (Havens, et al., 2009). Treatment retention was examined through an
ecological lens. Participants that were employed lived further away from the program and
had unstable living arrangements negatively affected the length of time in treatment.
Participants that had previously received treatment were shown to have stayed in
treatment longer (Havens, et al., 2009).
Kuo, et al., (2003) also conducted a treatment retention study, which examined
NEP users in Baltimore that were referred to a mobile opioid agonist treatment van for
levomethadyl acetate hydrochloride (LAAM). Researchers observed a reduction in drug
and alcohol use from baseline to monthly follow-up visits and positive drug tests for
cocaine and heroin also decreased. The majority of participants had a mean time in
treatment of slightly over 8 months, which is consistent with the research of Haven and
colleagues (2009).
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Barriers to Drug Treatment
Based on the research associated with process, treatment and client outcomes,
attention to barriers associated with NEP participation is appropriate. Literature
addressing barriers to NEP usage is limited and therefore, access issues with substance
abuse treatment programs has been included, due to their similarities. A systematic
literature review by Roberts, et al., (2010) was undertaken for the Independent Reference
Group to the United Nations on HIV and Injecting Drug Use to emphasize the problems
females who inject drugs face as part of the drug using population. The report
categorized barriers as “systemic, structural, social, cultural and personal” (Roberts, et
al., 2010, p. 73). Systemic barriers related to the lack of gender specific treatment
options and understanding the role gender has on health outcomes. A consistent barrier
for females was stigma and feeling judged. Structural barriers included insufficient
childcare, long waiting lists, limited services for pregnant females, lack of available
treatment services and the location of the service. Social, cultural and personal barriers
include a lack of social support, family and partner relationships and finances (Roberts, et
al., 2010).
A cross-sectional study of persons who inject drugs in Australia, examined nonNEP users and infrequent users (Treloar & Cao, 2005). The majority non-users did not
feel comfortable going to an NEP and were concerned about being identified as a person
who injects drugs. Infrequent users reported the NEPs were inconvenient in relation to
travel and hours of operation. Both groups expressed concerns regarding confidentiality
and stigma. Static NEP locations were favored by participants and non-users expressed
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they would be more comfortable accessing equipment without staff being present (e.g.
vending machines, delivery) (Treloar & Cao, 2005).
In a report prepared by Klein (2007) for the Canadian HIV/AIDS Legal Network,
NEP access barriers were examined through an extensive literature review and
discussions with key informants. Major access barriers identified were the operating
hours and location of the NEP, which is consistent with Trealoar and Cao’s findings.
Other issues were identified such as the enforcement of a one for one exchange of
needles, the need for a non-clinical environment and a setting, which does not stigmatize
participants. Klein (2007) echoed the findings of Treloar and Cao (2005) regarding the
method of distribution and suggested a variety of options be available to allow clients
access on their terms. Stigma and confidentiality when accessing an NEP were also
issues identified by Klein (2007), Trelor and Cao (2005).
Riley, et al., (2002) explored treatment barriers in a Baltimore study of NEP
clients. The study compared characteristics of NEP clients that did and did not request
referrals to methadone treatment. Females were more likely to request a treatment
referral but less likely to enter treatment. Females who had children living at home were
less likely than males with children to attend treatment. The researchers determined that
obstacles to entering treatment excessively affect females (Latkin, Davey & Hua, 2006).
Browne, et al., (2016) conducted qualitative interviews with rural U.S. clients to
determine barriers to substance abuse treatment. Clients in rural areas often have to
travel long distances for treatment and they often do not have transportation, which
makes it difficult to attend the program. The cost is also a barrier and includes the
expense of gas, paying someone for a ride, childcare, taking time off from work or paying
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to take the bus. Service hours were also mentioned, as an issue and that access should be
available on the weekends and in the evenings. Hours of operation were also identified
as problematic by Klein (2007) and Treloar and Cao (2005). Rural areas are known for a
lack a privacy and stigma was identified as a major concern that influenced usage
(Brown, et al., 2016).
The studies mentioned above provide no data by gender. The next several studies
are aimed at discussing the differences in accessing and receiving substance abuse
treatment services based on gender. While these studies do not focus on NEPs, it is
thought the barriers might be similar. In a qualitative study of 36 pregnant females
enrolled in residential treatment programs in Northern California, the major barrier to
receiving care was the fear of legal action such as losing custody of their child and/or
incarceration (Jessup, et al., 2003). Thirty-nine percent of participants had partners that
presented an obstacle to seeking treatment. Females were generally financially
dependent on their partner and experiencing domestic violence, which made it difficult to
pursue treatment (Jessup, et al., 2003).
When females decided to pursue treatment, the pre-admission requirements often
were a hindrance because many treatment programs do not allow children. Females who
were in an MAT program and wanted to transition to residential treatment found the
requirements difficult and often conflicting. Pregnant participants felt stigmatized and
excluded from some treatment programs and programs were often unable to meet
prenatal care needs. The research found pregnancy can be a motivator to seeking
treatment but females will have face obstacles with their partner and the treatment
program (Jessup, et al., 2003).
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Verisimo and Grella (2016) used the National Epidemiologic Survey on Alcohol
and Related Conditions (NESARC) to determine why assistance was not sought for drug
or alcohol problems based on race/ethnicity and gender. The researchers examined
structural and attitudinal, readiness for change and how these influenced help seeking
behavior. There were no differences between males and females related to structural
barriers and readiness for change. Females expressed more attitudinal barriers with
alcohol, but there were no differences for males or females related to drug use. A subanalysis showed females had negative feelings toward treatment and were often fearful of
the possible legal consequences such as loss of parental rights. This finding is consistent
with the qualitative study conducted by Jessup, et al., (2003).
A qualitative study of 85 rural pregnant females in Kentucky examined treatment
barriers which were classified into “the categories of availability, accessibility,
affordability and acceptability” (Jackson & Shannon, 2002, p. 1762). Over 80% of the
sample reported having a barrier to accessing treatment. Fifty-one percent (51%)
experienced an acceptability barrier in which stigma and their denial of the need for
treatment were the consistent concerns. Once again, stigma is consistent with Jessup, et
al., (2003), Verisimo, and Grella (2016). Forty-nine percent (49%) sited accessibility
issues, which included the need to take care of a family and/or lack of childcare, which is
similar to what Jessup, et al., (2003) indicated. Over 35% of participants reported
concerns with availability, which included extensive waiting lists and long waiting
periods (Jackson & Shannon, 2002). Affordability was the least significant barrier at
13% and on average participants reported at least two barriers (Jackson & Shannon,
2002).
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Service Providers Perspective of Usage Barriers
Research on service providers’ perspectives regarding barriers individuals who
inject drugs face accessing NEPs is limited. The majority of research located from a
provider perspective focused on NEP implementation barriers, which is not the focus of
the proposed study. Implementation barriers often exist due to local laws, community
perception and a lack of resources. While all are important issues, a goal of the current
study is determine what gender specific services exist and how access for females can be
increased. The studies discussed below provide a glimpse into the barriers clients face
accessing NEPs.
Philbin and FuJie (2014) conducted 35 qualitative interviews, which included 20
persons who inject drugs, and 15 community partners comprised of NEP staff,
government and non-government officials in Yunnan Province, China, to explore barriers
to NEP access. Interviewees commented that convenience and accessibility are major
factors that limit NEP usage. The location must be away from governmental offices and
operational times should vary. Over two-thirds of community partners identified a lack
of confidentiality as a barrier to utilization, which could cause “discrimination,
stigmatization, or arrest” (Philbin & FuJie, 2014, p. 4). The most reported barrier was the
fear of potential law enforcement harassment or arrest. Community partners felt persons
who inject drugs believe the potential legal risk of using an NEP often outweighs the
health benefits. To protect client confidentiality, it was suggested NEP services be
brought to the user through a mobile program. Other suggestions included educating law
enforcement personnel on the benefits of NEPs and the modification of paraphernalia
laws (Philbin & FuJie, 2014).
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A survey of pharmacy-based needle exchange programs in South East England
examined the operational policies, and daily work issues encountered (Sheridan, et al.,
2000). Over 40% of programs had a limit on equipment that could be dispensed at each
visit and nearly 50% had received requests for other equipment needs such as sterile
water, sharps containers and tourniquets). NEPs located in urban areas were associated
with more monthly transactions. Almost 45% of providers encouraged participants to
bring back their used syringes and most did not require a one for one transaction in order
to obtain new syringes. All NEPs provided printed materials on safe sex but did not
provide any other health care related services. The majority of pharmacy-based NEPs
were housed in a retail environment and therefore the biggest issue they encounter is
shoplifting. It was determined that staff needed additional training in the operational
protocols and interpersonal support in order to work with the injection drug use
population (Sheridan, et al., 2000).
Davis and colleagues (2018) conducted interviews with NEP directors, law
enforcement and individuals who inject drugs who were affiliated with two of the longest
standing exchange programs in West Virginia. A significant barrier surrounded
paraphernalia laws. Similar to Philbin and FuJie (2014), many community partners were
concerned that law enforcement interaction could result in legal repercussions for NEP
clients. There was also confusion noted by law enforcement interviewees regarding
imposing sanctions for possessing clean syringes due to conflicting laws and local
directives. Interviewees also felt that location, including proximity to law enforcement
facilities, is a substantial barrier that has to be considered. Community partners believed
irregular attendance of persons who inject drugs was often due to the availability of
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transportation and the length of time it took to travel to a location if the NEP is housed in
an urban region and users live in a rural area. Current statute does not allow NEPs to use
federal funds to purchase syringes for distribution, resulting in the need to find funding
from their local government, private donors and/or grants to purchase needles.
Community partners identified this as a problem given the demand for clean syringes
often exceeds what they can supply to users. Not having enough syringes available for
individuals who inject drugs contributes to secondary usage of existing needles and the
increase in health risks (Davis, et al., 2018).
Summary of the Extant Literature
In the area of disease prevention, results reflected a decrease in the utilization of
used syringes and injection frequency based on NEP participation (Knittel, Wren & Gore,
2010; Hue, et al., 2006; Hagan & Thiede, 2000; Hagan, et al., 2000). NEPs have been
shown to assist with decreasing the rates of HIV and significantly reducing HIV related
treatment costs (Nguyen, et al., 2014; Laufer, et al., 2001). Injection risk behaviors were
significantly reduced and communities that had an NEP saw a decline in HIV prevalence
by nearly 20% (Holtzman, et al., 2009; MacDonald, et al., 2003). Condom distribution is
a large service generally provided by an NEP and unprotected vaginal intercourse was
reduced by over 25% annually (Huo & Ouellet, 2009; Nigro, et al., 2000). While
literature has examined the outcomes associated with NEPs, examination of operational
factors important to NEP success is important, but the number of studies is limited. We
know little about NEPs in particular.
In reviewing extant literature regarding NEP operational issues and other
substance use treatment programs, several themes emerged. The location of an NEP is a
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pivotal factor and has been shown to have a far-reaching impact on utilization (Davis, et
al., 2018; Philbin & FuJie, 2014; McLean, 2012; Roberts, et al., 2010; Klein, 2007;
Treloar & Cao, 2005; Strike, Myers & Millson, 2004). Clients living in the area who
have easy accessibility to the NEP are more likely to use the service (Gindi, et al., 2009;
Klein, 2007; Philbin & FuJie, 2004). This was reiterated when usage barriers were
examined. Transportation issues such as relying on someone else for a ride and the cost
of gas can affect client participation (Brown, et al., 2016; Jackson & Shannon, 2002).
NEP operations can influence usage and risk behaviors specifically related to
hours of operation and the syringe dispensation policy. Researchers found the need to
diversify the hours of operation between daytime and evening, have weekend hours as
well as have longer hours for the convenience of the client (Fisher, et al., 2017; Brown, et
al., 2016; Klein, 2007; Treloar & Cao, 2005; Brahmbhatt, Bigg & Strathdee, 2000). NEP
syringe dispensation policies that did not limit the number of syringes a client could
receive were shown to decrease sharing and reuse (Davis, et al., 2018; Kerr, et al., 2010;
Bluthenthal, et al., 2007; Bluthenthal, et al., 2004; Sheridan, et al., 2000).
Stigma surrounding injection drug use has been found to be a significant
impediment to prevention efforts and FWID often report a higher incidence of stigma
(Semple, et al., 2012; Luoma, et al., 2007). Stigma and confidentiality were identified as
usage barriers to NEPs and drug treatment (Verisimo & Grella, 2016; Philbin & FuJie,
2014; McLean, 2012; MacNeil & Pauly, 2011; Klein, 2007; Strike, Myers & Millison,
2004; Jessup, et al., 2003; Treloar & Cao, 2005; Jackson & Shannon, 2002). FWID who
have experienced stigma will often not disclose use and participate in injection risk
behaviors (Latkin, et al., 2010).
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Another impediment to service usage identified was the involvement of law
enforcement. It is encouraged that law enforcement and NEPs work together but these
relationships often vary by jurisdiction (Beletsky, et al., 2010). These relationships are
often tricky to navigate due to conflicts between state and local drug policies.
Researchers found there were concerns about harassment from law enforcement as well
as potential arrest (Davis, et al., 2018; Philbin & FuJie, 2014).
While the international and rural locations of the discussed studies differ from the
proposed study, they provide a glimpse of the barriers community partners believe
contribute to the lack of NEP usage. The studies discussed above also included pesons
who inject drugs as part of their community partners, which will not be included in the
research. It is important to note that no study discussed NEP access barriers associated
with gender, contributing to the “one size fits all” approach and emphasizing the need for
the study.

Gaps in the Literature

The research reflects a breadth of topics related to NEPs but is not without
limitations. A large portion of the research has been conducted globally where drug
policy and context vary from the United States. Rural areas within the U.S. and
internationally face distinct challenges and are understudied.
The majority of studies presented do not differentiate their topic by gender and
therefore, neglect a population that has unique needs and challenges. While the number
of females who inject drugs is estimated to be nearly four million globally, we know this
is an under representation given the lack of research and stigma surrounding IDU
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(Tuchman, 2015; Roberts & Mathers, 2010; Degenhardt, et al., 2010). With this
significant gap in the research regarding the focus on female injection drug users
participation in NEPs, access to such subjects is difficult. Therefore, the proposal to fill
this gap is to examine the perception of service providers because of their daily
interaction with this obscure and often overlooked group. According to Lang, et al.
(2013), “there are a limited number of studies that examine barriers from the perspective
of the service provider” (p. 8).
A female who injects drugs typically has multiple social networks, often engages
in sex trading and serves as link for disease between those networks (De, et al., 2007).
Due to involvement in multiple networks, the probability of high risk behaviors and
disease increases for her as well as other network members. Larger social groups of
FWID put females at an increased risk for HIV due to sharing of equipment and
unprotected sex (Sherman, Latkin & Gielen, 2001).
Females have distinctive biological reactions to injection drug use and their health
outcomes vary compared to males. Female hormones contribute to a vulnerability to
stimulants (Greenfield, et al., 2010; Evans & Foltin, 2006; Sofuoglu, et al., 1999).
Females’s risk for endocarditis is heightened, HIV can be transmitted between mother
and child and six in ten females who inject drugs have been exposed to HCV (CDC,
2019, July; Graves & Soto, 1992 as cited in Frontera & Gordon, 2000; Iverson, et al.,
1999).
If a female who injects drugs decides to pursue drug treatment, they have to work
through numerous barriers, which are compounded if they have children or are pregnant
(Roberts, et al., 2010). It was determined that obstacles for entering treatment
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excessively affect females (Latkin, Davey & Hua, 2006). Treatment options have to be
located that allow children or offer childcare and pregnant females are often fearful their
child may be taken away if they enter a treatment program.
Given the estimated number of females who inject drugs, their numerous social
networks and females comprise more than half of all persons diagnosed with HIV; there
is a critical need to examine NEPs and the needs of FWID (El-Bassel & Strathdee, 2015).
This study contributes to an identified gap in the literature. If the global research focus
does not shift to include females who inject drugs, there will be long lasting implications
for generations.
Based on this review of the literature and identified gaps (see Figure 1 in Chapter
1), the study is exploratory in nature, and will attempt to determine which of the proposed
factors and program components offered in the conceptual model are perceived as most
relevant to females who inject drugs participation in NEPs through the lens of staff
working in such programs. The research contributes to increased knowledge from a
service provider perspective and adds to a limited body of knowledge regarding NEPs
and gender.
The following chapter outlines the methodology of the research. The chapter
discusses in detail the research questions and variables, data collection strategy,
instrumentation and human subjects protection.
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CHAPTER III
METHODS
Research Context
Needle exchange programs seek to reduce the transmission of bloodborne
diseases by providing sterile syringes to persons who inject drugs. This service allows
the individual who injects drugs to obtain new clean needles and other paraphernalia for
injecting drugs at little or no cost. Injection drug use is the second leading cause of HIV
in females (CDC, 2018). Females often face challenges accessing social services due to
familial care priorities and structural barriers such as stigma and mistrust (CDC, 2018).
The study examines service provider perspectives on facilitators and barriers to needle
exchange program participation by females who inject drugs.
Prior research conducted by Philbin in Mexico (2008) and China (2014) examined
facilitators and barriers to NEP use from a collaborator perception. The research found
that barriers to use include fears regarding confidentiality, unsupportive environments
and lack of awareness. Identified facilitators included providing more social services,
increasing awareness of the NEP within the community and within persons who inject
drugs and modifying the laws to decease law enforcement involvement (Philbin &
FuJuie, 2014).
Philbin’s research (2008; 2014) on NEP collaborator perceptions assisted in the
instrument development and variables in the current study. No similar U.S. NEP research
was located and therefore, this will contribute to a limited body of knowledge. The goal
of the study is not to simply document facilitators and barriers to NEP use for females but
to also examine the state service delivery approaches, policies that hinder participation
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and services that are not currently offered that may benefit female clients in order to gain
a holistic perspective. The study is particularly relevant given the current opioid crisis
and the increase in harm reduction programs across the country.
Research Questions
Several research studies examined barriers to accessing NEPs in rural and
international locations but no research study focused solely on usage facilitators and
barriers of females who inject drugs. As previously mentioned, females face a different
set of challenges in accessing NEP services.
In order to determine the faciltiators and access barriers, the existing research
literature was reviewed and a list of currently identified facilitators barriers was created.
Facilitators and barriers were categorized into organizational, practice or policy related.
The research questions that were explored are as follows:
Organizational Questions
1. What are the perceived NEP organizational facilitators and barriers that impact
use by females who inject drugs?
2. What NEP service delivery approaches may hinder and/or facilitate use by
females who inject drugs?
Practice Questions
3. What services are currently available for females at NEPs?
4. What additional service needs do females have that could be offered at NEPs?
Policy Questions
5. How do NEP service delivery approaches vary by state?
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6. What are the policies related to NEPs by state?
7. What state NEP policies may hinder the use by females who inject drugs?
Study Design
The study is descriptive and exploratory in nature using survey methodology.
Exploratory research methods allow for an in-depth look at the facilitators and barriers to
NEP access for female injection drug users from a service provider perspective. This
initial research will assist in developing a better understanding of the problem and lay the
foundation for the development of future research studies.
As part of the research, it was necessary to understand the state policies that NEPs
must adhere to. A policy analysis provided background on the problem, outlined the
syringe distribution laws by state and provided recommended solutions. Some data was
garnered from the NEP staff survey regarding local policies, but in order to fully
understand the scope of the issue the policy analysis was necessary. The policies may
directly contribute to the identified facilitators and barriers of NEP usage by females who
inject drugs based on the results of the survey.
Using community-engaged research, surveys were distributed to key community
partners who are NEP staff which have direct client contact. Several partners were asked
to review the data collection instrument prior to survey initiation. Also, as part of the
community-engaged research process reports will be developed and presented to the
NEPs based on statewide research findings (Kelley, Clark, Brown & Sitzia, 2003). Study
results may contribute to improving the service availability to the population of persons
who inject drugs and therefore enhance the well-being of the community the NEPs are
serving.
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Sample
A non-probability purposive sampling technique was employed. The sample
consisted of needle exchange program (NEP) staff from Kentucky and the seven
bordering states (Illinois, Indiana, Missouri, Ohio, Tennessee, Virginia, West Virginia) in
order to add to the strength of the exploratory research. States were purposively selected
because they border Kentucky and are faced with heightened drug issues. Kentucky and
several of the bordering states continue to suffer from the brunt of the opioid crisis.
Opioid prescription practices in southern states are “three times higher than the highest
prescribing state” (Gale, 2016, p. 2). In Appalachian Kentucky, prescription opioids are
injected more than injected cocaine and more than heroin (Havens, Oser, Crosby &
Leukefeld, 2010). Ohio and Kentucky had the “highest rates of death due to drug
overdoses in 2016” in the United States (CDC, 2017, para. 2). From 2014 to 2015 the
drug overdose death rate in Kentucky, Tennessee, Ohio and Illinois reflected a
statistically significant increase (CDC, 2017). Additionally, in 2016 southern states were
impacted dramatically and accounted for over half of all new HIV diagnoses (CDC,
2018). The south also had the highest death rate attributed to HIV (CDC, 2018). The
selected states are at the heart of the U.S. drug epidemic which enforced the need for this
exploratory research.
A list of needle exchange programs (NEPs) by state was created from the North
American Syringe Exchange Network (NASEN) directory (2020). The list included
name, address with zip code and phone number. Based on the directory, additional
internet searches were done to determine NEPs on the list that may no longer be in
existence and new NEPs that may not be listed in the NASEN directory since at the time
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the data was originally collected the last update was done as of May 2015. The NASEN
directory was updated again in 2019 and the list of NEPs by state was revised for
research purposes. Additionally, the NASEN list for Kentucky was compared to
Kentucky Cabinet for Health and Family Services NEP list in an attempt to capture as
many NEPs as possible. The final list of Kentucky needle exchange programs was
reviewed for accuracy by the Centers for Disease Control Epidemiology Field Officer for
the Kentucky Department of Public Health. The researcher has a professional
relationship with the Kentucky field officer. A similar process was not available for other
states.
The list of 145 NEPs was then categorized into urban or rural based on their zip
code and the Office of Rural Health Policy classification of urban and rural communities
(HRSA, 2020.). Classification of the sample into rural and urban categories was done in
hopes of examining the data from those perspectives and filling yet another gap in the
literature. The estimated number of NEPs by state reflect 60 (41.3%) in rural areas and
85 (58.6%) in urban areas (Table 1).
Table 1
Estimated Number of Needle Exchange Programs by State
State
Illinois
Indiana
Kentucky
Missouri
Ohio
Tennessee
Virginia
West Virginia
Total

Number of
Rural NEPs
0
4
45
0
8
0
1
2
60
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Number of
Urban NEPs
7
7
25
2
25
7
3
9
85

Needle exchange programs (NEPs) were contacted via phone to determine the
number of staff that work directly with clients in the exchange program in order to
develop an estimated sample of survey respondents (Table 2). Staff are defined as
persons (in paid or volunteer positions) that directly assist clients with NEP services and
referrals. Staff do not have to be employed by the NEP and can work for other agencies
that provide assistance and support to NEP clients. Program staff does not include clerks
who typically check clients in for their appointment. As of February, 2021 there was an
estimated sampling frame of 271 respondents. Because of the ever changing landscape of
harm reduction programs, if additional exchanges are located, those were included in the
sampling frame. This type of purposive sampling was considered expert sampling and it
is believed to be the most advantageous of purposive sampling techniques in exploring
the proposed research questions (Etikan & Bala, 2017). This sampling method allowed
the research to be grounded in the views and opinions of professionals which work in the
field and are knowledgeable of the study area. These professionals interact directly with
the population being studied and may also have contact with macro and micro
community partners. “Expert sampling is a positive tool to use when investigating new
areas of research, to garner whether or not further study would be worth the effort”
(Etikan, Musa & Alkassim, 2016, p. 3). This type of new knowledge discovery can be
beneficial in shaping future research.
Table 2
Estimated Survey Sample by State
State
Illinois
Indiana

Rural NEP
Personnel
5
3
70

Urban NEP
Personnel
41
16

State
Kentucky
Missouri
Ohio
Tennessee
Virginia
West Virginia
Total

Rural NEP
Personnel
70
0
4
2
3
19
106

Urban NEP
Personnel
52
3
21
4
6
22
165

A total of 145 needle exchange program (NEP) addresses were compiled for the
survey mail-out. Using the recommended technique from Dillman, Smyth and Christian
(2014) survey mail-outs and reminders were mailed over a five-week period. Mail-outs
were returned from 13 (9%) locations and no alternative address was located. The final
number of NEP locations included in the survey mail-out were 67 in Kentucky, seven in
Illinois, 11 in Indiana, two in Missouri, 27 in Ohio, five in Tennessee, three in Virginia
and 11 in West Virginia.
Instrumentation
An exhaustive search was conducted, and a data collection instrument was not
identified that was applicable for the study. The literature addressing barriers to other
types of care (medical care and different types of substance abuse treatment) for females
was reviewed and a table (Table 3) of potential impediments was created (Verissimo,
2017; Ponce, 2014; Jackson, 2012; Hecksher & Hesse, 2009; Neale, 2008; Treloar, 2006;
Jessup, 2003; Booth, 2000; Swift, 1998; Allen, 1994). For the purposes of the research, a
barrier is defined as something that prohibits someone from seeking a service. If a barrier
was identified in multiple research articles it was only listed once on the table. It is
assumed that barriers to NEP usage for females who inject drugs would be similar to
barriers related to other types of care. The faciltators and barriers was mapped back to
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the corresponding research question and health service access category (Wu, et al., 2012).
Health service access categories were taken from McCaughrin and Howard’s, (1996)
multidimensional model used to explore organization factors related to outpatient drug
treatment. The research question categories and definitions are as follows:
1. Organizational (O) – This is defined as how an organization is structured.
2. Practice (PR) – This is defined as how the organization operates through actual
application.
3. Policy (PO)– This is defined as the guiding principles which may impact practice
and organizational set-up.
Health service access categories (McCaughrin & Howard, 1996) are:
1. Accommodation (AN) – An organization’s willingness to implement operating
practices (e.g. appointment systems, hours of operation, walk in capability) based
on client needs.
2. Availability (AY) – The resource capacity and adequacy of supplies an
organization has to deliver services.
3. Service diversity (SD) – The quantity and array of services offered by
organization.
The table below contains each barrier identified in the research literature. The
barrier is then mapped pertinent research question and health service access category.
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Table 3
Facilitators and Barriers to Needle Exchange Program Usage

Facilitators and Barriers

Research
Question
Category(ies)

Health Service
Access Category

Staff have community affiliation
Staff do not have community affiliation
Staff are judgmental and stigmatize clients
Staff demographics
Pregnancy status of client
NEP staff turnover

O
O
O
O
O, PR, PO
O

AY
AY
AY
AY
AY
AY

Fear of punitive action
Community does not support harm reduction
Client does not have a support system
Client has an intimate partner who uses drugs
Client’s personal beliefs about NEPs
Child rearing responsibilities
Client has feelings of shame
Client must register at NEP
Days and times NEP open are not convenient
NEP is located in rural area
NEP is located in an impoverished area
NEP entrance is not hidden for to provide
confidentiality
NEP location is not on a public transportation
route
NEP not open on weekends
NEP not open on holidays
Mobile unit services limited
NEP does not provide a mobile services unit
Client lacks transportation
Long wait times to be seen
Limited number of staff
Policy limit on weekly amount of supplies
clients can receive

O, PR, PO
O, PR, PO
O
O, PR
O
O, PR, PO
O, PR
O, PR, PO
O, PR
O
O

AY
AY
AY
AY
AY
AY
AY
AY
AN
AN
AN

O, PR

AN

O, PR
O, PR
O, PR
O, PR
O, PR
O, PR
O, PR
O, PR

AN
AN
AN
AN
AN
AN
AV
AV

O, PR, PO

AV

O, PR

AV

O, PR

AV

Inconsistency or lack of available NEP supplies
Medical tests/treatment may require multiple
visits
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Facilitators and Barriers

Female clients lack knowledge about services
offered at NEP
Lack of childcare available at NEP
No days and times offered solely for females
Do not offer designated areas for female clients
to maintain privacy
Availability of male condoms
No availability of female condoms
Limited medical services provided
Prenatal services are not available
NEP staff are not knowledgeable about female
clients who trade sex for drugs
NEP staff do not have the skills needed to work
with female clients who trade sex for drugs
NEP staff are judgmental of female clients who
trade sex for drugs
NEP staff are not knowledgeable of sexual
abuse/trauma/domestic violence female clients
may have experienced
NEP staff do not have the skills needed to work
with female clients who have experienced
sexual abuse/trauma/domestic violence
NEP staff are judgmental of female clients who
have experienced sexual abuse/trauma/domestic
violence
NEP health communication campaigns do not
reflect cultural/gender norms

Research
Question
Category(ies)

Health Service
Access Category

O, PR
O, PR
O, PR

SD
SD
SD

O, PR
O, PR
O, PR
O, PR, PO
O, PR, PO

SD
SD
SD
SD
SD

O, PR

SD

O, PR

SD

O

SD

O, PR

SD

O, PR

SD

O

SD

O, PR

SD

The semi-structured questionnaire (Appendix E) included a variety of questions
with pre-determined response options representing all of the variables in the above table.
Questions required the respondent to rate the importance of items as barriers to care or
service availability. Close ended questions such as these allowed for the participant to
complete the survey in an expeditious manner (Kelley, Clark, Brown & Sitzia, 2003).
Questions were grouped by subject matter for ease of the participant (Kelley, Clark,
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Brown & Sitzia, 2003). The subject matter refers to the health service access categories
of acceptability, accommodation, availability and service diversity (McCaughrin &
Howard, 1996). Several open-ended questions were included to determine the number of
females utilizing the NEP monthly, and gather the participants opinion on improving
outreach to FWID, offering services to meet the particular needs of females and their
view on NEP policy changes.
Community Engaged Research
Community-engaged research is “the process of working collaboratively with
groups of people affiliated by geographic proximity, special interests, or similar
situations with respect to issues affecting their well-being” (CDC, 2011). The researcher
began working collaboratively with the Scott County Indiana Needle Exchange Program
in the fall of 2015 which sparked her interest in this research topic. She conducted
qualitative interviews with NEP staff and had regular interaction with clients. As a result
of her volunteering, the researcher developed professional relationships with NEP staff
and she assumed daily operations when staff were limited. This opportunity allowed her
to gain valuable hands on experience and understand the role of the NEP within the
community and its impact on the well-being of persons who inject drugs, service
utilization and program operations. Prolonged engagement in the field is a critical
element of rigor, trustworthiness and credibility which adds to the strength of the
research. Consistent with community engaged research, the researcher sought feedback
from local Health Department-based NEP staff on the study design and on the draft
survey before data collection was launched. Study results will be provided to
participating sites for their use in program assessment and development.
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Survey Expert Review
Using a community engaged research model, the survey instrument was reviewed
to confirm validity by an expert panel composed of NEP staff from the Louisville Metro
Health and Wellness (LMHW), Oldham County Health Department and a faculty
member at the School of Public Health & Information Sciences that is currently
conducting reseach on the LMHW NEP. The researcher has established relationships
with the expert panel. Piloting the survey allowed the researcher to determine if there
were adequate response categories and if any questions were consistently missed (Kelley,
Clark, Brown & Sitzia, 2003). The process provided added rigor to the exploratory
research study. Based on feedback from these community partners, the survey was
revised. NEP staff from LMHW were asked to complete the final survey and were
included in the sample size estimations. While it is not ideal that some survey
respondents had prior exposure to the survey instrument, the small estimated sample size
seemed to warrant their inclusion in the proposed study.
Data Collection
Both a hard copy and electronic survey were used for data collection purposes.
The researcher believed providing an option for survey completion may yield a better
response rate because it could be completed during any down time when out in the field
with or without an internet connection.
Using a recommended technique from Dillman, Smyth and Christian (2014) for
mailed surveys, a prenotice (Appendix B) was sent to all NEP directors two weeks prior
to the initial survey mailing. The prenotice letter notifed the agency personnel that a
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survey is forthcoming. The letter was on Kent School of Social Work letterhead and
provided a brief explanation regarding the purpose of the research, a request for their
assistance and expertise, relevant contact information and signed in black ink by the
researcher. The goal of the prenotice was to begin to establish trust with the participant
and alert them that a survey is forthcoming (Dillman, Smyth & Christian, 2014).
A large white 9 x 12” envelope was mailed to all NEPs in the previously
mentioned states. Each 9 x 12” envelope contained 10 packets of materials. Each packet
included a cover letter (Appendix C), preamble consent (Appendix D) the survey
(Appendix E) and postage paid addressed envelope. The cover letter was be attached to
each survey and included an overview of the survey, an explanation as to why their
assistance is needed, confidentiality and instructions on how to return the questionnaire
(Dillman, Smyth & Christian, 2014). Providing 10 of each item was derived based on the
largest number of estimated potential respondents as nine and providing additional
materials in case staffing had increased. Individuals completed the questionnaires
confidentially and returned them via mail to the researcher or electronically.
In order to increase the response rate, a follow-up 5 ¾ inch x 11 inch reminder
postcard (Appendix F) was mailed seven days following the survey packets to all sites.
This new format was used to introduce a contrasting (letter vs. postcard) stimulus which
has been shown to increase response rates (Dillman, Smyth & Christian, 2014). The
reminder was received by potential study participants immediately following the initial
mail-out before the survey is possibly lost or thrown away (Dillman, Smyth & Christian,
2014). The overall impact of the follow-up reminder has been shown to vary but is
generally worthwhile to increasing the response rate (Dillman, Smyth & Christian, 2014).
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In prior research studies, the prenotice combined with the reminder postcard warranted a
significant escalation in response rates (Dillman, Smyth & Christian, 2014).
Approximately two weeks from the date, the thank you reminder was mailed
(Appendix G) to encourage non-responders to complete the questionnaire. Due to
financial constraints it was not possible to send another packet of surveys and postage
paid return addressed envelopes to all NEP locations. Additionally, replacement hard
copy surveys may have be mistakenly completed again by a study participant were a new
set mailed (Dillman, Smyth & Christian, 2014). While this risk is minimal, it was best to
try to alleviate this concern (Dillman, Smyth & Christian, 2014).
An opinion on the timing of the contacts was discussed with the persons involved
in the pilot NEP provider survey. This was a crucial element given it was recommended
to keep the characteristics of the study population in mind when determining mail-out
dates (Dillman, Smyth & Christian, 2014). The mail-out dates recommended to avoid
were major holidays which did not impact the study (Dillman, Smyth & Christian, 2014).
Survey Incentives
Due to the lack of research funding, survey completion incentives were not
provided in each questionnaire as recommended by Dillman, Smyth & Christian (2014).
Instead, at the bottom of each survey and upon electronic survey completion, respondents
were able to complete a form to enter into a $25 Walmart gift card drawing. Walmart
was chosen because it is typically located in most areas. The form was a separate sheet
of paper at the conclusion of the survey and included their name, address and email. The
form indicated their responses were not be linked to the drawing and the contact
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information provided. Upon receipt of the surveys by the researcher any drawing entries
were immediately separated from the survey.
If the participant completed the survey electronically and they were interested in
being placed in the drawing, they were directed to another weblink to complete the
drawing information so their information was not associated with their survey responses.
Human Subjects Protection
The study was submitted to the University of Louisville Institutional Review
Board for approval. The researcher did not have a list of NEP staff by site and therefore
was not be able to determine who completed the survey. This allowed for the anonymity
of survey completion. A waiver of documentation of informed consent was approved by
the IRB therefore, a preamble unsigned consent form (Appendix D) was attached to each
survey. Informed consent of participants was assumed based on the return of the survey.
The cover letter (Appendix C) (included in the mailed packets) stated NEP staff were
under no obligation to complete the survey. If they chose to participate, the cover letter
stated if they did not wish to answer a question it may be skipped and that their responses
were confidential and would only be shared in aggregate form.
Completed surveys and drawing entries were stored in a locked filing cabinet at
the School of Public Health and Information Sciences. Surveys and drawing entries were
stored separately in order to maintain confidentiality. Electronic data was password
protected on a University computer. Access to these materials was only be available to
research study personnel.
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Analytic Strategy
Quantitative Data
Quantitative data was entered into the Statistical Package for Social Scientists
(SPSS) software for Windows, version 25.0 (IBM, 2017). Initially, frequency and
percent distributions were run to assist in determining the accuracy of the entered data.
The frequency and percent distributions also illustrated the range of the responses. This
process assisted in correcting data entry errors as well as gave the researcher an initial
depiction of the data.
Once data were cleaned, data analysis involved univariate analysis, including
frequencies, percentages and measures of central tendency (e.g., mean, median, mode,
deviance from the mean, etc.). Summaries of the data were provided in written, tabular
and graphic form.
Post Hoc Analysis
Several post hoc group analysis was conducted on the grounds it was an
exploratory study. Between group differences were examined and included Kentucky
versus non-Kentucky, employee type (health department versus non-health department),
NEP type (fixed location versus other location types) and NEP location (urban versus
rural) were assessed using chi-squared tests. Statistical significance was set at p=0.05.
Service Composite Scores
Four composite scores were created in order to determine the comprehensiveness
of NEP service offerings in various categories beyond basic NEP services. Score
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calculations were based on services that are offered and those that should be offered.
Composite scores were calculated based on the “offered” and “should be offered”
categories. It was determined the survey directions were not followed correctly by some
respondents related to the “not offered” category. Results should be viewed with caution.
The list of possible NEP services were divided into four categories and scores were
calculated to determine a Health Services Score (HSS), Educational Services Score
(ESS), Specialized NEP Service (SNS) Score and Basic Needs Score (BNS).
Qualitative Data
Qualitative descriptions were generated to compliment the quantitative data
analysis. Data from the open ended questions were initially summarized using content
analysis and descriptive first cycle coding (Miles, Huberman & Saldana, 2014).
Following this process, second cycle coding was completed and pattern codes with
corresponding categories were created (Miles, Huberman & Saldana, 2014). First cycle
codes were then tabulated within each category to recognize patterns within these data
(Sandelowski, 2001).
A data matrix was created to visually examine the first cycle coding and
associations between research questions. Using a check-list matrix the first cycle codes
were mapped to research questions in order to determine relationships between the codes
and questions (Miles, Huberman & Saldana, 2014). The quantitative data was integrated
with the qualitative data to provide a more robust description of the facilitators and
barriers females who inject drugs face utilizing NEPs.
The rigor of the qualitative data was addressed using Guba and Lincoln’s criteria
which includes credibility, confirmability, dependability and transferability (Nowell,
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Norris, White & Moules, 2017). Credibility and confirmability were established through
line by line coding, creation of a data matrix and comparison of the findings with the
quantitative results. The interpretations are heavily grounded in the data. While a formal
audit of the research process has not been conducted due to the independent nature of a
dissertation, the research process has been clearly documented which demonstrates
dependability. Confirmability has been fulfilled the achievement of credibility,
dependability and transferability (Nowell, Norris, White & Moules, 2017).
Transferability is constrained due to the limited generalizability of the findings and it is
unknown which sites may be interested in applying the findings to their site.
Policy Analysis
To understand the policies and laws impacting NEPs and females who inject
drugs a policy analysis was undertaken. The Burris (2017) and the Centers for Disease
Control (2017, September) NEP program components were used as a standard by which
to review each state’s laws which relate to NEPs to determine the extent to which state
policy was compliant with these guidelines. A list of policies which impact females who
use drugs was created based on an extensive internet search. Each policy was reviewed
for every state in the study to contrast the regulatory context in which each state’s NEPs
were operating.
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CHAPTER IV
ANALYSIS AND RESULTS
Summary Demographics
Respondent Demographics
As outlined in the methods chapter, NEPs were contacted via phone to obtain an
estimated number of staff. The population of NEP staff across states included in the
research was estimated to be 271. A total of 156 surveys were completed but six surveys
were not included in the final sample. Four surveys were received from staff in states not
included in the study and two surveys were received after significant data analysis had
been conducted. One hundred and fifty surveys were included in the study for a response
rate of 55.3%.
Gender, age and ethnicity. Females comprised 75% (n=113) of the respondents
and males comprised nearly 22% (n=33). The mean age of the respondents was 43.94
(SD = 14.83) years. The mean age of males was 39.94 (SD = 9.66) and females was
44.43 (SD = 15.20) years. The mean age of respondents varied by state with Ohio being
the oldest at 46.13 (SD = 16.72) years and Missouri being the youngest at 30.50 (SD =
12.12) years. Eighty-six percent (86%, n=129) of the respondents were White and almost
9% (n=13) were Black or African/American. Ninety-five percent (95%, n=143) reported
not being Hispanic or Latino, 3.3% (n=5) was unknown and 1% (n=2) reported being
Hispanic or Latino.
Needle exchange program organizations and staff. The majority (82%, n=123)
of NEP respondents were part of city/county social services which included local health
departments. Fourteen percent (14%, n=21) were part of other organizations such as a
83

university healthcare system or community-based organization. Over 50% (n=79) of
respondents were health department staff, 7% (n=11) were peer mentors, almost 7%
(n=10) included volunteers, social workers and physicians and nearly 30% (n=45) were
other staff such as administrators, health educators or risk reduction/prevention
navigator/specialists.
Needle exchange program locations. Surveys were received from all states
included in the study except Virginia. Responses from Kentucky NEPs accounted for
nearly 60% (n=87) of the sample followed by Indiana with 11.3% (n=17), Ohio with
10.7% (n=16), 6% were from Illinois (n=9) and Tennessee (n=9) and 2.7% were from
Missouri (n=4), West Virginia (n=4) and the state was unknown (n=4). Forty-seven
percent (47%, n=71) of NEP locations were fixed, 44% (n=66) offered both a fixed
location and a mobile unit and 5.3% (n=8) offered a mobile unit. The number of
respondents by state and NEP type is outlined in Table 4.
Table 4
Respondent’s Location and Type of Needle Exchange Program
State
Kentucky
Ohio
Missouri
Indiana
Tennessee
West Virginia
Illinois
Unknown
Total

Fixed
Location
42
15
4
3
2
2
1
2
71

Mobile
6
0
0
0
1
0
0
1
8

Fixed and
Mobile
37
1
0
14
6
2
6
0
66

Other/Unk

Total

2
0
0
0
0
0
2
1
5

87 (58%)
16 (10.6%)
4 (2.6%)
17 (11.3%)
9 (6%)
4 (2.6%)
9 (6%)
4 (2.6%)
150

Program clients. The majority (71.3%, n=107) of respondents stated males
comprised the bulk of their client population. Respondents estimated the percentage of
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female clients that utilized the NEP in an average month ranged from 10% - 75% with a
mean of 37.77 (SD = 17.05). Nearly 23% of respondents estimated females comprised a
monthly average of 40% (n=23) of their clients followed by 11% (n=16) that stated
females comprise 45% of their monthly clients.
Barriers to Needle Exchange Program Usage
Respondents were asked to indicate the extent to which they believed the items
listed in Table 5 were barriers for females who inject drugs (FWID) in using the NEP in
their community. Barriers were classified into three categories: organizational, practice
and policy. Table 5 provides descriptive statistics for the results of these items listed on
the survey.
Table 5
Barriers to Needle Exchange Program Usage
Item
Organizational Factors
Staff are community members
Staff are persons who
previously injected drugs
Staff interaction with clients
Number of NEP staff
Gender of staff
Age of staff
Race/ethnicity of staff
Staff turnover
Staff knowledge about FWID
and exchange sex for drugs
Staff knowledge of sexual
abuse/trauma/domestic violence
females may have experienced
Days and times NEP are open
Location of NEP
Availability of a parking space
Client confidentiality

Major
Barrier

Minor
Barrier

Not a
Barrier

Not
Applicable

7 (4.7%)
2 (1.3 %)

50 (34.7%)
12 (8%)

80 (55.3%)
81 (54%)

7 (4.8%)
52 (34.7%)

10 (6.7%)
9 (6%)
1 (.7%)
1 (.7%)
5 (3.3%)
6 (4%)
10 (6.7%)

25 (16.7%)
52 (34.7%)
13 (8.7%)
13 (8.7%)
25 (16.7%)
29 (19.3%)
53 (35.3%)

109 (72.7%)
85 (56.7%)
133 (88.7%)
131 (87.3%)
114 (76%)
106 (70.7%)
79 (52.7%)

4 (2.7%)
2 (1.3%)
2 (1.3%)
2 (1.3%)
3 (2%)
8 (5.3%)
7 (4.7%)

12 (8%)

51 (34%)

81 (54%)

5 (3.3%)

34 (22.7%)
19 (12.7%)
9 (6%)
8 (5.3%)

68 (45.3%)
71 (47.3%)
27 (18%)
25 (16.7%)

45 (30%)
57 (38%)
110 (73.3%)
113 (75.3%)

0
1 (.7%)
3 (2%)
3 (2%)
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Item
Accessibility of public
transportation
NEP mobile unit services
Wait times to be seen
Level of community support for
a harm reduction program
Availability of supplies
Quality of supplies
NEP staff knowledge regarding
services provided
Medical services provided
Number of visits for medical
tests/treatment
Health communication
campaigns reflect
community/cultural norms
Health communication
campaigns reflect
susceptibility/vulnerability of
health complications related to
injection drug use
Practice Factors
Availability of childcare
Specified days and times for
females
Private areas for females
Availability of male condoms
Availability of female/internal
condoms
Prenatal services provided
Clients concern of punitive
action (reporting to CPS, CJ
system, etc.) for NEP use
Policy Factors
NEP registration of clients
Number of supplies females can
receive weekly
Law enforcement involvement

Major
Barrier
62 (41.3%)

Minor
Barrier
52 (34.7%)

Not a
Barrier
35 (23.3%)

Not
Applicable
0

21 (14%)
2 (1.3%)
54 (36%)

36 (24%)
30 (20%)
68 (45.3%)

49 (32.7%)
114 (76%)
27 (18%)

41 (27.3%)
2 (1.3%)
0

13 (8.7%)
6 (4%)
1 (.7%)

42 (28%)
26 (17.3%)
25 (16.7%)

93 (62%)
116 (77.3%)
122 (81.3%)

1 (.7%)
1 (.7%)
0

13 (8.7%)
14 (9.3%)

56 (37.3%)
48 (32%)

66 (44%)
65 (43.3%)

12 (8%)
20 (13.3%)

15 (10%)

68 (45.3%)

47 (31.3%)

19 (12.7%)

15 (10%)

61 (40.7%)

56 (37.3%)

17 (11.3%)

40 (26.7%)
14 (9.3%)

49 (32.7%)
24 (16%)

21 (14%)
46 (30.7%)

36 (24%)
64 (42.7%)

13 (8.7%)
2 (1.3%)
7 (4.7%)

25 (16.7%)
4 (2.7%)
27 (18%)

67 (44.7%)
139 (92.7%)
102 (68%)

44 (29.3%)
4 (2.7%)
13 (8.7%)

20 (13.3%)
42 (28.7%)

26 (17.3%)
53 (35.3%)

46 (30.7%)
47 (31.3%)

57 (38%)
6 (4%)

4 (2.7%)
11 (7.3%)

34 (22.7%)
31 (20.7%)

109 (72.7%)
103 (68.7%)

2 (1.3%)
4 (2.7%)

27 (18%)

40 (26.7%)

62 (41.3%)

20 (13.3%)

Barriers. Organizational factors most frequently identified as major barriers were
accessibility to public transportation (41.3%, n=62), level of community support for a
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harm reduction program (36%, n=54) and days and times of NEP operation (22.7%,
n=34). Most frequently rated minor organizational barriers include the location of the
NEP (47.3%, n=71), level of community support for a harm reduction program (45.3%,
n=68) and health communication campaigns do not reflect community/cultural norms
(45.3%, n=68).
Respondents indicated major barriers associated with practice factors included the
clients concern of punitive action (reporting to CPS, CJ system, etc.) for NEP use
(28.7%, n=42) and the availability of childcare (26.7%, n=40). These items were also
selected as minor barriers at 35.3% (n=53) for concern regarding punitive action and
32.7% (n=49) the availability of childcare. Nearly 20% (n=27) of respondents indicated
law enforcement involvement was a major policy barrier. Minor policy barriers included
NEP registration of clients (22.7%, n=34), the quantity of supplies females can receive
weekly (20.7%, n=31) and law enforcement involvement as both a major (18%, n=27)
and minor (26.7%, n=40) barrier.
Non-barriers. Nearly 90% (n=133) of respondents did not believe the gender of
the NEP staff was an organizational barrier. Other items not considered barriers included
the age of staff (87.3%, n=131), staff’s knowledge of services provided (81.3%, n=122),
quality of supplies (77.3%, n=116), race/ethnicity of staff (76%, n=114) and wait times to
be seen (76%, n=114). Almost 93% (n=139) of respondents did not believe the
availability of male condoms was a practice barrier followed by 68% (n=102) who did
not believe the availability of female/internal condoms was an issue. Items that were not
considered policy barriers included NEP registration of clients (72.7%, n=109) and the
number of supplies females could receive weekly (68.7%, n=103).
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Chi-square Test of Independence
A chi-square test of independence was performed to determine if there was a
statistically significant association between the perception of NEP utilization barriers and
the respondent characteristics which included Kentucky versus non-Kentucky, employee
type (health department versus non-health department), NEP type (fixed location versus
other location types) and NEP location (urban versus rural). Kentucky versus nonKentucky was selected based on the small sample size of the other states compared to
Kentucky. Additionally, major and minor barriers were combined into one category of
barriers. Based on the characteristics of the sample, the frequencies to the responses and
the research questions it was determined the categories outlined above would provide the
most fruitful information. Details are provided below for each usage barrier identified as
statistically significant.
Barriers to NEP Usage by Kentucky versus Non-Kentucky
Staff are community members. The results indicated that the state the NEP was
located in and staff being community members are related in the population. The results
showed a significant association between the two variables X2 (1, N=138) = 4.00; p<.05.
The results of the contingency table showed 49.4% of respondents from Kentucky
viewed staff being community members as a barrier to usage. Over 32% of respondents
not from Kentucky viewed staff being community members as a barrier to usage. The phi
coefficient indicated that staff being community members explained 2.89% of the
variance in the state of the NEP, which reflected the two variables have a weak positive
relationship.
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Staff turnover. The results indicated that the state the NEP is located in and staff
turnover are related in the population. The results showed a significant association
between the two variables X2 (1, N=139) = 6.97; p<.05. The results of the contingency
table reflected 17.1% of respondents from Kentucky viewed staff turnover as a barrier to
usage. Nearly, 37% of respondents not from Kentucky viewed staff turnover as a usage
barrier. The phi coefficient indicated that staff turnover explained 5.02% of the variance
in the state of the NEP, which reflected the two variables have a weak negative
relationship.
Availability of a parking space. The results indicated that the state the NEP is
located in and the availability of a parking space are related in the population. The
results showed a significant association between the two variables X2 (1, N=142) = 7.05;
p<.05. The results of the contingency table showed 16.7% of respondents from Kentucky
viewed the availability of a parking space as a usage barrier. Over 36% of respondents
not from Kentucky viewed the availability of a parking space as a usage barrier. The phi
coefficient indicated that the availability of a parking space explained only 4.97% of the
variance in the state of the NEP, which reflected the two variables have a weak
relationship.
Accessibility of public transportation. The results indicated that the state the
NEP is located in and the accessibility of public transportation are related in the
population. The results showed a significant association between the two variables X2 (1,
N=145) = 14.15; p<.05. The results of the contingency table showed 87.4% of
respondents from Kentucky viewed the accessibility of public transportation as a usage
barrier. Over 60% of respondents not from Kentucky viewed the accessibility of public
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transportation as a usage barrier. The phi coefficient indicated that the accessibility of
public transportation explained 9.73% of the variance in the state of the NEP, which
reflected the two variables have a moderate positive relationship.
Availability of supplies. The results indicated that the state the NEP is located in
and the availability of supplies are related in the population. The results showed a
significant association between the two variables X2 (1, N=144) = 12.54; p<.05. The
results of the contingency table reflected 25.3% of respondents from Kentucky view the
availability of supplies as a usage barrier. Over 54% of respondents not from Kentucky
viewed the availability of supplies as a usage barrier. The phi coefficient indicated that
the availability of supplies explained 8.7% of the variance in the state of the NEP, which
reflected the two variables have a moderate negative relationship.
Table 6 provides a summary of statistically significant chi-square results of
utilization barriers by state.

Table 6
Barriers to NEP Usage by Kentucky versus Non-Kentucky
Kentucky

NonKentucky

Staff are community members
Barrier
49.4% (42)
32.1% (17)
Staff turnover
Barrier
17.1% (14)
36.8% (21)
Availability of a parking space
Barrier
16.7% (14)
36.2% (21)
Accessibility of public transportation
Barrier
87.4% (76)
60.3% (35)
Availability of supplies
Barrier
25.3% (22)
54.4% (31)
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Total

Sig

42.8%

.045

25.2%

.008

24.6%

.008

76.6%

.000

36.8%

.000

Barriers to Needle Exchange Program Usage by Employee Type
Registration of clients. The results indicated that the employee type and the NEP
registration of clients are related in the population. The results showed a significant
association between the two variables X2 (1, N=143) = 3.68; p<.05. The results of the
contingency table showed 30.8% of health department respondents view the NEP
registration of clients as a usage barrier. Nearly 17% of non-health department
respondents view the NEP registration of clients as a barrier to usage. The phi coefficient
indicated that the NEP registration of clients explained 2.56% of the variance in the type
of employee, which reflected the two variables have a weak positive relationship.
Barriers to NEP Usage by Needle Exchange Program Type
Gender of staff. The results indicated that the NEP type and the gender of staff
are related in the population. The results showed a significant association between the
two variables X2 (1, N=144) = 6.06; p<.05. The results of the contingency table showed
2.9% of respondents from a fixed NEP view the gender of staff as a usage barriers.
Almost 15% of respondents from other NEP types view the gender of staff as a usage
barrier. The phi coefficient indicated that the gender of staff explained 4.2% of the
variance in the NEP type, which reflected the two variables have a weak negative
relationship.
Race/ethnicity of staff. The results indicated that the NEP type and the
race/ethnicity of staff are related in the population. The results showed a significant
association between the two variables X2 (1, N=141) = 5.41; p<.05. The results of the
contingency table showed 11.8% of respondents from a fixed NEP view the
race/ethnicity of staff as a usage barrier. Almost 28% of respondents from other NEP
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types viewed the race/ethnicity of staff as a usage barrier. The phi coefficient indicated
that the race/ethnicity of staff explained <1% of the variance in the NEP type, which
reflected the two variables have a weak positive relationship.
Mobile unit services. These results indicated that the NEP type and the lack of
mobile unit NEP services are related in the population. The results showed a significant
association between the two variables X2 (1, N=103) = 12.58; p<.05. The results of the
contingency table indicated 78.8% of respondents from a fixed NEP view the lack of
NEP mobile unit services as a usage barrier. Over 41% of respondents from other NEP
types viewed the lack of NEP mobile unit services as a usage barrier. The phi coefficient
indicated that the lack of mobile unit NEP explained 12.18% of the variance in the NEP
type, which reflected the two variables have a moderate positive relationship.
Client concerns regarding punitive action. The results indicated that the NEP
type and the client concern regarding punitive action are related in the population. The
results showed a significant association between the two variables X2 (1, N=140) = 4.36;
p<.05. The results of the contingency table showed 75.4% of respondents from a fixed
NEP view the clients concern regarding punitive action as a usage barrier. Nearly 59% of
respondents from other NEP types view the clients concern regarding punitive action a
usage barrier. The phi coefficient indicated that the client concern regarding punitive
action explained 3.13% of the variance in the NEP type, which reflected the two variables
have a weak positive relationship.
Table 7 provides a summary of statistically significant chi-square results of
utilization barriers by NEP type.
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Table 7
Barriers to NEP Usage by Needle Exchange Program Type
Fixed NEP

Other NEP
Type

Gender of staff
Barrier
2.9% (2)
14.7% (11)
Race/ethnicity of staff
Barrier
11.8% (8)
27.4% (20)
Mobile unit services
Barrier
78.8% (26) 41.4% (29)
Client concern regarding punitive action
Barrier
75.4% (49) 58.7% (44)

Total

Sig

9%

.014

19.9%

.020

53.4%

.000

66.4%

.037

Barriers to Needle Exchange Program Usage by Program Location
Staff are community members. The results indicated that the NEP location and
staff being community members are related in the population. The results showed a
significant association between the two variables X2 (1, N=137) = 13.34; p<.05. The
results of the contingency table reflected 26.6% of respondents from an urban NEP
viewed staff being community members as a usage barrier. Over 57% of respondents
from a rural NEP viewed staff being community members a barrier to usage. The phi
coefficient indicated that staff being community members explained 9.73% of the
variance in the NEP location, which reflected the two variables have a moderate negative
relationship.
Race/ethnicity of staff. These results indicated that the NEP location and the
race/ethnicity of staff are related in the population. The results showed a significant
association between the two variables X2 (1, N=139) = 8.06; p<.05. The results of the
contingency table showed 30.3% of respondents from an urban NEP view the
race/ethnicity of staff as a usage barrier. Eleven percent (11%) of respondents from a
rural NEP view the race/ethnicity of staff as a usage barrier. The phi coefficient indicated
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that the race/ethnicity of staff explained 5.8% of the variance in the NEP location, which
reflected the two variables have a weak positive relationship.
Staff turnover. These results indicated that the NEP location and staff turnover
are related in the population. The results showed a significant association between the
two variables X2 (1, N=138) = 11.94; p<.05. The results of the contingency table
reflected 37.9% of respondents from an urban NEP view staff turnover as a usage barrier.
Almost 13% of respondents from a rural NEP view staff turnover as a barrier to usage.
The phi coefficient indicated that staff turnover explained 8.64% of the variance in the
NEP location, which reflected the two variables have a weak positive relationship.
Availability of a parking space. The results indicated the NEP location and the
availability of a parking space are related in the population. The results showed a
significant association between the two variables X2 (1, N=141) = 8.28; p<.05. The
results of the contingency table showed 35.8% of respondents from an urban NEP view
the availability of a parking space as a usage barrier. Almost 15% of respondents from a
rural NEP viewed the availability of a parking space as a usage barrier. The phi
coefficient indicated that the availability of a parking space explained 5.85% of the
variance in the NEP location, which reflected the two variables have a weak positive
relationship.
Accessibility to public transportation. The results indicated that the NEP
location and the accessibility to public transportation are related in the population. The
results showed a significant association between the two variables X2 (1, N=144) =
12.36; p<.05. The results of the contingency table reflected 63.2% of respondents from
an urban NEP viewed the accessibility to public transportation as a usage barrier. Over
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88% of respondents from a rural NEP viewed the accessibility to public transportation as
a usage barrier. The phi coefficient indicated that the accessibility to public
transportation explained 8.58% of the variance in the NEP location, which reflected the
two variables have a weak negative relationship.
Availability of supplies. The results indicated the NEP location and the
availability of supplies are related in the population. The results showed a significant
association between the two variables X2 (1, N=143) = 4.04; p<.05. The results of the
contingency table showed 45.6% of respondents from an urban NEP view the availability
of supplies as a usage barrier. Nearly 30% of respondents from a rural NEP viewed the
availability of supplies as a usage barrier. The phi coefficient indicated the availability of
supplies explained 2.82% of the variance in the NEP location, which reflected the two
variables have a weak positive relationship.
Availability of childcare. The results indicated the NEP location and the
availability of childcare are related in the population. The results showed a significant
association between the two variables X2 (1, N=109) = 4.10; p<.05. The results of the
contingency table reflected 74.1% of respondents from an urban NEP view the
availability of childcare as a usage barrier. Over 89% of respondents from a rural NEP
viewed the availability of childcare as a barrier to usage. The phi coefficient indicated
that the availability of childcare explained 3.76% of the variance in the NEP location,
which reflected the two variables have a weak negative relationship.
Table 8 provides a summary of statistically significant chi-square results of
utilization barriers by NEP location type.
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Table 8
Barriers to NEP Usage by Needle Exchange Program Location
Urban

Rural

Staff are community members
Barrier
26.6% (17)
57.5% (42)
Race/ethnicity of staff
Barrier
30.3% (20)
11% (8)
Staff turnover
Barrier
37.9% (25)
12.5% (9)
Availability of a parking space
Barrier
35.8% (24)
14.9% (11)
Accessibility to public transportation
Barrier
63.2% (43)
88.2% (67)
Availability of supplies
Barrier
45.6% (31)
29.3% (22)
Availability of childcare
Barrier
74.1% (40)
89.1% (49)

Total

Sig

43.1% .000
20.1% .005
24.6% .001
24.8% .004
76.4% .000
37.1% .044
81.7% .043

Facilitators to Needle Exchange Program Usage
Respondents were asked to indicate the extent to which they believed the item
listed in Table 9 was a facilitator for females who inject drugs (FWID) in using the NEP
in their community. Facilitators were classified into three categories which included
organizational, practice and policy.
Table 9
Facilitators to Needle Exchange Program Usage
Item
Organizational Factors
Staff are community members
Staff are persons who
previously injected drugs
Staff interaction with clients
Number of NEP staff
Gender of staff
Age of staff

Major
facilitator

Minor
facilitator

Not a
facilitator

Not
applicable

38 (25.3%)
29 (19.3%)

50 (33.3%)
29 (19.3%)

52 (34.7%)
42 (28%)

7 (4.7%)
45 (30%)

91 (60.7%)
32 (21.3%)
43 (28.7%)
25 (16.7%)

22 (14.7%)
54 (36%)
47 (31.3%)
39 (26%)

29 (19.3%)
54 (36%)
52 (34.7%)
73 (48.7%)

3 (2%)
7 (4.7%)
5 (3.3%)
10 (6.7%)

96

Item
Race/ethnicity of staff
Staff turnover
Staff knowledge about FWID
and exchange sex for drugs
Staff knowledge of sexual
abuse/trauma/domestic violence
female may have experienced
Days and times NEP are open
Location of NEP
Availability of a parking space
Client confidentiality
Accessibility of public
transportation
NEP mobile unit services
Wait times to be seen
Level of community support for
a harm reduction program
Availability of supplies
Quality of supplies
NEP staff knowledge regarding
services provided
Medical services provided
Number of visits for medical
tests/treatment
Health communication
campaigns reflect
community/cultural norms
Health communication
campaigns reflect
susceptibility/vulnerability of
health complications related to
injection drug use
Practice Factors
Availability of childcare
Specified days and times for
females
Private areas for females
Availability of male condoms
Availability of female
condoms/internal condoms
Prenatal services provided
Clients concern of punitive
action (reporting to CPS, CJ
system, etc.) for NEP use

Major
facilitator
14 (9.3%)
16 (10.7%)
41 (27.3%)

Minor
facilitator
44 (29.3%)
20 (13.3%)
55 (36.7%)

Not a
facilitator
79 (52.7%)
81 (54%)
44 (29.3%)

Not
applicable
10 (6.7%)
30 (20%)
6 (4%)

50 (33.3%)

51 (34%)

39 (26%)

6 (4%)

49 (32.7%)
46 (30.7%)
39 (26%)
80 (53.3%)
37 (24.7%)

41 (27.3%)
50 (33.3%)
41 (27.3%)
30 (20%)
42 (28%)

52 (34.7%)
47 (31.3%)
62 (41.3%)
32 (21.3%)
63 (42%)

3 (2%)
2 (1.3%)
5 (3.3%)
3 (2%)
5 (3.3%)

30 (20%)
44 (29.3%)
30 (20%)

30 (20%)
42 (28%)
46 (30.7%)

34 (22.7%)
52 (34.7%)
66 (44%)

49 (32.7%)
9 (6%)
5 (3.3%)

66 (44%)
64 (42.7%)
75 (50%)

39 (26%)
42 (28%)
35 (23.3%)

39 (26%)
38 (25.3%)
36 (24%)

3 (2%)
3 (2%)
2 (1.3%)

25 (16.7%)
18 (12%)

56 (37.3%)
45 (30%)

51 (34%)
55 (36.7%)

16 (10.7%)
28 (18.7%)

18 (12%)

54 (36%)

57 (38%)

19 (12.7%)

24 (16%)

53 (35.3%)

52 (34.7%)

17 (11.3%)

14 (9.3%)
9 (6%)

23 (15.3%)
19 (12.7%)

54 (36%)
57 (38%)

57 (38%)
62 (41.3%)

16 (10.7%)
44 (29.3%)
32 (21.3%)

21 (1%)
48 (32%)
38 (25.3%)

55 (36.7%)
54 (36%)
59 (39.3%)

54 (36%)
2 (1.3%)
19 (12.7%)

14 (9.3%)
24 (16%)

25 (16.7%)
38 (25.3%)

55 (36.7%)
75 (50%)

53 (35.3%)
8 (5.3%)
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Major
facilitator

Item

Policy Factors
NEP registration of clients
36 (24%)
Number of supplies females can 56 (37.3%)
receive weekly
Law enforcement involvement
20 (13.3%)

Minor
facilitator

Not a
facilitator

Not
applicable

44 (29.3%)
37 (24.7%)

64 (42.7%)
50 (33.3%)

4 (2.7%)
4 (2.7%)

24 (16%)

73 (48.7%)

30 (20%)

Facilitators. Organizational factors identified as major facilitators were the staff
interaction with clients (60.7%), client confidentiality (53.3%) and NEP staff knowledge
regarding services provided (50%). Minor organizational facilitators identified were the
staff’s knowledge about FWID and the exchange of sex for drugs (36.7%), number of
staff (36%), health communication campaigns reflect community/cultural norms (36%)
and health communication campaigns reflect susceptibility/vulnerability of health
complications related to injection drug use (35.3%).
Major practice facilitators were the availability of male condoms (29.3%),
availability of female/internal condoms (21.3%) and the clients lack of concern regarding
punitive action (reporting to CPS, CJ system, etc.) for NEP use (16%). These were also
noted as minor practice facilitators at 32% for the availability of male condoms, 25.3%
for the availability of female/internal condoms and 25.3% for concern regarding punitive
action. Major policy facilitators include the number of supplies females can receive
weekly (37.3%) and the NEP registration of clients (24%). Both items are also
considered minor facilitators, NEP registration (29.3%) and the number of supplies
(24.7%).
Non-facilitators. Organizational factors that were reported as not being
facilitators to NEP usage include staff turnover (54%), race/ethnicity of staff (52.7%),
age of staff (48.7%), the level of community support for a harm reduction program (44%)

98

and accessibility of public transportation (42%). Practice factors that are not a facilitator
include the clients concern regarding punitive action (50%) and availability of female
condoms/internal condoms (39.3%). Law enforcement involvement (48.7%) is not
considered a policy facilitator and neither is the NEP registration of clients (42.7%).
Chi-square Test of Independence
A chi-square test of independence was performed to determine if there was a
statistically significant association between the perception of facilitators to utilization and
the respondent characteristics which included Kentucky versus non-Kentucky, employee
type (health department versus non-health department), NEP type (fixed location versus
other location types) and NEP location (urban versus rural). Kentucky versus nonKentucky was selected based on the small sample size of the other states compared to
Kentucky. Additionally, major and minor facilitators were combined into one category
of facilitators. Details are provided for each usage facilitator identified as statistically
significant.
Facilitators of NEP Usage by Kentucky versus Non-Kentucky
Availability of supplies. The results indicated the state the NEP is located in and
the availability of supplies are related in the population. The results showed a significant
association between the two variables X2 (1, N=140) = 8.35; p<.05. The results of the
contingency table reflected 63.9% of respondents from Kentucky view the availability of
supplies as a usage facilitator. Eighty-six percent (86%) of non-Kentucky respondents
viewed the availability of supplies as a facilitator to usage. The phi coefficient indicated
the availability of supplies explained 5.95% of the variance in the state of the NEP, which
reflected the two variables have a weak negative relationship.
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Facilitators of Needle Exchange Program Usage by Employee Type
Availability of supplies. The results indicated the employee type and the
availability of supplies are related in the population. The results showed a significant
association between the two variables X2 (1, N=140) = 3.80; p<.05. The results of the
contingency table showed 66.2% of health department respondents viewed the
availability of supplies as a usage facilitator. Eighty-one percent (81%) of non-health
department respondents view the availability of supplies as a facilitator to usage. The phi
coefficient indicated the availability of supplies explained 2.72% of the variance in the
type of employee, which reflected the two variables have a weak negative relationship.
Law enforcement involvement. The results indicated the employee type and law
enforcement involvement are related in the population. The results showed a significant
association between the two variables X2 (1, N=113) = 9.60; p<.05. The results of the
contingency table reflected 23.8% of health department respondents view law
enforcement involvement as a facilitator to usage. Fifty-two percent (52%) of non-health
department respondents viewed law enforcement involvement as a usage facilitator. The
phi coefficient indicated law enforcement involvement explained 8.46% of the variance
in the type of employee, which reflected the two variables have a weak negative
relationship.
Facilitators of Needle Exchange Program Usage by Program Type
Availability of a parking space. The results indicated the NEP type and mobile
NEP services are related in the population. The results showed a significant association
between the two variables X2 (1, N=139) = 5.47; p<.05. The results of the contingency
table reflected 66.2% of respondents from fixed NEPs view mobile unit services as a
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facilitator to usage. Over 46% of respondents from other NEP types viewed NEP mobile
unit services as a usage facilitator. The phi coefficient indicated mobile NEP services
explained 3.92% of the variance in the NEP type, which reflected the two variables have
a weak positive relationship.
Quality of supplies. The results indicated the NEP type and the quality of
supplies are related in the population. The results showed a significant association
between the two variables X2 (1, N=141) = 4.09; p<.05. The results of the contingency
table showed 80.9% of respondents from a fixed NEP viewed the quality of supplies as a
facilitator to usage. Almost 66% of respondents from other NEP types viewed the quality
of supplies as a usage facilitator. The phi coefficient indicated the quality of supplies
explained 2.89% of the variance in the NEP type, which reflected the two variables have
a weak positive relationship.
Staff knowledge regarding services provided. The results indicated the NEP
type and the NEP staff knowledge regarding services provided are related in the
population. The results showed a significant association between the two variables X2 (1,
N=144) = 4.28; p<.05. The results of the contingency table reflected 82.6% of
respondents from a fixed NEP view NEP staff knowledge regarding services provided as
a facilitator to usage. Almost 68% of respondents from other NEP types viewed NEP
staff knowledge regarding services provided as a usage service facilitator. The phi
coefficient indicated that staff knowledge explains 2.99% of the variance in the NEP
type, which reflected the two variables have a weak positive relationship.
Availability of male condoms. The results indicated the NEP type and the
availability of male condoms are related in the population. The results showed a
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significant association between the two variables X2 (1, N=143) = 5.18; p<.05. The
results of the contingency table showed 72.5% of respondents from a fixed NEP viewed
the availability of male condoms as a usage facilitator. Over 54% of respondents from
other NEP types viewed the availability of male condoms as a facilitator to usage. The
phi coefficient indicated that staff knowledge explains 3.61% of the variance in the NEP
type, which reflected the two variables have a weak positive relationship.
Number of supplies females can receive weekly. The results indicated the NEP
type and the number of supplies females can receive weekly are related in the population.
The results showed a significant association between the two variables X2 (1, N=140) =
4.38; p<.05. The results of the contingency table showed 73.1% of respondents from a
fixed NEP viewed the number of supplies females can receive weekly as a usage
facilitator. Over 56% of respondents from other NEP types viewed the number of
supplies females can receive weekly as a facilitator to usage. The phi coefficient
indicated the number of supplies a female can receive weekly explained 3.13% of the
variance in the NEP type, which reflected the two variables have a weak positive
relationship.
Table 10 provides a summary of statistically significant chi-square results of
facilitators to utilization by NEP type.
Table 10
Facilitators of Needle Exchange Program Usage by Program Type
Fixed NEP

Other NEP
Type

Availability of a parking space
Facilitator
66.2% (45) 46.5% (33)
Quality of supplies
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Total

Sig

56.1% .019

Fixed NEP

Other NEP
Type

Total

Facilitator
80.9% (55) 65.8% (48) 73%
Staff knowledge regarding services provided
Facilitator
82.6% (57) 67.6% (50) 74.8%
Availability of male condoms
Facilitator
72.5% (50) 54.1% (40) 62.9%
Number of supplies females can receive weekly
Facilitator
73.1% (49) 56.2% (41) 64.3%

Sig

.043
.038
.023
.036

Facilitators of Needle Exchange Program Usage by Program Location
Staff are community members. The results indicated the type of NEP location
and staff being community members are related in the population. The results showed a
significant association between the two variables X2 (1, N=135) = 4.69; p<.05. The
results of the contingency table showed 72.3% of respondents from an urban NEP viewed
staff being community members as a usage facilitator. Over 54% of respondents from a
rural NEP viewed staff being community members a facilitator to usage. The phi
coefficient indicated staff being community members explained 3.45% of the variance in
the type of NEP location, which reflected the two variables have a weak positive
relationship.
Gender of staff. The results indicated the type of NEP location and the gender of
staff are related in the population. The results showed a significant association between
the two variables X2 (1, N=137) = 4.81; p<.05. The results of the contingency table
showed 72.3% of respondents from an urban NEP viewed the gender of staff as a usage
facilitator. Over 54% of respondents from a rural NEP viewed the gender of staff as a
usage facilitator. The phi coefficient indicated the gender of staff explained 3.49% of the
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variance in the NEP location, which reflected the two variables have a weak positive
relationship.
Race/ethnicity of staff. The results indicated the type of NEP location and the
race/ethnicity of staff are related in the population. The results showed a significant
association between the two variables X2 (1, N=132) = 5.82; p<.05. The results of the
contingency table reflected 53.1% of respondents from an urban NEP viewed the
race/ethnicity of staff as a usage facilitator. Over 32% of respondents from a rural NEP
viewed the race/ethnicity of staff a facilitator to usage. The phi coefficient indicated the
race/ethnicity of staff explained 4.41% of the variance in the NEP location, which
reflected the two variables have a weak positive relationship.
Accessibility of public transportation. The results indicated the type of NEP
location and the accessibility of public transportation are related in the population. The
results showed a significant association between the two variables X2 (1, N=137) =
10.47; p<.05. The results of the contingency table reflected 69.2% of respondents from
an urban NEP viewed the accessibility of public transportation as a facilitator to usage.
Nearly 42% of respondents from a rural NEP viewed the accessibility of public
transportation as a usage facilitator. The phi coefficient indicated the accessibility of
public transportation explained 7.67% of the variance in the NEP location, which
reflected the two variables have a weak positive relationship.
Level of community support for a harm reduction program. The results
indicated the type of NEP location and the level of community support are related in the
population. The results showed a significant association between the two variables X2 (1,
N=137) = 12.47; p<.05. The results of the contingency table reflected 68.2% of
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respondents from an urban NEP viewed the level of community support for a harm
reduction program as a usage facilitator. Thirty-eight percent (38%) of respondents from
a rural NEP viewed the level of community support for a harm reduction program as a
facilitator to usage. The phi coefficient indicated the level of community support for a
harm reduction program explained 9.12% of the variance in the NEP location, which
reflected the two variables have a moderate positive relationship.
Availability of supplies. These results indicated the type of NEP location and the
availability of supplies are related in the population. The results showed a significant
association between the two variables X2 (1, N=139) = 8.46; p<.05. The results of the
contingency table indicated 84.8% of respondents from an urban NEP viewed the
availability of supplies as a usage facilitator. Sixty-three percent (63%) of respondents
from a rural NEP viewed the availability of supplies as a facilitator to usage. The phi
coefficient indicated the availability of supplies explained 6.1% of the variance in the
NEP location, which reflected the two variables have a weak positive relationship.
Table 11 provides a summary of statistically significant chi-square results of
facilitators to utilization by NEP location type.
Table 11
Facilitators to Needle Exchange Program Usage by Program Location
Urban

Rural

Staff are community members
Facilitator
72.3% (47) 54.3% (38)
Gender of staff
Facilitator
72.3% (47) 54.2% (39)
Race/ethnicity of staff
Facilitator
53.1% (34) 32.4% (22)
Accessibility of public transportation
Facilitator
69.2% (45) 41.7% (30)
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Total

Sig

63%

.030

62.8% .028
42.4% .016
54.7% .001

Urban

Rural

Total

Sig

Level of community support for a harm reduction program
Facilitator
68.2% (45) 38% (27)
52.6% .000
Availability of supplies
Facilitator
84.8% (56) 63% (46)
73.4% .004

Needle Exchange Program Services
Respondents were asked to indicate if the services outlined in Table 12 were
offered or not offered at their NEP. If a service was not offered, they were asked to
indicate if they believed it should be offered at their NEP. Over 97% of respondents
stated their NEP offers drug treatment referrals, 96.7% offer NARCAN, 94% offer HIV
testing, 92% offer hepatitis testing and 90.7% offer male condoms.
In regards to unavailable services, 83.3% do not offer specified days and times for
females only, 82.7% do not offer vision services and 77.3% do not offer dental services.
Services that are not offered but respondents felt should be offered included human
trafficking literature (25.3%), other birth control options (22%), sexual abuse literature
(21.3%), female/internal condoms (20.7%) and the ability to apply for state health
insurance (20.7%).
Table 12
Needle Exchange Program Services
Offered

Not Offered

141 (94%)
138 (92%)
5 (3.3%)

3 (2%)
3 (2%)
125 (83.3%)

Should be
Offered
3 (2%)
7 (4.7%)
18 (12%)

75 (50%)
72 (48%)
104 (69.3%)
61 (40.7%)

55 (36.7%)
37 (24.7%)
20 (13.3%)
67 (44.7%)

18 (12%)
38 (25.3%)
24 (16%)
19 (12.7%)

Service
HIV testing
Hepatitis testing
Specified days and times for females
only
Flu shot
Pre-exposure prophylaxis (PrEP) for HIV
STI/STD testing
Tetanus shot
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Service
Other vaccinations/immunizations
NARCAN
Drug treatment referrals
Mental health counseling referrals
Medication assisted treatment referrals
Mobile NEP services
Female/internal condoms
Male condoms
Other birth control options
Feminine hygiene products
OBGYN services
Dental services
Vision services
Self-help classes
Pediatric health services
Wound care supplies
Childcare for NEP visit only
Parenting classes
Housing assistance
Employment services
Clothing services
Food bank
Human trafficking literature
Domestic violence literature
Sexual abuse literature
HIV literature
STI/STD literature
Ability to apply for state health insurance
Ability to apply for a birth certificate
Ability to apply for a state ID
card/driver’s license

Offered
81 (54%)
145 (96.7%)
146 (97.3%)
135 (90%)
119 (79.3%)
90 (60%)
70 (46.7%)
136 (90.7%)
46 (30.7%)
67 (44.7%)
26 (17.3%)
6 (4%)
2 (1.3%)
22 (14.7%)
19 (12.7%)
108 (72%)
8 (5.3%)
16 (10.7%)
53 (35.3%)
36 (24%)
50 (33.3%)
65 (43.3%)
57 (38%)
82 (54.7%)
82 (54.7%)
127 (84.7%)
125 (83.3%)
54 (36%)
56 (37.3%)
20 (13.3%)

Not Offered
46 (30.7%)
2 (1.3%)
1 (.7%)
6 (4%)
10 (6.7%)
26 (17.3%)
36 (24%)
1 (.7%)
58 (38.7%)
44 (29.3%)
83 (55.3%)
116 (77.3%)
124 (82.7%)
87 (58%)
106 (70.7%)
22 (14.7%)
112 (74.7%)
101 (67.3%)
62 (41.3%)
77 (51.3%)
71 (47.3%)
57 (38%)
44 (29.3%)
29 (19.3%)
25 (16.7%)
6 (4%)
7 (4.7%)
55 (36.7%)
59 (39.3%)
91 (60.7%)

Should be
Offered
19 (12.7%)
1 (.7%)
0
6 (4%)
8 (5.3%)
22 (14.7%)
31 (20.7%)
1 (.7%)
33 (22%)
27 (18%)
28 (18.7%)
17 (11.3%)
13 (8.7%)
30 (20%)
14 (9.3%)
10 (6.7%)
19 (12.7%)
23 (15.3%)
24 (16%)
27 (18%)
19 (12.7%)
18 (12%)
38 (25.3%)
29 (19.3%)
32 (21.3%)
7 (4.7%)
8 (5.3%)
31 (20.7%)
24 (16%)
27 (18%)

Services Composite Scores
Healthcare services composite score. The Healthcare Services Score (HSS) was
computed for each respondent by taking the sum of 19 items in the NEP services list.
Healthcare service score variables included HIV testing, Hepatitis testing, flu shot, PreP
for HIV, STI/STD testing, tetanus shot, other vaccinations/immunizations, NARCAN,
drug treatment referrals, mental health counseling referrals, MAT referrals,
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female/internal condoms, male condoms, other birth control options, OBGYN services,
dental services, vision services, pediatric health services and wound care supplies.
HSS scores ranged from 3.0 to 54.0, with a mean of 34.77 and a standard
deviation of 8.39. Fifty-two percent (52%) of respondents scored a 35 or higher on the
HSS score. High scores on the HSS indicated the NEP the respondent works for offers or
should offer a large number of healthcare services to clients.
Independent t-Test
An independent t-test was performed to examine the HSS and statistically
significant differences between the means of Kentucky versus non-Kentucky, employee
type (health department versus non-health department), NEP type (fixed location versus
other location types) and NEP location (urban versus rural).
The independent t-test examined the HSS based on Kentucky versus nonKentucky respondents. The results showed a significant difference between Kentucky
versus non-Kentucky t(143)=2.44, p=.016. Kentucky reporter higher levels of health
services (M=36.33, SD=7.50) than non-Kentucky (M=32.93, SD=9.17). The mean
difference was 3.4. The results are supported by the Mann-Whitney U, which also
showed a significant difference between Kentucky versus non-Kentucky in regard to the
Health Services Score (z=-2.06; p=.020).
The independent t-test examined the HSS based on employee type (health
department employee and non-health department employee). The results showed a
significant difference between health department employees and non-health department
employees t(143)=2.27, p=.024. Health department employees reported a higher HSS
(M=36.04, SD=6.28) than non-health department employees (M=32.92, SD=10.01). The
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mean difference was 3.12. The results are supported by the Mann-Whitney U, which also
showed a significant difference between employee type in regard to the Health Services
Score (z=-2.04; p=.023).
The independent t-test examined the HSS based on NEP type (fixed and other
NEP types). The results showed a non-significant difference between fixed NEPs and
other NEP types.
The independent t-test examined the HSS score based on NEP location (urban and
rural). The results showed a significant difference between urban and rural NEPs t(142)=2.37, p=.019. Respondents from rural areas reported higher levels of health services
(M=36.49, SD=7.90) than urban areas (M=33.22, SD=8.61). The mean difference was
3.27. The results are supported by the Mann-Whitney U, which also showed a significant
difference between urban and rural NEP locations in regard to the Health Services Score
(z=.094; p=.46).
Educational services composite score. The Educational Services Score (ESS)
was computed for each respondent by taking the sum of the variable which included selfhelp classes, parenting classes, literature on human trafficking, domestic violence, sexual
abuse, HIV and STI/STDs. ESS scores ranged from 3.0 to 21.0, with a mean of 12.5 and
a standard deviation of 4.30. Over 51% of respondents scored a 13.0 or higher on the
ESS. High scores on the ESS indicated the NEP the respondent works for offers or
should offer a large number of educational services to clients.

Independent t-Test
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An independent t-test was performed to examine the ESS and statistically
significant differences between the means of Kentucky versus non-Kentucky, employee
type (health department and non-health department), NEP type (fixed location and other
location types) and NEP location (rural and urban). The results showed they are
statistically non-significant.
Specialized needle exchange program score. The Specialized NEP Score
(SNS) was computed for each respondent by taking the sum of three items in the NEP
services list which included specified days and times for females, mobile NEP services
and childcare for the NEP visit. SNS scores ranged from 1.0 to 7.0, with a mean of 3.09
and a standard deviation of 1.23. Over 24% of respondents scored a 4.0 or higher on the
SNS. High scores on the SNS indicate the NEP the respondent works for offers or should
offer a large number of specialized NEP services to clients.
Independent t-Test
An independent t-test was performed to examine the SNS and statistically
significant differences between the means of Kentucky versus non-Kentucky, employee
type (health department and non-health department), NEP type (fixed location and other
location types) and NEP location (rural and urban). The results showed all but employee
type are statistically non-significant.
The independent t-test examined the SNS based on employee type (health
department employee and non-health department employee). The results showed a
significant difference between health department employees and non-health department
employees t(113)=-2.12, p=.039. Non-health department employees reported a higher
specialized NEP services score (M=3.31, SD=1.27) than health department employees
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(M=2.84, SD=1.10). The mean difference was .47. The results were supported by the
Mann-Whitney U, which also showed a significant difference between employee type in
regard to the Specialized NEP Services Score (z=2.045; p=.021).
Basic needs score. The Basic Needs Score (BNS) was computed for each
respondent by taking the sum of eight items in the NEP services list. Basic needs score
variables included feminine hygiene products, housing assistance, employment services,
clothing services, food bank services, ability to apply for state health insurance, ability to
apply for a birth certificate and the ability to apply for state ID card/driver’s license.
BNS scores ranged from 1.0 to 24.0, with a mean of 10.77 and a standard
deviation of 5.89. Over 44% of respondents scored an 11.0 or higher on the BNS. High
scores on the BNS indicated the NEP the respondent works with offers or should offer a
large number of basic need services to clients.
Independent t-Test
An independent t-test was performed to examine the BNS and statistically
significant differences between the means by Kentucky versus non-Kentucky, employee
type (health department versus non-health department), NEP type (fixed location versus
other location types) and NEP location (urban versus rural). The results showed all but
employee type are statistically non-significant.
The independent t-test examined the basic needs services score based on
employee type (health department employee and non-health department employee). The
results showed a significant difference between health department employees and nonhealth department employees t(107)=-3.56, p=.001. Non-health department employees
reported a higher basic needs score (M=12.69, SD=6.00) than health department
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employees (M=9.04, SD=5.24). The mean difference was 3.65. The results were
supported by the Mann-Whitney U, which also showed a significant difference between
employee type in regard to the Basic Needs Services Score (z=3.46; p=.001).
Targeted Outreach to Females
Respondents were asked if their NEP conducted any targeted
recruitment/outreach initiatives toward females who inject drugs. Nearly 17% indicated
they had conducted some form of targeted recruitment/outreach toward FWID.
Chi-square Test of Independence
The results indicate the NEP type and targeted recruitment toward FWID are
related in the population. The results showed a significant association between the two
variables X2 (1, N=122) = 3.89; p<.05. The results of the contingency table reflected
87.7% of respondents from a fixed NEP had not conducted targeted recruitment toward
FWID. Almost 74% of respondents from other NEP types had not conducted targeted
recruitment toward FWID. The phi coefficient indicated targeted recruitment toward
FWID explained 3.20% of the variance in the NEP type, which reflected the two
variables have a weak positive relationship.
Independent t-Test
An independent t-test was performed to examine targeted recruitment/outreach
initiatives and statistically significant differences between the means of Kentucky versus
non-Kentucky, employee type (health department versus non-health department), NEP
type (fixed location versus other location types) and NEP location (urban versus rural).
The results showed all but NEP type are statistically non-significant.
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The independent t-test examined targeted recruitment/outreach initiatives based
on NEP type (fixed location and other location types). The results showed a significant
difference between a fixed NEP location and other location type t(120)=-1.99, p.054.
Other NEP location types reported more targeted recruitment/outreach initiatives toward
FWID (M=1.26, SD=.444) than fixed NEP locations (M=1.12, SD=.331). The mean
difference was .24. The results were supported by the Mann-Whitney U, which also
showed a significant difference between NEP type in regard to targeted outreach (z=1.97;
p=.049).
Advantages of Offering Females Only Services
Respondents were asked if they believed there were advantages to offering female
only services. Over 51% indicated there were advantages to offering females only
services.
Chi-square Test of Independence
The results indicated the state the NEP is located in and offering females only
services are related in the population. The results showed a significant association
between the two variables X2 (1, N=122) = 6.77; p<.05. The results of the contingency
table showed 52.8% of respondents in Kentucky believe there are advantages to offering
females only services. Seventy-six percent (76%) of non-Kentucky respondents do not
believe there are advantages to offering females only services. The phi coefficient
indicated offering females only services explained <1% of the variance in the state of the
NEP, which reflected the two variables have a weak positive relationship.
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Advantages of Offering Females Only Services by Program Location
Chi-square Test of Independence
The results indicated the NEP location and offering females only services are
related in the population. The results showed a significant association between the two
variables X2 (1, N=121) = 3.58; p<.05. The results of the contingency table reflected
29.3% of respondents from an urban NEP believed there are advantages to offering
females only services. Forty-six percent (46%) of respondents from a rural NEP believed
there are advantages to offering females only services. The phi coefficient indicated
offering females only services explained 2.95% of the variance in the NEP location,
which reflected the two variables have a weak negative relationship.
Qualitative Data Analysis
Barriers to Needle Exchange Program Usage
Respondents were asked if there were any other barriers to NEP usage. Three
themes emerged (n=41) from these data: (a) operational barriers; (b) stigma; and (c)
service restrictions. Almost 59% of respondents commented operational barriers (n=24)
were an issue. This included the inability to educate specific populations about the NEP,
extending NEP days and times, the need for more volunteers, issues relating to the
agency running the NEP, the lack of services linkages within the community, law
enforcement involvement and the need for a mobile NEP unit.
Stigma (n=11) was identified by over 26% of respondents. These concerns
included lack of trust with staff, confidentiality and females’s relationship dynamics with
staff. Services restrictions (n=6) were identified by nearly 15% of respondents.
Restrictions mentioned were the one-to-one rule, inability to use federal funds to
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purchase syringes, the lack of NEP services being offered in rural areas, city
government’s unwillingness to allow NEP advertising and expanding the days and times
of NEP services and downplaying the drug problem within the service area.
Respondent quotes enhance the richness of the data and provides additional
perspective. Quotes related to emergent themes are outlined in Table 13.
Table 13
Needle Exchange Program Usage Barriers Quotes
Theme
Operational barrier –
educating specific
populations about the NEP

Quote
“The biggest barrier we face is engaging
the black/brown communities”

Operational barrier – law
enforcement involvement

“They (NEP client) feel they cannot take
and use a sharps container or dispose of
a used syringe properly, because they are
afraid of being arrested for having drug
residue on the used syringes in the
sharps container”.

Stigma

“Males can sleep around, and no one
bats and eye, but when females do it,
she’s promiscuous”.

Service restrictions

“The rule makes it difficult for
participants to get all the supplies they
need”.

Facilitators to Needle Exchange Program Usage
Staff were asked if there were any additional facilitators (n=23) they believed
should be discussed and four themes were identified: (a) supportive relationships; (b)
staffing; (c) NEP operations; and (d) client awareness. A facilitator identified by almost
35% of the respondents was the supportive relationships (n=8) that staff build with clients
through providing a welcoming environment, educating clients about NEP services and
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motivating them to continue to use their services. As one respondent stated “a big
facilitator is establishing a good rapport with participants so they feel comfortable using
the services and will return/refer others”.
Over 25% of respondents mentioned facilitators related to staffing (n=6) which
included the consistency in staff, adequate staff salaries, staff training and the ability of
clients to request to be seen by a staff member based on their gender. NEP operations
(n=5) as a facilitator were noted in over 20% of the responses. Specifics mentioned were
providing linkages to other services, accessibility of the program and offering private
individual visits. Client awareness (n=4) of the NEP through word of mouth was
reported by 17.3% of the respondents as facilitator to NEP usage for FWID.
Other Services Provided
Respondents were asked if additional services were provided, and two themes
emerged (n=23) which included: (a) referrals; and (b) on-site services. Referrals for
service (n=12) were identified by over 52% of respondents and included HIV and
Hepatitis C treatment, clothing, healthcare, food pantry, drug treatment and housing.
Over 45% of respondents mentioned on site services (n=11) which included providing
other injection equipment such as sharps containers and fentanyl test strips, WIC, NA/AA
meetings, medical care, peer support services and providing personal items such as
hygiene kits.
Targeted Outreach Initiatives
Respondents were asked to provide information on targeted recruitment/outreach
initiatives conducted toward females who inject drugs. Two themes were identified
(n=29) which included: (a) networking; and (b) advertising. Over 72% of respondents
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reported they network with other community agencies and target specific populations
(n=21). Agencies included treatment facilities, shelters, food pantries and hotels with
high drug activity and overdose rates. Specific populations focused on are sex workers,
persons who are homeless and those that are being released from incarceration. As one
respondent mentioned “we target known areas of high drug activity with our mobile
unit”.
Advertising targeted at females who inject drugs was noted by nearly 28% of
respondents (n=8). Advertising included the use of Facebook and other social media,
posting printed flyers and word of mouth by other female clients.
Encouraging Continuation of Needle Exchange Program Usage
NEP staff were asked how they encouraged females who inject drugs to continue
NEP usage. Five themes emerged (n=151) from these data: (a) positive client
interactions; (b) client education; (c) providing on-site services and referrals; (d)
promoting awareness; and (e) confidential service. Over 40% of respondents believed
positive client interaction promoted continual NEP usage (n=65). Specific items
mentioned included staff not being judgmental, developing a positive rapport with female
clients, creating a welcoming environment and making sure that FWID are made to feel
safe and comfortable. As one respondent stated, “I encourage them by telling them I want
them to be safe and stay alive. I give them my phone number and tell them to reach out
to me if they need anything”.
Almost 30% of staff indicated regular client education (n=33) encouraged the
return of FWID to the NEP. This included educating clients about the services the NEP
offers and the harms associated with reusing syringes.
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Providing female specific onsite services and referrals (n=17) was noted as
facilitating the return of female clients. Specific services included providing feminine
hygiene products, other female health related supplies and screening females for assault
and domestic violence.
Promoting awareness of the NEP through various mechanisms was identified by
almost 11% of respondents (n=16). Promotion included female clients encouraging other
females who inject drugs to use the NEP, offering peer support, staff gender and ability
of clients to request specific staff. Formal outreach included working with other
community agencies, advertising via social and print media and offering large quantities
of syringes as part of a secondary exchange.
Nearly 6% of respondents believed continual NEP usage is promoted through
providing individual and confidential service (n=9). This type of environment includes
seeing clients individually away from males and allowing for one-on-one communication
with staff.
Respondent quotes are provided for context and to enhance the depth of the data.
Quotes related to emergent themes are outlined in Table 14.
Table 14
Needle Exchange Program Continuation Quotes
Theme
Positive client interactions

Quote
“I treat them like a real person that they are. I show
them respect without any stigmatization”.

Client education

“I stress the importance of harm reduction services
and wanting to be a partner with the person to assist
them in staying as healthy as possible. Developing a
positive and personal relationship with all
participants is crucial to the success of NEPs”.
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Theme
Quote
Providing on-site services and “We encourage large secondary exchanges so that
referrals
supplies get to where they are needed without having
to show up in person”.
Promoting awareness

“Ask FWID to bring in other FWID. Honestly, it
has never been a problem”.

Confidential service

“Continue to let them know everything is
confidential”.

Improvement of Outreach
Respondents were asked how outreach to females who inject drugs could be
improved and three themes were identified (n=36): (a) increased program awareness; (b)
site improvements; and (c) environment. Over 40% of respondents felt there was a need
to increase program awareness (n=13). Ideas mentioned were to collaborate with more
community partners, focus on specific populations such as persons released from jail and
sex workers, finding new locations for the mobile unit to serve and providing time for
NEP staff to conduct outreach.
Site improvements (n=11) were mentioned by over 30% of respondents.
Suggested upgrades were offering peer support, providing more resources to females,
having a larger space, increasing the number and gender of staff and offering more
availability of NEP services.
Improving the environment (n=10) was commented on by 27.7% of respondents.
This included addressing stigma, providing consistent and thoughtful approaches to care
and offering female only services.
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Advantages to Female Only Services
Staff were asked if they believed there were advantages to offering females-only
services and what they believed the advantages were. Four themes emerged (n=95) from
these data: (a) increased connection to resources; (b) empowerment; (c) education; and
(d) increase in usage. Over 55% of respondents felt females only services allowed for an
increased connection to resources (n=54) which in turn impacts a FWID health and wellbeing. This included offering female specific services and supplies, referrals and
providing a safe space.
Over a quarter (25.2%) of respondents believed offering female services allows
females to feel empowered. This included a safe, comfortable environment where FWID
do not feel like they are being judged. A respondent shared “making females feel
empowered, safe, connected, and heard is vital to their well-being and is very
advantageous. The advantages are more meaningful conversations/connections and more
useful referrals to outside resources”.
Nearly 12% of respondents believed another advantage was the ability to educate
females (n=11). Educating FWIDs included providing self-help classes, educating them
on harms against females, drug related crimes, the dangers of drug use during pregnancy
and the role of child protective services. As one staff member stated “females are
historically caretakers and victims. By providing (female only) services we can help
children and others in their care as well as help prevent drug-related crimes against
females”. Over 6% of staff believed offering female only services would promote
increased NEP usage (n=6).
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Modifying Needle Exchange Program Policy
Respondents were asked to provide recommendations for policy changes at their
NEP. Three themes were identified (n=98) which included: (a) site service
improvements; (b) one-to-one exchange policy; and (3) law enforcement education. Over
68% of staff would like to see service site improvements. Nearly a third of the
suggestions pertained to increasing operating days and times and allowing clients to make
appointments. Items also mentioned included offering peer support, providing more
referrals to drug treatment, a larger location, offering a mobile unit, advertising, increase
in staff and staff training. A respondent stated “if we were able to advertise our services
more openly then we would be able to reach more users and not make them feel like they
should be ashamed of using”. Site policy changes mentioned included reducing red tape
for clients and staff and allowing children at the NEP. A staff member shared “no ID
...don't need an ID to vote, but need an ID to get supplies that may save a life”.
Almost a quarter (24.4%) of staff believed the one-to-one needle exchange policy
needs to be modified (n=24). As one respondent stated “I wish we offered more supplies
and syringes for our people. The more clean product we get on the streets the more
people who will inject with clean supplies and lower and slow the transmission of
HIV/Hepatitis C. As well as STDs”.
Four percent (4%) of respondents believed law enforcement should be educated
about the NEP in order to ease client’s fears of their involvement. A staff member stated
“it would greatly help if participants didn't have to fear criminal justice consequences
when getting pulled over with new and used syringes. We don't receive nearly as many
used syringes back, simply because of this very real and very scary reality”.
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Additional Comments
Respondents were asked to provide additional comments and three themes
emerged (n=19) which included: (a) organizational operations; (b) program awareness;
and (3) future research. Over 50% of staff commented on the need to improve
organizational operations. This included the ability to increase staffing, provide staff
training, provide additional services, offer a mobile unit and revise funding limitations.
Increased program awareness through education and advertising was mentioned
by 21% of respondents. As one person stated “the population needs education on
addiction and how the disease runs its course. The stigma is horrible,
media/TV/Hollywood exploit people with SUD as monsters...that is just not true”.
Over a quarter (26.3%) of respondents provided comments related to the survey
and future research suggestions. Comments included clarifying the definition of a
community member, not using the verbiage of needle exchange but syringe service
program and making a distinction between female as gender and female as sex. A
respondent stated “I do feel there needs to be research done for the male population.
There are just as many males who have access issues as the females. This should not be a
one-way street. Everyone regardless of age, race, religion etc. etc. are welcomed to the
syringe program and no one is turned away, everyone is given the same opportunities
equally. It’s up to the individual syringe participant on how successful the program works
for them”.
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Policy Analysis
State Law Considerations for Needle Exchange Programs
As previously mentioned in Chapter 1, Burris (2017) and the Centers for Disease
Control (2017, September) proposed the following program components for NEP
programs, which must be considered at the state level. Table 7 reflects the components
which are in place in each state included in the research.
Table 15
Needle Exchange Program Components by State
Component
Is the sale
and
distribution
of drug
paraphernalia
prohibited by
state law?
Does
paraphernalia
include
syringes?
Does
paraphernalia
exclude any
drug related
equipment?

IL
Yes

IN
Yes

KY
Yes

MO
Yes

OH
Yes

TN
Yes

VA
Yes

WVA
Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

No

No

No

No

No

No

No

If
paraphernalia
includes
syringes, are
there any
exceptions
for disease
prevention?

Yes

Yes

Yes

No

No

Yes

Yes

No

If so, what
are the
exceptions
(e.g., NEP

NEP

NEP

NEP

n/a

n/a

NEP

NEP
n/a
Pharmacy
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Component
use, medical
purposes,
etc.)?
Are the sale
of syringes
regulated by
state law?

IL

IN

KY

MO

OH

TN

VA

WVA

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Is a
prescription
required for
the purchase
of syringes?

Yes

No

No

No

No

No

No

No

If so, is there
a minimum
number of
syringes that
can be
obtained
without a
prescription?
Can syringes
only be sold
through a
pharmacy?

<100 n/a

n/a

n/a

n/a

n/a

n/a

n/a

Yes

Yes

Yes

No

Yes

Yes

Yes

No

What
information
is the buyer
required to
provide to
purchase
syringes?
Does state
law prohibit
NEPs?

No

Name
Name
n/a
Address Address
Purpose

No

Purpose Name
Address
Purpose

n/a

No

No

No

No

No

No

No

No

Does a NEP
require local
approval?

No

Yes

Yes

No

No

No

No

Yes

Are NEPs
required to
operate a
one-to-one

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

124

Component
exchange for
syringes?

IL

IN

KY

MO

OH

TN

VA

WVA

Are syringe
starter sets
permitted?

No

No

No

No

No

No

No

No

In reflecting on the relevant considerations that Burris (2017) and the Centers for
Disease Control (2017, September) suggest when considering a NEP, 100% of the states
prohibit the sale and distribution of drug paraphernalia, the definition of paraphernalia
includes syringes and there are no exclusions to paraphernalia with regards to drug use
equipment. Nearly 38% of the states do not exclude syringes from the definition of
paraphernalia based on disease prevention. Those states that do offer an exclusion based
on disease prevention allow syringes for NEP use. Illinois is the only state that requires a
prescription for syringes for more than 100. Missouri and West Virginia allow syringes
to be sold in other settings than a pharmacy. Fifty percent (50%) of states require some
form of information from the buyer when purchasing syringes. All of the states
examined allow NEPs and almost 38% require local approval to operate. One-hundred
percent (100%) of states require a one-for-one exchange and do not permit starter sets.
Policies Impacting Females Who Use Drugs
A list of policies has been compiled which impact females who use drugs are
outlined in Table 16. Policy data was collected through an extensive internet search.
Table 16
Policies Impacting Females Who Use Drugs by State
Policy
IL
Legal Policies/Laws
Substance abuse No
during

IN

KY

MO

OH

TN

VA

WVA

No

No

No

No

Yes

No

No
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Policy
IL
IN
pregnancy is a
crime
Substance abuse Yes
Yes
during
pregnancy is
child abuse
Females have
Yes
Yes
been prosecuted
for drug use
during
pregnancy
Drug charge may Yes
Yes
impact child
custody and
visitation
State has felony No
Yes
3 strikes law
State has
No
Yes
habitual offender
law
Drug Testing and Treatment
Drug testing is
No
No
required if drug
use during
pregnancy is
suspected
Drug use
Yes
No
diagnosed or
suspected during
pregnancy state
requires
reporting
Drug use during No
No
pregnancy
considered
grounds for civil
commitment
Drug treatment
No
Yes
for pregnant
females targeted
Pregnant females Yes
No
given priority
access in general
treatment
programs

KY

MO

OH

TN

VA

WVA

Yes

Yes

Yes

No

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

No

No

Yes

Yes

No

No

No

No

Yes

No

No

Yes

No

No

No

No

No

Yes

No

Yes

No

Yes

No

No

No

No

No

No

No

Yes

No

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

No

No
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Policy
IL
IN
KY
MO
Pregnant
Yes
No
Yes
Yes
substance
abusing females
protected from
discrimination in
publicly funded
drug treatment
programs
Eligibility for Social Services and Other Services
SNAP public
No
M1
M1
M1
assistance with
drug charge
TANF public
M1
M1
M1
Yes
assistance with
drug charge
Section 8
Yes
Yes
Yes
Yes
Housing
Social security
Yes
Yes
Yes
Yes
Educational
Yes
Yes
Yes
Yes
financial aid
Voting after
Yes
Yes
Yes
Yes
completing
probation/parole
1
2

OH
Yes

TN
Yes

VA
No

WVA
No

No

M1

M1

Yes

Yes

M1

M1

Yes

Yes

Yes

Yes

Yes

Yes
Yes

Yes
Yes

Yes
Yes

Yes
Yes

Yes

No

No2

Yes

Modified ban
Have to apply to be reinstated.

Legal Policies/Laws
Tennessee is the only state that makes it a crime to use drugs while pregnant.
Tennessee and West Virginia do not consider drug use during pregnancy child abuse. All
of the states have prosecuted females for drug use during pregnancy and drug use can
impact child custody and visitation. Almost 38% of states have a federal felony 3-strikes
law which requires a mandatory life sentence for anyone with a “serious violent felony
who have two or more prior felony convictions” (Felonies.org, 2020, para. 9). Habitual
offender laws are in place in Indiana and Tennessee and may increase the penalty
received for being convicted of a crime regardless of the seriousness of the offense.
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Drug Testing and Treatment
Kentucky requires drug testing of babies born to females who have reported or are
suspected of drug use. Fifty percent (50%) of states require the reporting of pregnant
females who have been diagnosed or are suspected of using drugs. None of the states
have the authority to use civil commitment for drug use while pregnant. Nearly 63% of
states target pregnant females for drug treatment and provide them priority access to
treatment. Discrimination of substance abusing females is prohibited in almost 63% of
states.
Eligibility for Social Services and Other Services
In examining social services such as Supplemental Nutrition Assistance Program
(SNAP) benefits, females convicted of a drug charge are not eligible in Illinois and Ohio.
Five states offer a modified ban on receiving SNAP benefits. Modified bans allow states
to impose eligibility restrictions which may include requiring drug testing, drug treatment
participation, etc. (NCSL, 2019). Five states have a modified ban on the receipt of
Temporary Assistance for Needy Families (TANF) with a drug conviction. All of the
states allow females who have a drug conviction to be eligible for Section 8 Housing.
Those who have been convicted of producing methamphetamine in federally assisted
housing are ineligible for Section 8 Housing (hirefelons.org, 2021). In all states females
who have been convicted of a drug charge are eligible to receive social security and
educational financial aid. A convicted substance abusing female will lose their voting
rights in Tennessee. Virginia allows for reinstatement of voting rights through an
application process.
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This chapter reflects a detailed analysis on NEP service provider opinions related
to barriers, facilitators and services that promote or impede NEP usage by FWID. The
qualitative data provides additional insights and confirms some of the quantitative
findings. The policy analysis focuses on the extent to which policies in each state are
consistent with recommended best practices. Chapter V contains a detailed discussion of
the research findings and their implications for practice, policy and research.
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CHAPTER V
DISCUSSION AND CONCLUSION
Overview
While research has shown NEPs are an effective tool in combatting the health
effects of injection drug use, little is known about females and their utilization of this
service (Mills, 2015; Bowen, 2012; Knox, 2012; Kerr et al., 2010; Villarreal & Fogg,
2006; Wodak & Cooney, 2004). Historically, much of the information examining
individuals who inject drugs is “gender neutral or male focused” (UNODC, 2014). If
studies do recognize gender as part of the drug culture, “females’s experiences still lag
behind males’s in research around drugs” (Ettorre, 2004).
The purpose of this exploratory research was to investigate service provider
perspectives on barriers and facilitators to needle exchange program participation by
females who inject drugs (FWID). This chapter includes a discussion of major findings
based on the research questions within the context of the extant literature, limitations of
the research and implications for practice, policy and research as they relate to needle
exchange program usage by females who inject drugs. The research questions are
outlined below.
Organizational Questions
•

What are the barriers and facilitators to NEP participation by females who inject
drugs?

•

What NEP service delivery approaches may hinder and/or facilitate use by
females who inject drugs?

Practice Questions
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•

What services are currently available for females at NEPs?

•

What additional service needs do females have that could be offered by NEPs?

Policy Questions
•

How do NEP service delivery approaches vary by state?

•

What are the policies related to NEPs by state?

•

What state NEP policies may promote and hinder the use of NEPs by females
who inject drugs?
The theoretical frameworks which were used to help explain NEP utilization by

FWID include: (a) exchange theory; (b) the health belief model; and (c) feminist theory
and intersectionality. Factors which promote or impede usage are often a combination of
NEP organizational, practice and policy characteristics which are rooted within these
frameworks.
Interpretation of Research Findings
Barriers and facilitators to NEP usage were examined overall, and then explored
for differences based on respondent characteristics, which included Kentucky versus nonKentucky, employee type (health department versus non-health department), NEP type
(fixed location versus other location types) and NEP location (urban versus rural). Table
17 provides a directional summary to remind the reader of the barriers and facilitators
that had a statistically significant difference in perceptions based on chi-square testing.
While detailed results were reported in the prior chapter, this discussion will highlight the
extent to which these items are consistent with existing research or represent a significant
new contribution to the literature. Differences based on the NEP location (urban versus
rural) was associated with the largest number of barriers and facilitators.
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Table 17
Chi-square Summary of Barriers and Facilitators to Needle Exchange Program Use

Barriers
Staff are community
members
Staff turnover
Availability of a
parking space
Accessibility of public
transportation
Availability of supplies
Registration of clients
Gender of staff

KY vs.
Non-KY

Employee
Type (Health
dept. vs. nonhealth dept.)

Rural

Non-KY

Urban

Non-KY

Urban

KY

Rural

Non-KY

Urban
Health Dept.
Other NEP
types
Other NEP
types
Fixed NEP

Mobile unit services
Client concern
regarding punitive
action
Availability of
childcare

Gender of staff
Race/ethnicity of staff
Law enforcement
involvement
Availability of a
parking space
Quality of supplies

Urban

Fixed NEP
Rural
KY vs.
Non-KY

Employee
Type (Health
dept. vs. nonhealth dept.)

NEP Type
(Fixed NEP
vs. other
NEP types)

Staff are community
members
Accessibility of public
transportation
Availability of supplies

NEP Location
(Urban vs.
rural)

KY

Race/ethnicity of staff

Facilitators

NEP Type
(Fixed NEP
vs. other
NEP types)

NEP Location
(Urban vs.
rural)
Urban
Urban

Non-KY

Non-health
dept.

Urban
Urban
Urban

Non-health
dept.
Fixed NEP
Fixed NEP
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Staff knowledge
regarding services
provided
Availability of male
condoms
Number of supplies
females can receive
weekly
Level of community
support for a harm
reduction program

Fixed NEP
Fixed NEP
Fixed NEP

Urban

Barriers to Needle Exchange Program Participation
The majority of the usage barriers identified by the current study are consistent
with what had already been established in NEP and other research literature (except the
availability of supplies and the availability of a parking space). It should be noted that
most of the research is not gender specific, except the availability of childcare. It was
surprising that the availability of a parking spot was identified as an obstacle. While no
other NEP research was located addressing this factor, several international healthcare
studies found parking was a barrier to care and created patient stress (Shaheen, et al.,
2020; McGrath, 2015; Kale, 2012). While a parking space may seem like a trivial issue,
the more difficult it is to obtain NEP services the less likely a FWID will utilize the
service. This was particularly true for urban versus rural sites, and certain states which
may also be associated with where their NEPs were located.
Urban and rural areas each face their own challenges and a closer examination of
barriers by location (urban and rural) revealed respondents from urban sites identified
slightly more obstacles to NEP usage compared to rural sites. Current findings mirror
existing literature regarding research with nongender-specific samples, except the
availability of childcare. An example of a barrier identified by rural respondents was the
133

availability of childcare. This has been shown to be one of the largest barriers females
face in obtaining social services (MacMaster, 2013; Jackson & Shannon, 2012; Tuchman,
2010). Many females in rural areas often live in poverty and/or may be unemployed.
Therefore, the financial resources needed to pay for childcare are often limited. NEPs
typically do not allow children to be present with the client and therefore females in rural
areas face tough decisions regarding NEP utilization.
While urban areas may offer a variety of services, it is often problematic to access
services due to operating hours. This finding underscores the importance of
acknowledging that barriers exist in urban areas which appear to be somewhat
overlooked in the research.
Race/ethnicity of staff was acknowledged as a barrier across two respondent
types. Urban respondents viewed this as more of barrier than rural respondents. In a
recent drug treatment study, it was determined that while clients and counselors may be
the same race and/or gender there were variables such as acculturation that impacted
client engagement and completion of treatment (Scoles, 2020). While no NEP research
was located on this topic, drug treatment studies have produced varied retention
outcomes when clients were matched with staff of the same race and gender (Sterling,
Gottheil, Weinstein & Serota, 2001; Sterling, Gottheil, Weinstein & Serota, 1998;
Beutler, Zetzer & Yost, 1997). A 2007 correctional drug treatment study emphasized staff
should be reflective of the population they are serving (Covington & Bloom, 2007). A
prison study found Black inmates had higher rates of behavioral issues compared to other
races, but issues decreased when staff were Black (Wade-Olson, 2016). A community
court study found the racial makeup of court staff was beneficial in supporting a
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therapeutic relationship with non-white defendants (Connor, 2020). Based on the varied
results, further research on this topic should be considered.
Facilitators to Needle Exchange Program Participation
Perceptions regarding the extent to which the availability of supplies was viewed
as a facilitator in two of four respondent categories, suggesting that this programmatic
feature may be greatly influenced by context. Former research has not examined this
factor. Further study of this is warranted.
Respondents from urban locations identified the largest number of facilitators to
NEP usage. The majority of facilitators identified are well documented throughout the
NEP literature. It should be noted, however, that prior NEP research has not focused on
females specifically which is an important contribution made by the current study.
Accessibility to public transportation was viewed as both a facilitator and a barrier. NEPs
located near or on the public transportation system allows for accessible services. A
recent study on primary care usage by persons who inject drugs found convenient
transportation contributed to the receipt of care (Motavalli, et al., 2021). A facilitator to
HCV treatment adherence among persons who inject drugs was also found to be
transportation (Rich, et al., 2016).
Urban NEP respondents viewed community support for harm reduction programs
as more of a facilitator compared to rural respondents. Community support for harm
reduction programs has been well documented in the literature and is critical to program
operations (Davis, et al., 2018; Downing, et al., 2005, Sherman & Purchase, 2001;
Henman, et al., 1998). Some believe NEPs promote continued drug use and therefore,
buy-in from key community partners is necessary (Davis, et al., 2018). Even with buy-in,
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current drug paraphernalia and syringe laws are viewed as contradictory to NEP
operations and often cause confusion and frustration for clients, law enforcement and
community members.
Service Delivery Approaches
While fixed locations are an important approach to NEP service delivery, these
locations often have usage barriers such as accessibility to public transportation, lack of
client parking and fear of punitive action as identified by the current research. Varied
models of needle exchange program delivery are designed to increase utilization and
improve access for persons who inject drugs (Strike, Challacombe, Myers & Millson,
2002). Sixty (60%) of respondents reported they offer mobile unit services. When
service data was examined by respondent characteristics, health department staff
endorsed the need to offer mobile unit services. This was also confirmed throughout the
qualitative data. The findings are consistent with the NEP research literature and
indicates respondents understand there are accessibility issues that may be overcome
through the use of mobile units. Research on mobile NEP usage has been examined by
gender in conjunction with offering additional services such as reproductive health
(Moore, et al., 2012).
Services for Females
Since this study contributes to the evidence base regarding facilitators and barriers
to NEP usage by FWIDs specifically, results regarding services of particular relevance to
females are particularly notable. In examination of the descriptive statistics, drug
treatment referrals were the most common service provided which is consistent with the
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mission of a NEP. Human trafficking literature and PrEP for HIV were the services
selected by the largest number of respondents that should be offered.
Service Composite Scores
When differences of composite scores were examined by respondent
characteristics the educational services score showed no statistically significant
differences. The healthcare services score (HSS) revealed rural NEPs in Kentucky with
health department employees have a higher composite score. This finding is reflective of
the study respondents which is comprised of a large portion of health department
employees from rural areas of Kentucky and therefore may not reflect a more generalized
difference in comprehensiveness of services in rural locations. Health department
employees comprise over 62% of the Kentucky respondents. Kentucky respondents from
rural areas comprised three and a half times more of the respondents than respondents
from urban areas. Therefore, it is determined that while there were statistically
significant differences the information has limited relevance given the numbers of
respondents within each respondent characteristic.
The specialized needle exchange program score (SNS) and basic needs score
(BNS) showed non-health department respondents provide more comprehensive
specialized and basic needs services compared to health department respondents. This
may reflect that NEPs which are not affiliated with a health department view the NEP as
a more holistic service compared to a health department affiliated NEP. This does not
mean that NEPs operated by the health department do not view these services as
important but their sites appear to follow the traditional mission of a health department.
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The HSS confirmed this and reflected health department respondents provided a more
comprehensive array of healthcare services such as STI/STD testing and tetanus shots.
Service Delivery Approaches by State
Service delivery approaches varied across states and included fixed and mobile
sites. Other delivery approaches mentioned by two respondents in the qualitative data
included an after-hours drop box and persons delivering supplies on foot with a
backpack. Both methods are consistent with the NEP research literature (Montigny,
Moudon, Leigh & Young, 2010; Herbert, et al., 2008; Riley, et al., 1998). Research
findings will be summarized and disseminated back to the NEP staff from participating
sites. Key data will be provided which may useful to NEP operational decision-making.

Needle Exchange Program Policies by State
In order to examine state policy, the the needle exchange program best practice
components developed by Burris (2017) and the Center for Disease Control (2017,
September) to eliminate barriers to NEP access were used. It is notable that policies in the
studied states are inconsistent with several of these best practice recommendations. All
states included in the study have drug paraphernalia laws which include syringes and
have been a source of confusion when applied to needle exchange programs. Two states
(Missouri and West Virginia) do not allow exceptions to drug paraphernalia laws for
disease prevention and allow the purchase of syringes through sites that are not affiliated
with a pharmacy. Both states made the news this year with substantial legal changes
related to NEPs. In May 2021, a Missouri bill legalizing NEP operation was passed, and
therefore the law related to syringe exception for disease prevention may be revised as a
result (Associated Press, 2021). In April 2021, West Virginia enacted a law that required
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NEP clients to show photo identification to access services, labeled syringes are linked to
clients and only a one-for-one exchange is permitted (Associated Press, 2021). Within
the qualitative data, a respondent provided feedback on current NEP policy and stated
“No ID . . . don’t need an ID to vote, but need an ID to get supplies that may save a life.
Absurd.”. Based on the tightening of the laws in West Virginia surrounding NEPs, it
could be assumed that the syringe exception for disease prevention will not be revised
and the syringe purchasing laws may also change. The West Virginia law restricts access
to NEPs and clean syringes and is contradictory to suggested best practices.
Policies that Promote or Hinder Needle Exchange Program Use
Needle exchange program usage is encouraged through current laws which allow
for syringes to be excluded from the definition of drug paraphernalia for disease
prevention and NEP use. Persons who inject drugs can utilize the NEP to obtain sterile
syringes hopefully without fear of legal prosecution. Syringe prescription laws also
promote NEP usage given syringes are available for purchase without a prescription.
FWID may not have the money to purchase syringes and use the NEP where they can be
obtained at no cost.
The majority of policies reviewed as part of this study hinder NEP utilization,
such as the sale of syringes, are regulated by state law in all of the studied states. Many
identified barriers in this study support those noted in previous research including: (a)
confusion surrounding the drug paraphernalia laws; (b) one-to-one exchange; and (3)
NEP operational days and times, all of which are consistent with prior research
(Fernandez-Vina, et al., 2020; Mgbere, et al., 2015; State ex Rel Atlantic County, 2005;
Beletsky, Macalino & Burris, 2005; Davis, et al., 2005; Kerr, et al., 2005; Bluthenthal, et
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al., 2004; Doe, 2001; Heimer, et al., 1998; Spokane County, 1992). Newly identified
barriers include the availability of a parking space and the availability of supplies
The policy analysis found mandatory drug testing, restrictive treatment and
eligibility policies related to social services may also impact NEP use as well as
healthcare service utilization more broadly. It is important to note there are consequences
for children related to the nutritional assistance program and TANF policies if a FWID
has had a drug conviction. Longitudinal research should be conducted on policies related
to FWID with a drug charge and the consequences on her children.

Limitations of the Research
There are limitations to this study that must be acknowledged. Purposive
sampling was employed which is often susceptible to researcher bias and generalizability
may be limited (Etikan, Musa & Alkassim, 2016). Individual state policies vary on drug
laws and NEPs which may impact results related to perceptions of facilitators and
barriers to NEP use. Additionally, the states included in the research are at the height of
the opioid epidemic and this may also impact current policy (NIDA, 2020). The barriers,
facilitators and services identified by this sample may not be representative of the overall
population of needle exchange program staff across the United States.
It is also important to acknowledge that this study is based on the opinions of
treatment providers and not female clients of the NEP. While the perceptions of staff are
relevant, future research should focus on FWID and their lived experience to better
understand the facilitators and barriers to NEP utilization. In order to truly understand
what may facilitate or hinder NEP usage by FWID, they, themselves, are the ultimate
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source of information, despite difficulties gaining access to this population. The extent to
which perceptions of service providers may differ from those of FWID is unknown.
During the development of this study, it was determined there was not a validated
survey instrument available for use, and therefore one had to be created. A review of the
survey results indicated several revisions should be made to the instrument which
include: (a) definitions should have been provided with the phrasing of the categories in
the services section because skip patterns can be difficult in paper surveys and result in
high error rates (Dillman, Smyth & Christian 2014); (b) the visual design elements of
both the web and paper survey need to be improved due to the impact of how respondents
process questions (Dillman, Smyth & Christian 2014); (c) identical variables were used
in both the examination of barriers and facilitators, which resulted in some redundancy as
they can be interpreted as two sides of the same coin; (d) self-administered survey
measurement differences may have been impacted by the primacy and recency of the
response options given the length of the variable lists respondents were asked to provide
feedback on (Dillman, Smyth & Christian 2014); and (e) the survey lends itself to
potential respondent fatigue in which the quality of the data provided may have been
impacted and may require a decrease in the amount of information being collected
(Revilla & Ochoa, 2017 B2B International, n.d. Bogen, n.d.). These instrumentation
issues may have influenced study results to some degree.
Another limitation of a self-administered survey is that there is a possibility that
the intended respondent did not personally complete the survey or may have had
assistance with its completion (Coughlan, Cronin & Ryan, 2008). This can further
impact the sampling error and the “representativeness of the sample” which is already
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viewed as problematic when using a convenience sample (Coughlan, Cronin & Ryan,
2008, p. 2; Kelley, Clark, Brown and Sitzia, 2003).
The qualitative data should be viewed with caution. Rather than providing
additional information not included in the survey instrument, many used the open-ended
questions to discuss some of these existing items. Because of this, there was an inability
to gather more robust qualitative data on factors that may impact utilization not already
present in the literature. However, some of the qualitative data lent further support to the
quantitative results.
A more extensive piloting of the survey could have resulted in decreased
measurement error, identification of unnecessary questions and detection of issues with
item comprehension as mentioned above. The pilot could have also included potential
respondents in addition to experts in the field (Ruel, Wagner & Gillespie, 2016).
Additionally, during this process an individual debriefing with each respondent to solicit
additional feedback on the survey may have been useful in preventing instrumentation
limitations (Ruel, Wagner & Gillespie, 2016).
An example of differences related to respondent interpretation was found in the
services section of the survey. Respondents indicated if a service listed was offered, not
offered or should be offered. Directions asked that if respondents indicated a service was
not offered and believed it should be offered to select should be offered. Some of those
that selected they offered the service as well as those that stated the service was not
offered responded the service should be offered. Measurement of whether services were
offered should have been separated from measurement of perception of what services
should be offered for clarity purposes and ease on the respondent.
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While surveys were received from all states included in the study except Virginia,
the survey response rate was still over 50%. It is not known why no surveys were
submitted by staff from Virginia NEP sites. Providing a token of appreciation with each
survey request may have yielded a higher response rate but was not feasible due to
limited fiscal resources (Dillman, Smyth & Christian 2014). Despite these limitations,
this study does contribute to the literature on NEPs, particularly as relates to usage by
FWID.
Implications for Practice, Policy and Research
Practice
NEPs may provide a comprehensive, integrative approach to prevent the harms
associated with injection drug use (Gibson, et al., 2011; Blome, et al., 2011; MacNeil &
Pauly, 2010; Azim, et al., 2008; Wood, et al., 2007; MacDonald, et al., 2003; Rabound, et
al., 2003, Belanger, et al., 2002). They are also a key form of outreach to a population
that is difficult to reach due to stigma and fear of law enforcement (Brown, et al., 2016;
Philbin & FuJie, 2014; Roberts, et al., 2010; Beletsky, et al., 2010; Klein, 2007; Treloar
& Cao, 2005). NEPs have the ability to make a positive impact on the life of FWID
(Islam, et al., 2013; Moore, et al., 2012; Riley, et al., 2002; Miller, et al., 2001; Hay &
McKenganey, 2001; Brienza, et al., 2000; Brahmbhatt, Bigg & Strathdee, 2000). The
study results paint a picture of what a NEP could do to increase utilization by FWID, a
previously understudied population. Qualitative results suggest that targeted outreach to
females needs to be conducted which should include the development of collaborative
partnerships with community organizations and law enforcement. Regular outreach
should be conducted at shelters, areas with high sex work and drug use statistics. These
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types of initiatives have the ability to increase NEP utilization by all persons who inject
drugs.
This study, unlike most existing NEP literature, was focused on FWID. When
respondents were asked about offering female only services, a mixed response was
received. It may be that NEP staff do not believe it is needed but FWID would like to see
this service available. Further research with FWID is needed on this topic.
Certainly some of the results may not be unique to female clients. Research
results which could be applied across all NEPs include offering mobile unit services,
placing NEP sites close to or on public transportation routes and offering NEP client
parking. Community support and positive law enforcement involvement could improve
utilization. This will require extensive time and relationship building but can empower
FWID and decrease stigma. Law enforcement agencies need to be educated on the
positive outcomes NEPs produce and the impact their relationship has on NEP utilization.
NEP staff should make clients feel welcome, be knowledgeable regarding services
offered and reflect the gender and race/ethnicity of NEP clients. Mechanisms should be
developed to decrease NEP staff turnover. There should also be consistent availability of
quality supplies including male condoms. Childcare or a monitored child waiting area
should be available for persons who inject drugs when using the NEP. Clients should not
be fearful of children being removed from their custody or legal consequences for NEP
use. The findings confirm prior research and should be considered by programs.

Policy
Policies that promote or hinder NEP use were discussed earlier in this chapter,
including drug paraphernalia laws and the one-to-one exchange rule. It should be
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acknowledged that all states included in the research had several of the recommended
NEP components that were not followed. For example, state policies regarding the
purchasing of syringes from pharmacies and whether a prescription is required were not
consistent with practices and policies recommended by the CDC (2017, September) and
others (Burris, 2017). These best practice components should be considered in order for
states to maximize the positive outcomes NEPs may yield.
The policy analysis highlighted concerns associated with the criminalization of
drug use during pregnancy. This policy nearly doubled across the United States between
2000 and 2015 (Faherty, et al., 2019). Policy makers hoped this policy would protect the
neonate, discourage females from using drugs and encourage them to seek treatment. A
recent study examining states that criminalize drug use during pregnancy found there
were higher odds of neonatal abstinence syndrome (NAS) (Faherty, et al., 2019). The
policy has been shown to deter females who use drugs from seeking medical care if they
are of reproductive age, pregnant or recently had a child (Gressler, Shah & Shaya, 2019;
Patrick & Schiff, 2017; Angelotta, C., Weiss, Angelotta, J. & Friedman, 2016; Krans &
Patrick, 2016; Roberts & Pies, 2011).
Criminalization of drug use during pregnancy may detract from NEP usage
because the FWID may fear being reported. Pregnant females who use drugs should be
encouraged to use a NEP and staff need to educate clients on their role and the role of the
NEP. A NEP client Bill of Rights may be beneficial to promote awareness and
emphasize that an NEP is a safe place for FWID.
NEP staff can be a conduit to promote prenatal care so both mother and child
have the opportunity for better health outcomes (Moore, et al., 2012). Prenatal services
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may be a gateway into treatment. The female should be referred to a family friendly
residential drug treatment program that specializes in NAS. While these services would
be costly, it may not be as costly as continuing to incarcerate females who use drugs
while pregnant and placing their children in foster care.
Three states (Indiana, Kentucky and West Virginia) require local approval of a
NEP to operate. This can be problematic for areas that have a high infectious disease rate
due to injection drug use and do not have the community support for a harm reduction
program. This gives the local population enormous power related to an issue that can
impact lives outside their area. In Indiana, a NEP is allowed to operate for two years and
can be renewed or terminated by the local government (Associate Press, 2021). In June,
2021 Scott County, Indiana commissioners voted to close the NEP at the end of the year,
which curtailed the largest HIV outbreak caused by injection drugs in U.S. history
(Bruce, 2021). Local approval may negatively influence availability of this service due
to the lack of information and bias, when research has demonstrated NEPs are effective
(Nguyen, et al., 2014; Knittel, Wren & Gore, 2010; Holtzman, et al., 2009; Hue, et al.,
2006; MacDonald, et al., 2003; Laufer, et al., 2001; Hagan & Thiede, 2000; Hagan, et al.,
2000). If there is a validated need which can impact the health and safety of the
population, states should have the ability to implement a NEP. The Scott County NEP
closure is an example of a community that has been positively impacted by this service
and two county commissioners were given the ability to impact an unprecedented number
of lives (Cafardi & Feinberg, 2021; Gonsalves & Crawford, 2018; Janowicz, 2016). The
current study contributes an array of information that could inform revision of individual
state policies regarding NEP structures and practices.
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Research
While surveying the NEP providers yielded worthwhile data, additional research
on barriers and facilitators to NEP usage needs to be conducted with FWID. Further
studies should include FWID that have not used a NEP to understand barriers to
participation and service needs.
Additional research should examine barriers, facilitators and services based on
NEP location (urban and rural) since each present different challenges as suggested in the
current study, but it is unclear the extent to which these data were skewed by the rural
nature of the sample. Further research into urban/rural differences in factors associated
with utilization will allow for the modification of services which can assist in decreasing
the spread of infectious diseases within a hard to reach population. Research has shown
drug treatment services should be designed to address the needs of females (Jemal, Gunn
& Inyang, 2020; Grace, 2017; Covington, Burke, Keaton & Norcott, 2011). NEP
services also need to be designed to meet the needs of females who inject drugs.
Future research should also explore strategies for offering basic medical services
at NEPs not affiliated with a health department. Several medical services such as
STI/STD testing and vaccinations/immunizations were found to be services that
respondents believed should be offered. This could yield an opportunity to create several
types of collaborative models and evaluate their effectiveness.
The relationship between specific factors associated with accessibility to NEPs
and health outcomes needs further study. Research on accessibility barriers should be of
utmost importance given the impact it has on NEP utilization. For example, research
should examine NEP utilization based on location and proximity to public transportation.
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Additionally, parking at NEP sites warrants further exploration based on the current
research findings. As previously mentioned, this has been examined in the use of
healthcare services and yielded fruitful recommendations (Shaheen, et al., 2020;
McGrath, 2015; Kale, 2012).
NEP outreach campaigns toward FWID need to be assessed to determine if they
increase utilization. Effective and ineffective messaging and recruitment strategies
deserve study. Data should be collected from both NEP participants and non-participants
in order to inform the field on factors associated with program usage decisions.
Outcomes research on NEPs and FWID should assess the relative impact of
facilitators, barriers, and services and their relationship to service needs and utilization,
frequency of NEP use and NEP program satisfaction. For example, a randomized study
could be conducted to examine outcomes associated with one-to-one versus unlimited
exchange policies. This would allow for examination of differences in the number of
syringes distributed, types of drugs used, syringe sharing practices and health status.
Based on the policy analysis, research on pregnant FWID should be conducted to
examine the impact these policies have had on the clients, as well as the criminal justice
and healthcare systems. Characteristics of this population need to be further explored to
examine their service needs and barriers and facilitators to NEP use. Pre-pregnancy,
during pregnancy and post pregnancy NEP usage, injection/sharing practices and health
status should also be examined.
Conclusion
Findings from this study indicate there are multiple barriers to and facilitators of
NEP utilization for FWID. Identified environmental and policy factors viewed through
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feminist intersectionality theory reflect a highly punitive and repressive environment
toward FWID. The failed “war on drugs” has shown drug use should be viewed through
a public health lens of treatment and prevention that acknowledges the value of these
outcomes for FWID, their families and the community (The Lancet, 2001). Efforts to
provide needed services and address current issues will require NEP staff, community
partners, politicians and law enforcement to work collaboratively to create viable
solutions, if decreasing infectious diseases and creating better health outcomes for FWID
is of importance. This will no doubt be an arduous task but can be an impactful practice
which will yield a plethora of positive outcomes for both the FWID and her community.
There is a continued need for research on FWID, NEPs and drug policy if we want to
implement gender responsive harm reduction programs. Increasing the number of NEPs
across the United States and connecting FWID to this service is essential if we are going
to decrease the infectious disease rates within this population.
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This study was also approved through 45 CFR 46.116 (C), which means that an
IRB may waive the requirement for the investigator to obtain a signed informed
consent form for some or all subjects.
The following items have been approved:
Submission Components
Form Name
Submit for Initial Review
Review Response Submission
Form
IRB Study Application

Version
Version 1.1
Version 1.0

Outcome
Approved as Submitted
Approved as Submitted

Version 1.2

Approved as Submitted
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Study Document
Title
Thank you reminder postcard clean copy
Follow-up reminder and thank you letter clean copy
Survey Cover Letter Clean Copy
Survey Prenotice Clean Copy
Revised Research Protocol Clean Copy
NEP mailing list
NEP Survey
Preamble Consent clean copy
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Version #
Version 1.0
Version 1.0
Version 1.0
Version 1.0
Version 1.0
Version 1.0
Version 1.0
Version 1.0

Version Date
02/18/2021
02/18/2021
02/18/2021
02/18/2021
02/18/2021
02/08/2021
02/07/2021
02/18/2021

Outcome
Approved
Approved
Approved
Approved
Approved
Approved
Approved
Approved

IRB policy requires that investigators use the IRB “stamped” approved version of informed
consents, assents, and other materials given to research participants. For instructions on
locating the IRB stamped documents in iRIS visit:
https://louisville.edu/research/humansubjects/iRISSubmissionManual.pdf
Your study does not require annual continuing review. Your study has been set with a three
year expiration date. If your study is still ongoing you will receive iRIS automated reminders to
submit a request to continue your study prior to the expiration date above.
All other IRB requirements are still applicable. You are still required to submit amendments,
personnel changes, deviations, etc… to the IRB for review. Please submit a closure amendment
to close out your study with the IRB if it ends prior to the three year expiration date.
Human Subjects & HIPAA Research training are required for all study personnel. It is the
responsibility of the investigator to ensure that all study personnel maintain current Human
Subjects & HIPAA Research training while the study is ongoing.
Site Approval
Permission from the institution or organization where this research will be conducted must be
obtained before the research can begin. For example, site approval is required for research
conducted in UofL Hospital/UofL Health, Norton Healthcare, and Jefferson County Public
Schools, etc...
Privacy & Encryption Statement
The University of Louisville's Privacy and Encryption Policy requires identifiable medical and
health records; credit card, bank account and other personal financial information; social
security numbers; proprietary research data; and dates of birth (when combined with name,
address and/or phone numbers) to be encrypted. For additional information:
http://louisville.edu/security/policies.
Implementation of Changes to Previously Approved Research
Prior to the implementation of any changes in the approved research, the investigator must
submit modifications to the IRB and await approval before implementing the changes, unless
the change is being made to ensure the safety and welfare of the subjects enrolled in the
research. If such occurs, a Protocol Deviation/Violation should be submitted within five days
of the occurrence indicating what safety measures were taken, along with an amendment to
revise the protocol.
Unanticipated Problems Involving Risks to Subjects or Others (UPIRTSOs)
A UPIRTSO is any incident, experience, or outcome, which has been associated with an
unexpected event(s), related or possibly related to participation in the research, and
suggests that the research places subjects or others at a greater risk of harm than was
previously known or suspected. The investigator is responsible for reporting UPIRTSOs to
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the IRB within 5 working days. Use the UPIRTSO form located within the iRIS system. Event
reporting requirements can be found at:
http://louisville.edu/research/humansubjects/lifecycle/event-reporting.
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Payments to Subjects
In compliance with University policies and Internal Revenue Service code, payments to
research subjects from University of Louisville funds, must be reported to the University
Controller's Office. For additional information, please call 852-8237 or email
controll@louisville.edu. For additional information:
http://louisville.edu/research/humansubjects/policies/PayingHumanSubjectsPolicy201412.pd
f
The committee will be advised of this action at a regularly scheduled meeting.
If you have any questions, please contact: Jackie Powell 852-4101 jspowe01@louisville.edu

Peter M. Quesada, Ph.D., Chair
Social/Behavioral/Educational Institutional Review
Board PMQ/jsp
We value your feedback; let us know how we are doing:
https://www.surveymonkey.com/r/CCLHXRP
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Survey Pre-notice
Date
Dear Needle Exchange Program Director,
I am writing to ask for your assistance with my dissertation research project. In a couple
of weeks, your NEP will receive a large envelope of surveys. There will be a cover letter
and survey for each staff member that works at your needle exchange program (NEP) as
well as a postage paid, return addressed envelope. The packet of information will also
provide information regarding completing the survey electronically. If you could notify
your staff a survey is forthcoming, this would be extremely beneficial. I know you and
your staff are extremely busy and the survey should take approximately 15 - 20 minutes
to complete.
The purpose of the research is to explore the perspectives of service providers on
facilitators and barriers to needle exchange program participation by females who inject
drugs. I am contacting NEP personnel in Kentucky, Indiana, Missouri, Tennessee, Ohio,
West Virginia and Illinois. These states were selected because they are suffering from
the brunt of the opioid epidemic and the consequences of injection drug use. There is
limited research on females who inject drugs and needle exchange programs and this
study will assist in filling an important gap in the literature and may directly benefit your
community.
The survey is confidential and can be completed in hard copy format or electronically via
a web link that will be provided. The researchers will make no attempt to link any staff
person’s individual answers to your NEP. All information will be presented in aggregate
format. The participation of your staff is voluntary and if they come to a question they
prefer not to answer, they are welcome to skip it and go to the next question. Should you
have any questions or comments, please contact me at tammi.thomas@louisville.edu or
Dr. Crystal Collins-Camargo, dissertation committee chair at
crystal.collinscamargo@louisville.edu
I look forward to your feedback and appreciate your assistance with my dissertation.
Many thanks,
Tammi Alvey Thomas, MSSW
Doctoral Student
Kent School of Social Work
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Survey Cover Letter
Date
Dear Needle Exchange Program Staff Member,
I am writing to ask for your assistance with my dissertation research project. The purpose
of the research is to explore the perspectives of service providers on facilitators and
barriers to needle exchange program participation by females who inject drugs. I am
contacting NEP personnel in Kentucky, Indiana, Missouri, Tennessee, Ohio, West
Virginia and Illinois. These states were selected because they are suffering from the
brunt of the opioid epidemic and the consequences of injection drug use. There is limited
research on females who inject drugs and needle exchange programs and this study will
assist in filling an important gap and may directly benefit your community.
The survey should take approximately 15-20 minutes to complete. A postage-paid return
addressed envelope has been provided for your ease and convenience. You can also
complete the survey electronically at: (insert survey link).
The survey is confidential and can be completed in hard copy format or electronically.
The researchers will make no attempt to link your individual answers to your NEP. All
information will be presented in aggregate format. Your participation is voluntary and if
you come to any question you prefer not to answer, you are welcomed to skip it and go to
the next. Should you have any questions or comments, please contact me at
tammi.thomas@louisville.edu or Dr. Crystal Collins-Camargo, dissertation committee
chair at crystal.collinscamargo@louisville.edu
I know you are extremely busy and I appreciate your assistance with my dissertation.
Many thanks,

Tammi Alvey Thomas, MSSW
Doctoral Student
Kent School of Social Work
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EXPLORING SERVICE PROVIDER PERSPECTIVES ON FACILITATORS
AND BARRIERS TO NEEDLE EXCHANGE PROGRAM PARTICIPATION
BY FEMALES WHO INJECT DRUGS
Date
Dear NEP staff member,
You are being invited to participate in a research study by answering questions in the
attached survey or electronically about facilitators and barriers to needle exchange program
participation by females who inject drugs. This study is conducted by Dr. Crystal CollinsCamargo and Tammi Alvey Thomas, a doctoral student of the University of Louisville.
There are no known risks for your participation in this research study. The information
collected may not benefit you directly. The information learned in this study may be
helpful to others. The information you provide will assist in explaining facilitators and
barriers to needle exchange programs of female injection drug users. Your completed
survey will be stored at the University of Louisville, School of Public Health and
Information Sciences in a locked filing cabinet. The survey will take approximately 15 –
20 minutes time to complete.
Individuals from the Kent School of Social Work, the Institutional Review Board (IRB),
the Human Subjects Protection Program Office (HSPPO), and other regulatory agencies
may inspect these records. In all other respects, however, the data will be held in
confidence to the extent permitted by law. Should the data be published, your identity will
not be disclosed.
Taking part in this study is voluntary. By answering survey questions you agree to take
part in this research study. You do not have to answer any questions that make you
uncomfortable. You may choose not to take part at all. If you decide to be in this study you
may stop taking part at any time. If you decide not to be in this study or if you stop taking
part at any time, you will not lose any benefits for which you may qualify. Your individual
answers will not be linked to your NEP. All information will be presented in aggregate
format.
You will have the opportunity to register for a $25 Walmart gift card drawing. The entry
form will be at the end of the survey. If your return a hard copy survey, upon receipt of
your survey, the gift card entry form will be removed from the survey and stored in a
different file. This will provide confidentiality safeguarding of your data. If you complete
a survey electronically, at the end of the survey you will be directed to a new web link to
register for the drawing to prevent the data from being linked to you.
If you have any questions, concerns, or complaints about the research study, please contact:
Dr. Crystal Collins-Camargo at 502-599-4661 or Tammi Alvey Thomas at 502-262-7210.
If you have any questions about your rights as a research subject, you may call the
Human Subjects Protection Program Office at (502) 852-5188. You can discuss any
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questions about your rights as a research subject, in private, with a member of the
Institutional Review Board (IRB). You may also call this number if you have other
questions about the research, and you cannot reach the research staff, or want to talk to
someone else. The IRB is an independent committee made up of people from the
University community, staff of the institutions, as well as people from the community not
connected with these institutions. The IRB has reviewed this research study.
If you have concerns or complaints about the research or research staff and you do not
wish to give your name, you may call 1-877-852-1167. This is a 24 hour hot line
answered by people who do not work at the University of Louisville.
Sincerely,

Crystal Collins-Camargo, MSW, PhD
Tammi
Alvey
Thomas,
MSSW
Associate Dean for Research and Professor
Doctoral Student
Kent School of Social Work
School of Public Health
University of Louisville
University of Louisville
109 Oppenheimer Hall
485 E. Gray Street
Louisville, KY 40292
Louisville, KY 40202
502-599-4661
502-262-7210
crystal.collinscamargo@louisville.edu
tammi.thomas@louisville.edu
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University of Louisville
Kent School of Social Work
Needle Exchange Program Provider Perception Survey
Research Objective: To explore service provider perspectives on facilitators and
barriers to needle exchange program participation by females who inject drugs.
SECTION A: DEMOGRAPHIC INFORMATION
INSTRUCTIONS: As the survey respondent, please provide your information below.
Only respond once to the survey via mail or electronically.
Date: ______________
Gender:

Race:

Ethnicity:

Age: ____________

 Male
 Female
 Prefer not to say

 Prefer to self-describe:
___________________

 Asian
 Black or African
American
 American Indian/Alaskan
Native

 White
 Native Hawaiian or
Pacific Islander
 2 or more races
 Other: _______________

 Hispanic or Latino
 Not Hispanic or Latino

Zip code of the NEP you are completing the survey for: __________
The NEP organizational type is:
 Part of City/County Social Services (includes health departments)
 Part of substance abuse treatment facility
 Part of a hospital
 Other: ____________________
What is your role at the NEP?
 Health department employee nursing staff
 Health department other employee - Role: ___________
 Volunteer
 Social worker
 Physician
 Peer mentor
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 Other agency employee – Agency: _____________ Position:
____________
 Other agency employee – Agency: _____________ Position:
____________
Which type of NEP do you offer?
 Fixed location
 Mobile
 Both fixed and mobile
location
 Other:
____________________
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In a typical week at the NEP, do you see more male or female clients? Male

Female

In an average month, what is the percentage of your clients that identify as female?
________
SECTION B: BARRIERS TO USAGE
INSTRUCTIONS: In your opinion, indicate ( or X in the box) the extent to which you
believe the item listed below is a barrier for females who inject drugs (FWID) in using
the Needle Exchange Program (NEP) in your community. Mark only 1 response.
Item

Major
barrier

Minor
barrier

Organizational Factors
Staff are community members
Staff are persons who
previously injected drugs
Staff interaction with clients
Number of NEP staff
Gender of staff
Age of staff
Race/ethnicity of staff
Staff turnover
Staff knowledge about FWID
and exchange sex for drugs
Staff knowledge of sexual
abuse/trauma/domestic violence
females may have experienced
Days and times NEP are open
Location of NEP
Availability of a parking space
Client confidentiality
Accessibility of public
transportation
NEP mobile unit services
Wait times to be seen
Level of community support for
a harm reduction program
Availability of supplies
Quality of supplies
NEP staff knowledge regarding
services provided
Medical services provided
Number of visits for medical
tests/treatment
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Not a
barrier

Not
applicable

Item

Major
barrier

Minor
barrier

Not a
barrier

Not
applicable

Health communication
campaigns reflect
community/cultural norms
Health communication
campaigns reflect
susceptibility/vulnerability of
health complications related to
injection drug use
Practice Factors
Availability of childcare
Specified days and times for
females
Private areas for females
Availability of male condoms
Availability of female condoms
Prenatal services provided
Clients concern of punitive
action (reporting to CPS, CJ
system, etc.) for NEP use
Policy Factors
NEP registration of clients
Number of supplies females can
receive weekly
Law enforcement involvement
List any other barriers you believe are important for us to be aware of.

SECTION C: FACILITATORS TO USAGE
INSTRUCTIONS: In your opinion, indicate ( or X in the box) the extent to which you
believe the item listed below is a facilitator for females who inject drugs (FWID) in using
the Needle Exchange Program (NEP) in your community. Mark only 1 response.
Item

Major
facilitator

Organizational Factors
Staff are community members
Staff are persons who
previously injected drugs
Staff interaction with clients
Number of NEP staff
Gender of staff
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Minor
facilitator

Not a
facilitator

Not
applicable

Item

Major
facilitator

Age of staff
Race/ethnicity of staff
Staff turnover
Staff knowledge about FWID
and exchange sex for drugs
Staff knowledge of sexual
abuse/trauma/domestic violence
female may have experienced
Days and times NEP are open
Location of NEP
Availability of a parking space
Client confidentiality
Accessibility of public
transportation
NEP mobile unit services
Wait times to be seen
Level of community support for
a harm reduction program
Availability of supplies
Quality of supplies
NEP staff knowledge regarding
services provided
Medical services provided
Number of visits for medical
tests/treatment
Health communication
campaigns reflect
community/cultural norms
Health communication
campaigns reflect
susceptibility/vulnerability of
health complications related to
injection drug use
Practice Factors
Availability of childcare
Specified days and times for
females
Private areas for females
Availability of male condoms
Availability of female
condoms/internal condoms
Prenatal services provided
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Minor
facilitator

Not a
facilitator

Not
applicable

Item

Major
facilitator

Minor
facilitator

Not a
facilitator

Not
applicable

Clients concern of punitive
action (reporting to CPS, CJ
system, etc.) for NEP use
Policy Factors
NEP registration of clients
Number of supplies persons can
receive weekly
Law enforcement involvement
List any other facilitators you believe are important for us to be aware of.

SECTION D: SERVICES
INSTRUCTIONS: Below is a list of services that may be offered through your NEP.
Please indicate ( or X in the box) if the service is offered or not offered at your NEP. If
a service is not offered, indicate ( or X in the box) if you believe it should be offered at
your NEP.

Service

Offered

HIV testing
Hepatitis testing
Specified days and times for females only
Flu shot
Pre-exposure prophylaxis (PrEP) for HIV
STI/STD testing
Tetanus shot
Other vaccinations/immunizations
NARCAN
Drug treatment referrals
Mental health counseling referrals
Medication assisted treatment referrals
Mobile NEP services
Female condoms/internal condoms
Male condoms
Other birth control options
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Not
Offered

Should
be
Offered
(only if
not
offered
selected)

Service

Offered

Not
Offered

Should
be
Offered
(only if
not
offered
selected)

Feminine hygiene products
OBGYN services
Dental services
Vision services
Self-help classes
Pediatric health services
Wound care supplies
Childcare for NEP visit only
Parenting classes
Housing assistance
Employment services
Clothing services
Food bank
Human trafficking literature
Domestic violence literature
Sexual abuse literature
HIV literature
STI/STD literature
Ability to apply for state health insurance
Ability to apply for a birth certificate
Ability to apply for a state ID card/driver’s license
List any services you offer that are not mentioned above.

SECTION E: OPEN ENDED QUESTIONS
1. Has there been any targeted recruitment/outreach initiatives conducted toward
FWID?
No
Yes. If yes, please explain below.

2. How do you encourage females who inject drugs to continue to use the NEP?

3. If outreach to females who inject drugs has been conducted, how could it be
improved?
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4. Do you believe there are advantages of offering females-only services? No
Yes
If yes, what do you believe are the advantages?

5. If you could change one NEP policy at your site what would it be? Why?

6. Please feel free to share any additional comments.

Thank you for your time. Your responses are greatly appreciated!
Tammi Alvey Thomas, MSSW
485 E. Gray Street
Louisville, KY 40202
Phone: 502-262-7210
Email: tammi.thomas@louisville.edu
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If you would like to be entered into a $25 dollar Walmart gift card drawing, please
complete the information below. For confidentiality purposes, this information will be
separated from your survey responses.
Gift Card Drawing Entry
Name:
Mailing Address:
Email:
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Follow-up Reminder Notice
Date
Dear Needle Exchange Program Staff Member,
About three weeks ago, I sent you a request to participate in research by answering
survey items asking for your opinion on the facilitators and barriers to needle exchange
program participation by females who inject drugs. I do not know if you have completed
the survey but would appreciate it if you do. Many states across the country are battling
the opioid epidemic and the harmful effects of an increase in injection drug use. My
hope is that this study will provide needle exchange staff with information that can be
used to increase participation of females who inject drugs in NEP services.
I am writing again because of the importance that your responses have for helping to get
the best results. It is only by hearing from nearly everyone in the sample that I can
accurately depict the facilitators and barriers females who inject drugs have accessing
NEPs. Thus, I hope you will complete the survey soon.
Simply complete the previously mailed survey and return it in the postage paid return
addressed envelope provided or you can complete the survey electronically at: (insert
survey link). Your responses are voluntary and will be kept confidential. If you have any
questions about this survey please contact me at tammi.thomas@louisville.edu or 502852-3289.
Thank you so much for assisting me with my dissertation research project.
With sincere gratitude,

Tammi Alvey Thomas, MSSW
Doctoral Student
Kent School of Social Work
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Thank you reminder postcard
FRONT of a 5 ¾ in. x 11 in. postcard
Reminder
Please help me complete my dissertation research by completing the NEP survey.
BACK OF POSTCARD

Dear Needle Exchange Program Staff Member,
Last week, I mailed you a request to participate in research by answering survey items
asking for your feedback on the facilitators and barriers to needle exchange program
participation by females who inject drugs.
If you have already completed the questionnaire, please accept my sincere thanks. If not,
please take the time to complete the survey as soon as possible. The survey can also be
completed online at: https://www.surveymonkey.com/r/259DMZQ. I am very grateful
for your assistance with this important study.
If you do not have a survey, or if you have any questions, please feel free to contact me at
tammi.thomas@louisville.edu or 502-852-3289.
Thank you for your feedback!

Tammi Alvey Thomas, MSSW
Doctoral Student
Kent School of Social Work
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